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1.1. Problem statement 
To counter donor shortage when organ transplantation is required and to tackle 
commonly observed problems associated with prosthetic devices and transplanted 
organs (mismatch in mechanical properties or dimensions, infections, organ 
rejection)2–4, tissue engineering has emerged in the biomedical field over the last four 
decades.5 In tissue engineering, the aim is to develop biological substitutes to restore, 
maintain or improve tissue function.3 In this field, hydrogels are of great interest, as 
their properties (soft, elastic behaviour, network structure and high water content) are 
quite similar to those of the extracellular matrix. 6–9 
However, hydrogels are difficult to process into complex, well-defined shapes.8 To 
maintain their shape under in vitro and in vivo conditions (pH changes, mechanical 
effects, enzymatic degradation, calcification, adsorption, …)10 hydrogels require 
chemical or physical crosslinking through for example photo-initiated free radical 
polymerization (chemical crosslinking)11 or ionic bonds (physical crosslinking)12,13. 
Using the former approach, typically a photo-initiator generates radicals upon 
irradiation. These radicals initate the polymerization of reactive groups, such as 
acrylates or methacrylates resulting in network formation. These  tunable crosslinked 
polymer networks can be created in a reproducible fashion, while maintaining temporal 
and spatial control over the reaction.11  
One major drawback is that free radical polymerization relies on the mobility of the 
reactive groups and currently needs to be performed in solution or in the molten state. 
Therefore, the crosslinking method is generally incompatible with processing 
techniques which result in solid structures after processing including electrospinning 
and fused deposition modelling: the reactive groups in the processed structures 
posses insufficient mobility to allow for significant functional group conversion.14,15 This 
makes hydrogels difficult to process into well-defined shapes, which is often highly 
important for their final application.1,8,16 
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1.2. Hydrogels in tissue engineering 
1.2.1. Concept of tissue engineering 
Over the course of history, mankind always had a desire to prolong life or increase life-
quality.3–5 Consequently, the treatment of large tissue defects and organ failure has 
always been a field of research with increasing interest.17 Currently, the major 
treatment for organ/tissue failure consists of artificial substitutes (e.g. joints), non-living 
processed tissue (e.g. heart valves), or tissue taken from another site from the patients 
themselves or from a donor (transplantation).5,18 However, problems typically arise 
using the latter approaches including scarcity of suitable donor organs (63.620 people 
were on the EU transplant waiting list in 2013)19 and problems associated with intense 
immunosuppressive treatments (more susceptible to infections, increased risk of 
cardiovascular disease and cancer, strong side effects, noncompliance, …)20–22. 
Furthermore, prosthetic devices are often characterized by mismatched mechanics 
combined with wear and tear resulting in mechanical stresses exerted on the 
surrounding tissue and inflammation.23 To tackle these problems, four decades ago 
“tissue engineering” (TE) emerged as an alternative approach in the biomedical field. 
The fundamental goal of tissue engineering has been defined by Langer and Vacanti 
as “An interdisciplinary field that applies the principles from engineering and life 
sciences toward the development of biological substitutes that restore, maintain or 
improve tissue function.”3 It is a highly complex and interdisciplinary field combining 
engineering and life science principles.8 
The extracellular matrix (ECM), which is the native environment of cells, consists of a 
complex mixture of structural and functional proteins and polysaccharides.24 It provides 
support for the cells, and initiates a number of biochemical and biomechanical 
processes.25,26 Of crucial importance in tissue engineering is the creation of 3D culture 
environments which mimic the ECM both in terms of (bio)mechanics as well as 
biological features to grow 3D tissue constructs starting from cells of the targeted 
tissue.27–33 To this end, the cells are combined with so-called “scaffolds”, developed 
from synthetic or natural materials, that should ideally guide cell growth towards the 
envisioned regenerated tissue in terms of architecture and cellular behaviour.34,35 Non-
toxic, often biodegradable building blocks are essential.36 Consequently, healthy cells 
can gradually substitute the scaffold with natural ECM during biosynthesis.36,37 ECM 
generation can be guided by the use of growth factors and/or interactions between the 
Chapter 1: Introduction 
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cells and scaffold material (mechanical properties, chemical composition, 
hydrophilicity, …).38,39 
Two distinct approaches can be distinguished to realize tissue engineering (Figure 1). 
In the first approach, artificial tissue is grown in vitro using cells from donor tissue (cell-
based approach), which can be combined with a support system.40 In the second 
approach, tissue is regenerated in vivo by guiding cell growth and function (cell-free 
approach), using growth factors or relying on the interactions between the cells and 
the biomaterial.41 In both approaches, the scaffold plays a major role in the support 
and cultivation of cells. Using the cell-free method, it is important that the scaffold 
promotes cell migration to the scaffold and supports tissue regeneration to repopulate 
the scaffold by the host cells which are recruited from the surrounding tissue. When 
cells are seeded prior to implantation (i.e. in case of the cell-based method), the 
scaffold needs to be cell-instructive and should promote cell proliferation and 
differentiation when using stem cells. 40 
 
Figure 1: Scheme representing the different steps characteristic for the two approaches commonly 
applied in tissue engineering 
Another way to classify approaches in tissue engineering is the top down approach, 
and the bottom up approach. In the former, a scaffold is used to support cell growth. 
Cells populate this scaffold, and create the extracellular matrix and microarchitecture, 
using growth factors, perfusion and/or mechanical stimulation. In the latter approach, 
no scaffold is used, but the cells are combined with bio-inks to enable tissue growth. 
The aim is to replicate the intricate microstructure of complex tissues, so often a 
modular approach is used where these structures are recreated on a microscale. Using 
a modular approach, the microstructures are combined to build larger complex 
tissues.42 In this work, the scaffold-based top-down approach is used for all in vitro 
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tests. However, when the materials are further developed to allow for cell 
encapsulation, they can also be used in the bottom-up approach. To this end, the 
degradation time of the developed polymers will need to be modified to allow for faster 
degradation times (e.g. using degradable links or spacers). 
When applying in vitro tissue cultivation prior to implantation, an alternative to cell 
seeding exists. Indeed, cells can be incorporated in the scaffold while processing (i.e. 
cell encapsulation: cells are mixed with the hydrogel solution prior to processing). Cells 
can be quite sensitive to the processing conditions; e.g. for a viability of HepG2-cells 
above 40%, the pressure needs to be below 40 psi (2.8 bar) and nozzle diameter above 
150 µm 43. Therefore, the seeding approach can be considered more straightforward 
from a technical point of view, as the absence of cells during processing reduces the 
processing limitations.44–48 In contrast, cell encapsulation is beneficial as it can 
maximize cell content within the scaffold, results in a more homogeneous cell 
distribution (cell seeding can result in a reduced cell density in the center of the 
scaffold), and provides the possibility to encapsulate different cells into different zones 
of the scaffold.40,49–57 This is highly relevant as tissues and organs often consist of 
distinct regions with different cell types.58 To expand the cell population and to enable 
tissue development prior to implantation, a bioreactor is generally used.59,60 The latter 
is a device in which biological and/or biochemical processes are manipulated through 
close control over environmental and operating conditions such as pH, temperature, 
pressure and nutrient and waste flow.60 The use of tissues created by cultivation of 
cells onto scaffolds in vitro is not restricted to tissue regeneration applications, as cell-
seeded scaffolds can also be utilized in other domains of regenerative medicine, such 
as external organ support devices61 or model systems for pathological conditions in 
drug screening62. 
Generally, interconnected porous scaffolds are considered beneficial to facilitate 
diffusion-driven transport of oxygen, nutrients and waste towards and away from the 
cells respectively, as cells must be sufficiently close (100–200 μm) to oxygen and 
nutrient supply.34,56,57,63 Additionally, the presence of an interconnected porous 
network improves the cell seeding and cell migration, resulting in homogenous cellular 
distributions throughout the scaffold compared to non-porous scaffolds, where the cells 
will only reside on the surface. To obtain this beneficial interconnective porosity, 
several techniques can be applied such as particle leaching and supercritical CO2 
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treatment or processing techniques such as solid freeform fabrication (SFF) and 
electrospinning. 33,64,65 
1.2.2. Hydrogel scaffolds for tissue engineering purposes 
Wichterle and Lim66 were the first to report on hydrogels. In their work, they presented 
a hydrophilic gel based on poly(2-hydroxyethyl methacrylate) which could be used for 
biological purposes (e.g. to be applied as soft contact lenses). Ever since, there has 
been an increasing interest in hydrogels for biomedical and pharmaceutical purposes, 
with applications as wound dressings, biomedical coatings, tissue engineering 
constructs, contact lenses and drug delivery systems. 13,67–70  
Hydrogels can be defined as water-swollen, three-dimensional crosslinked networks. 
Depending on their composition, they can absorb up to thousands of times their dry 
weight.8,9 The nature of the crosslinks is quite diverse and ranges from strong chemical 
crosslinks (covalent bonds), to physical links based on chain entanglements, ionic 
bonds, micro-crystalline zones, association bonds (e.g. hydrogen bonds) and van der 
Waals interactions or combinations thereof.12,13 Hydrogels can be classified according 
to the origin of the constituting polymers (synthetic versus natural), their preparation 
method (homo- or copolymer-based hydrogels), their charge, their physical structure 
(amorphous versus semi-crystalline) or their crosslinking mechanism (permanent or 
reversible and chemical or physical). To permanently crosslink a hydrogel, radiation-
induced polymerization (UV or visible light, gamma-rays, electron beam, …) is one of 
the more commonly applied mechanisms, as it offers both spatial and temporal control 
over the crosslinking.11 In the category of reversible hydrogel materials, lower critical 
solution temperature (LCST) and upper critical solution temperature (UCST) behaviour 
can be distinguished. 71,72 Thermo-responsive hydrogels undergo a thermoreversible 
gelation above (cfr. LCST, e.g. Pluronic® F127 (Tgel = ± 20°C))71 or below (UCST, e.g. 
gelatin(Tgel = ± 38°C))72 a characteristic temperature.  
Their characteristic soft, elastic behaviour (Young’s modulus ranging from a few kPa 
to several MPa, and elongations up to 500%)6,7 and high water uptake capacity, up to 
thousands of times their original dry weight8,9, render hydrogels similar to the ECM, 
which explains their popularity to become used as tissue engineering constructs.73–75 
An important aspect when developing TE scaffolds is the required material 
biocompatibility. Two aspects can be distinguished in this respect including the surface 
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and the structural biocompatibility. Surface biocompatibility is associated with the 
chemical and physical characteristics of a material surface and is therefore strongly 
influenced by the material type and/or the application of coatings or other surface 
modification techniques.76 Absorption or adsorption of biological molecules which 
regulate cell activities such as migration and adhesion, is typically also mediated by 
the surface chemistry.77 The structural biocompatibility on the other hand is influenced 
by the scaffold architecture, both on a micro- (nm and µm sized features) as well as on 
macroscopic level (mm and cm sized features) and is obviously influenced by the 
processing method.77  
Furthermore, the scaffold needs to provide structural integrity and define a space for 
the engineered tissue, guiding the restructuring process that occurs through 
proliferation of cells and ingrowth of host tissue.78 Despite the importance of the outer 
scaffold geometry, one of the main disadvantages associated with the use of hydrogels 
is the difficulty to process them into pre-designed geometries.8 Common applications 
of hydrogels include defect-filling scaffolds, soft tissue repair or matrices enabling drug 
and/or cell delivery.79–81 
1.2.3. Polymers in tissue engineering 
The majority of tissue engineering scaffolds is constructed from polymers, either from 
natural or synthetic origin. In addition to polymers, another important material category 
includes ceramics, which are mainly used for bone tissue engineering.77 Often used 
ceramics include hydroxyapatite82, β-tricalcium phosphate83,84 and blends thereof.85,86 
Applying ceramics in solid freeform fabrication is quite challenging.82 Therefore, these 
materials are often processed using indirect rapid prototyping. More information about 
the latter technique as well as the use of ceramic materials can be found in section 
1.3.2. 
The aim of the following paragraphs is to provide an overview of the most important 
material classes used for tissue engineering and biomedical applications, and to 
provide background information on materials mentioned and used throughout the work. 
As an important aspect of tissue engineering consists of the biocompatibility of the 
material, the biocompatibility of the selected materials is further evidenced by providing 
an overview of common biomedical applications of the selected materials, rather than 
solely focusing on their tissue engineering applications.  
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1.2.3.1. Overview and applications of synthetic polymers  
The use of synthetic hydrogels for tissue engineering purposes can be considered 
advantageous as their synthesis is straightforward, scalable and reproducible, and the 
physical properties of final material are tuneable.87–89 Their main drawback however is 
their lack of cell adhesion sites. To increase the cell-interactive properties of synthetic 
materials, modification or coating with biological molecules such as ECM proteins, 
peptide sequences and/or growth factors is a commonly used approach.90–92 
Alternatively, the bioactive properties can be enhanced via the fabrication of hydrogel 
composites by the integration of inorganic compounds (e.g. calcium phosphate or 
silicate-based) into the hydrogel.89,93–97 In the following sections, an overview will be 
provided of the synthetic polymers commonly used in tissue engineering, and of those 
most relevant for this work. In addition, general material properties and common 
synthesis routes are discussed.  
1.2.3.1.1. Urethane-based materials 
Although polyurethanes have already been discovered in 1947 by Otto Bayer98 and his 
co-workers, the first polyurethane applied for biomedical applications was only 
reported in 1967 by Boretos and Pierce99 and commercialized by Ethicon Inc. as 
Biomer®. This segmented poly(ether)urethane was tested for a range of applications 
going from in vivo shunts, heart assist pumps and endotracheal tubes towards 
pacemaker wire insulation and chambers for the first artificial heart models.100 The 
main advantage of urethane-based materials is their synthetic versatility, resulting in a 
broad range of products, covering thermoplastic elastomers to thermoset resins.101,102 
Polyurethanes are the fifth most used raw polymer based material in industrial 
production, and are quite interesting for biomedical applications as a result of their 
superior mechanical properties (tensile strength typically in the 6000-8000 psi (414-
552 bar) range) 100, excellent flexibility (elongations from 400-700%)100 and haemo- 
and tissue compatibility.103–106 The (micro)phase separation107 between hard, rigid 
segments and soft, flexible segments combined with the strong hydrogel bonds 
between the urethane linkages explains the exceptional mechanical properties of these 
materials.108  




Figure 2: General synthesis scheme for a linear polyurethane based on a diol and a diisocyanate.  
In a typical polyurethane synthesis, polyols such as polyethers, polyesters and diols 
are reacted with a diisocyanate (aromatic or aliphatic). In some cases, a low molecular 
weight chain extender is added. To catalyze the reaction, organometallics or tertiary 
amines are used, and often additives such as stabilizers or blowing agents (for foamed 
polyurethanes) are added. To create a linear polyurethane, a diol is reacted with a 
diisocyanate as depicted in Figure 2. Multifunctional polyols and/or multifunctional 
isocyanates are used to create branched or crosslinked structures. An overview of 
commonly used diisocyanates is shown in Figure 3.100,109 Diphenylmethane 
diisocyanate (MDI) is an aromatic diisocyanate often used to synthesize PUs for  
biomedical applications, as it is used in two families of biomedical grade thermoplastic 
PUs: Pellethane™ and Vialon™. The main drawback of using aromatic diisocyanates 
is their inherent yellowing tendency, especially when exposed to UV-light (300-540 nm) 
due to the formation of chromophore groups as a result of oxidation reactions.77 When 
targeting medical applications that require a transparent appearance, hydrogenated 
diphenylmethane diisocyanate (HMDI) has already been used as an aliphatic 
diisocyanate in Texoflex™, a non-yellowing, thermoplastic polyurethane.110  




Figure 3: Overview of aromatic and aliphatic diisocyanates used in polyurethane synthesis. 
To catalyze the reaction, tertiary amines and organometallic tin, lead and iron 
complexes are habitually used. As organotin compounds can be quite toxic, they need 
to be removed after the reaction.111  
Applications of urethane-based materials in the biomedical industry are quite 
numerous, as depicted in Figure 4. In the following paragraphs, an overview of the 
most important applications is provided.  




Figure 4: Overview of biomedical applications of polyurethanes 
For cardiovascular applications, a range of commercially available polyurethanes have 
already been applied.112 Cardiothane®, a thermoplastic, aromatic poly(ether 
urethane)-polydimethylsiloxane copolymer, is used in intra-aortic balloons for open-
heart surgeries. To isolate pacemaker leads from the surrounding tissue, a 
thermoplastic polyurethane coating (Pellethane®) is applied as insulator. For the 
development of an artificial, implantable heart, poly(ether urethanes) and 
poly(carbonate urethanes) are extensively researched. 113–117 Biomer™, Tecoflex™, 
Avcothane™ and Biospan™ are other examples of commercially available 
polyurethanes in clinical use.  
Polyurethanes are also used as a housing compound embedding hollow fiber 
membranes applied for haemodialysis. In addition, polyurethanes based on MDI, 
poly(propylene oxide) and various linear and cyclic aliphatic and aromatic diols have 
already been investigated as dialysis membranes. 118 
Artificial oxygenators provide oxygen and remove carbon dioxide from the blood and 
are applied as artificial lungs during cardiopulmonary surgery. Owing to their high 
haemocompatibility, polyurethanes are utilized as membranes, mostly in combination 
with other support materials. 100 
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Due to their oxygen permeability and barrier properties, a range of polyurethanes are 
also applied in wound dressings. An ideal wound dressing accelerates the wound 
healing while minimizing scar formation. Typically, hydrogel materials are used as they 
absorb the wound exudate, generating a hydrated environment.119,120 Examples of 
commercially available polyurethanes in wound healing include Opsite® CH, 
Tegaderm® Plus and Granuflex®.  
Polyurethanes are attractive scaffold materials due to their tunability. Poly(ester 
urethanes) for example are often applied because their degradation profile can be 
adapted with respect to the desired application. When a slowly degrading or biostable 
material is desired, pol(ether urethane ureas) and poly(ether urethane dialkylsiloxanes) 
are well suited.103,121–125  
1.2.3.1.2. Poly(α-esters) 
Polyesters are thermoplastic polymers commonly used in applications for which 
biodegradability is desired (with the exception of poly(ethylene terephthalate) or PET, 
which is not biodegradable). These materials degrade through hydrolysis of the 
aliphatic ester linkages within their backbone. Because of the degradation time frame 
required for most biomedical applications, only aliphatic polyesters with short chains 
between the ester bonds are considered.126 In the category of polyesters, the poly(α-
hydroxy acid)s are extensively investigated to serve biomedical purposes. They are 
either synthesized through ring opening or condensation polymerization, depending 
whether a cyclic lactone monomer or the corresponding α-hydroxy acid monomer or 
derivatives thereof are used respectively.127 As the latter mechanism leads to lower 
molecular weights, ring opening polymerization is the preferred route for applications 
that require a high molecular weight (e.g. to increase degradation time)128 For 
biomaterials, polyesters based on lactide, glycolide and ε-caprolactone are mainly 
researched and applied.129 The chemical structure of these monomers and their 
corresponding homopolymers are depicted in Figure 5.  
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Figure 5: Common cyclic lactones and their corresponding homopolymers 
Polyglycolide is one of the first degradable synthetic polymers investigated for 
biomedical applications. Due to its high degree of crystallinity (around 50%), it is 
characterized by a high Young’s modulus (i.e. 12.5 GPa).130 It is used in resorbable 
sutures and was the first FDA-approved polyester, known as Dexon®, in 1969. In 
addition, polyglycolide-based materials have already been investigated as tissue 
engineering scaffolds and as bone fixation devices.131  
Another often applied polyester is polylactide. As lactide is a chiral molecule, poly(L-
lactide) and poly(D-lactide) both exist as semi-crystalline polymers, while the 
polymerization of racemic (D,L)-lactide leads to an amorphous polymer. Because L-
lactide occurs naturally, poly(L-lactide) or PLLA is applied most frequently. It has a 
lower degree of crystallinity (around 40%) compared to polyglycolide, which results in 
a modulus of approximately 4.8 GPa.129 It is used in many orthopedic products as well 
as in suture fibers, blood vessel conduits and scaffolding materials for ligament 
replacement.132,133 Due to the increased hydrophobicity compared to polyglycolide, it 
has a longer degradation time up to 5 years, depending on the degree of crystallinity 
and the molecular weight. In-vivo studies estimate a total degradation rate of over 3 
years for in vivo degradation of high molecular weight PLA.134 To decrease the 
degradation time, copolymers such as poly(L-lactide-co-glycolide) or PLGA and poly(L-
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lactide-co-D,L-lactide) are often investigated and used for applications such as implant 
materials, sutures and skin replacement.135   
As a result of the relatively low cost of the ε-caprolactone monomer, poly(ε-
caprolactone) or PCL is frequently implemented in both biomedical as well as non-
biomedical products. In addition, it dissolves in a wide range of organic solvents and is 
characterized by a low melting point (55-60°C) rendering it straightforward to 
process.126 Crystallinity is around 50% (crystallized at room temperature).134 It’s mainly 
of interest for long-term applications as it degrades rather slowly over 2-3 years 
depending on the molecular weight and the degree of crystallinity. Again the 
degradation can be tuned by copolymerization, e.g. with DL-lactide or glycolide. It has 
a relatively low tensile modulus of approximately 23 MPa, but is highly flexible with an 
elongation at break of more than 700%.136 Clinical applications include a long-term 
contraceptive device130, meniscal tissue engineering137 and bone tissue engineering138 
1.2.3.1.3. Poly(ethylene glycol)-based materials 
Poly(ethylene glycol) (PEG) or poly(ethylene oxide) (PEO) is heavily investigated as a 
biomaterial. It is a highly hydrophilic material and will therefore restrict and control the 
attachment of cells and proteins. As antibodies will have difficulties to attach, adverse 
immune responses to biomaterials can be decreased when using PEG/PEO.139 If the 
molecular weight of the polymer exceeds 20,000 g/mol, the term PEO is used, while 
for lower molecular weights, PEG is applied. It is a viscous, colorless liquid at molecular 
weights below 1000 g/mol and forms a waxy solid at higher molecular weights. The 
most common synthesis mechanism uses ethylene oxide monomers which are 
initiated with water, ethylene glycol or ethylene glycol oligomers through an anionic 
initiation, which is associated with limited chain-transfer and termination, leading to a 
lower polydispersity compared to cationic polymerization.140  
 




Figure 6: Chemical structures of poly(ethylene glycol) and poly(ethylene glycol) di(meth)acrylate 
PEG can be easily modified to enable subsequent chemical crosslinking, for example 
by reaction of the terminal hydroxyl groups with acryloyl or methacryloyl chloride in the 
presence of trimethylamine.141 Free radical polymerization is a crosslinking mechanism 
for (meth)acrylate-modified PEG and other (bio)polymers. Initiation mechanisms 
include thermal, redox and photo-initiation. The latter is advantageous as it offers both 
temporal and spatial control over the reaction, which will lead to a controlled reaction 
exotherm. The major drawback of photopolymerization is the limited penetration depth 
of the UV-light, which is a few millimeters depending on the refractive index of the 
material. Furthermore, it can be applied to create complex structures using lasers or 
photo-masks during polymerization.142 
PEG-based materials have already been used for a range of applications including 
membranes for the encapsulation of islets of Langerhans141,143,144, barriers to reduce 
intimal thickening after balloon angioplasty145, matrices for encapsulation of 
chondrocytes, osteoblasts and mesenchymal stem cells146–151, tissue engineering 
scaffolds87 and for drug and peptide delivery.152–155 Covalent attachment of PEG to 
active proteins (PEGylation technology) is another well-known application of PEG and 
has led to a number of FDA-approved compounds (e.g. PEGylated bovine adenosine 
deaminase (Adagen), PEGylated l-asparaginase (Oncaspar) and PEGylated products 
of interferon-alpha (IFN-alpha): peginterferon-2b (PegIntron) and peginterferon-2a 
(Pegasys)).156–158  
However, over the last few years, a number of studies have shown that these 
PEGylated proteins can elicit an antibody response against PEG (anti-PEG).156,159,160 
In 22-25% of healthy blood donors, these PEG antibodies have already been 
detected.161,162 This might reduce the therapeutic effect of PEG. Moreover, the 
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immunogenic response to PEG appears to be growing over the years, most likely due 
to the increased exposure to PEG present in cosmetics, pharmaceuticals and 
processed food products.161 Polyoxazolines offer a valuable alternative, as their stealth 
behavior avoids antibody response.163 Furthermore, as there is no frequent exposure 
to polyoxazolines in non-medical applications, the immunologic response to these 
polymers is not anticipated. 
1.2.3.2. Natural polymers 
Natural scaffolds are often constituted starting from ECM-components.72 Two main 
categories can be distinguished including polysaccharide-based materials (e.g. 
hyaluronic acid, chondroitin sulfate, chitosan, alginate, cellulose, …) and protein-based 
materials (e.g. collagen, elastin, ….). The main advantage of natural polymers applied 
in TE is that they are inherently biocompatible and that they promote extracellular 
functions due to the numerous endogenous factors present (i.e. cell-specific peptide 
sequences such as RGD, IKVAV, …).151,164,165 However, they result in complex and 
often ill-defined scaffolds in respect to the chemical composition, rendering it difficult 
to determine exactly which signals promote cell response. Moreover, in most cases 
their material properties cannot be manipulated easily, degradation is often too fast 
while they elicit an inherent batch to batch variability with respect to their mechanical, 
biological and chemical properties.166  
1.2.3.2.1. Polysaccharides and derivatives 
Polysaccharides consist of monosaccharide units connected by glycosidic linkages, 
with biological functions ranging from cell signaling to immune recognition.126 
Polysaccharides are a diverse class of biomaterials from human or non-human origin. 
An overview of the different polysaccharides is provided in Figure 7 and will be 
discussed in the upcoming paragraphs.  




Figure 7: Chemical structure of common polysaccharides of human and non-human origin 
Hyaluronic acid is a glycosaminoglycan consisting of alternating N-acetyl-D-
glucosamine and glucuronic acid units. It can be found in most tissues in vertebrates 
and is not covalently bound to proteins, unlike other glycosaminoglycans. It is a major 
component of skin and plays a structural role in many other tissues as well.167 In 
addition to being a structural component, it is actively involved in biological processes 
such as the modulation of cell migration and differentiation, the regulation of ECM 
organization and wound healing.167,168 Modifications such as esterification have been 
explored and will influence the degradation rate.169,170 Hyaluronic acid is heavily 
investigated for a range of applications such as synthetic bone grafts171, injectable soft 
tissue fillers172, synovial fluid substitutes173 and to treat vascular diseases174. 
Chondroitin sulfate is the major component of aggrecan, which is found in the 
proteoglycans of articular cartilage. It increases the metabolic response of cartilage 
tissue and plays an important role in wound healing.175,176 Chondroitin sulfate consists 
of a repeating N-acetyl galactosamine unit and sulfate-modified glucuronic acid.177 Its 
main applications cover wound dressings178 and scaffolds for cartilage tissue 
engineering.179 Several mechanisms have already been explored to create crosslinked 
chondroitin sulfate, e.g.hydrazide and aldehyde modifications 180,181 
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In addition to the polysaccharides found in the human body, three other types are 
extensively studied including chitosan, originating from crustacean skeletons, alginate 
which is a brown algae derivative and cellulose from green plants, algae and micro-
organisms. Chitosan consists of β-(1-4)-linked D-glucosamine with random N-acetyl 
glucosamine pending groups. An often used crosslinking strategy to create hydrogels 
applies glutaraldehyde, while the crosslinking degree affects the degradation rate.182 
Tissue engineering applications involving the use of chitosan include the regeneration 
of cartilage, skin and bone.183  
Alginate consists of β-(1-4)-linked D-mannuronic acid and α-L-guluronic acid 
monomers. In the presence of multivalent cations, it will form a physically crosslinked 
gel.184 In addition, the  carboxylic acid groups can be chemically modified to allow 
chemical crosslinking.28 Applications of alginate include scaffold materials for bone 
regeneration.185 Alginate and chitosan have already been investigated both separately 
as well as in combination as wound dressings and for drug and cell delivery.186–189 
The last example, cellulose, is the most abundant organic biomaterial and consists of 
D-anhydroglucopyranose units.190 The chemical modification of cellulose has mainly 
been performed on its hydroxyls groups. Modification reactions include esterification, 
etherification and oxidation and are mainly constrained by its limited solubility in 
organic solvents.190 It is used for drug delivery applications,191–194 to create stimuli-
responsive hydrogels195,196 and membranes197 
1.2.3.2.2. Collagen and its derivatives.  
The most abundant protein in the human body is collagen. It accounts for 25-35% of 
all proteins in animals and can be found in tendon, cartilage, bone and skin.198,199 A 
single collagen chain (α-chain) forms an open helix structure and three single helical 
chains pack together in a tropocollagen right-handed triple helix.200 Gelatin is a 
collagen derivative, obtained through acidic (gelatin A) or alkaline (gelatin B) 
hydrolysis. Typically, raw materials such as fish or pig skin, bovine hides and pig or 
bovine bones are used for the industrial production of gelatin.201 As a result of the 
different hydrolysis mechanisms, the isoelectric points of gelatin A and gelatin B are 
different: gelatin A has a pH between 6 and 9, while gelatin B has a pH of 5. At 
physiological pH, gelatin A is positively charged while gelatin B has a negative charge. 
In addition, gelatin B shows an increased biocompatibility compared to gelatin A.202  
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Gelatin and collagen are often applied as ECM-mimicking tissue engineering material 
due to its non-immunogenic properties and the presence of RGD (arginine, glycine and 
aspartic acid) signaling sequences along its backbone which promote cell adhesion. In 
addition, it displays UCST behavior with a thermoreversible  gel point around 38°C. 
Most applications require modifications to enable chemical crosslinking, as gelatin 
itself forms a very weak gel that dissolves at body temperature as a result of its UCST 
behaviour. Crosslinkable groups (e.g. photo-crosslinkable methacrylates) can be 
introduced by modifying the gelatin side chains such as lysine and hydroxylysine with 
methacrylamide.203  
1.3. Development of porous scaffolds 
1.3.1. Solid freeform fabrication  
1.3.1.1. Advantages and drawbacks of the technique 
SFF is a general term comprising all techniques that enable the production of 
structures via the sequential delivery of energy and/or materials according to a 
computer-aided design (CAD).8 However, often other terms are applied to describe the 
same principle including additive manufacturing (AM), rapid prototyping (RP) and 3D 
printing (3DP).8 Recently, an ISO/ASTM norm has been published regarding additive 
manufacturing nomenclature (ISO/ASTM 52900). This norm has been taken into 
account when selecting the appropriate terms for the different techniques.RP and AM 
can be considered general terms, whereas 3DP only refers to one subcategory based 
on the main technological concept.8 These subcategories include irradiation-based 
systems, nozzle-based systems and printer-based systems. 
Currently, SFF is considered as the “golden standard” for the generation of scaffolds 
due to its significant benefits over conventional porous scaffold production 
technologies. In conventional approaches the micro-architecture is mainly process-
determined rather than design-driven and often requires extensive manual 
manipulation.34,204 Furthermore, the obtained porosity is often random and poorly 
interconnected, resulting in limited transport of oxygen and nutrients.63,205 In addition, 
industrially applied fabrication methods such as injection moulding or hot embossing, 
can never generate equally complex internal structures.34 In contrast, SFF enables 
precise control over both macro- and microstructure with a high degree of 
reproducibility and homogeneity.34,204,206,207 Additionally, the architecture of the 
Chapter 1: Introduction 
29 
 
micropores can influence cellular behaviour.207,208 As a result, SFF enables superior 
control over diffusion-driven transport, cell growth and differentiation.35,36,208 Hence, 
the mechanical properties of the scaffolds can be tailored by design. Even gradient 
mechanical properties can be generated by combining different pore 
sizes/architectures within one single construct.209,210 Moreover, the unique 
straightforward translation from CAD to CAM allows to tailor each implant to meet 
specific needs/designs often based on a 3D model obtained from medical imaging 
techniques.211–214 Consequently, since the construction of each specific implant does 
not require the expensive production of robust moulds, patient specific implants 
become sufficiently cost-efficient for translation to the clinic.214,215 In conclusion, SFF 
is the preferential technique to generate cost-efficient, patient-specific constructs 
closely mimicking the tissue defect based on medical imaging techniques.34,86,211,212   
However, SFF techniques also exhibit certain limitations. For instance, the application 
of laser-based systems is limited to photo-polymerizable materials (e.g. 
Stereolithography, SLA or Two Photon Polymerization, 2PP) or highly controllable 
melting materials (Selective Laser Sintering, LS). In addition, unreacted monomers and 
photo-initiators applied in SLA can exhibit cytotoxicity.34 Constructs generated via 
printing are often very brittle and mostly require a post-processing treatment to 
increase robustness.8,216,217 As for nozzle-based systems, certain design limitations 
exist. For example, the resolution is inferior to printing and irradiation-based 
techniques. Also, certain shortcomings can be attributed to SFF techniques in general. 
First, each SFF technique is only suitable for the processing of a limited range of 
materials which exhibit the required properties. Secondly, resolution and architectural 
control are often highly dependent on applied material and SFF technique. Finally, 
successful SFF of novel materials frequently requires extensive and time-consuming 
optimization of processing parameters. 8,218,219 Therefore, compromises often have to 
be made in terms of resolution or material properties to generate suitable constructs.56 
1.3.1.2. Overview of the different methods 
Most SFF techniques share a similar process flow. First, a 3D CAD design is generated 
which can be obtained from medical imaging or designed to meet specific needs. Next, 
it is sliced along the Z-axis into several consecutive ‘2D’ layers. Finally, these 
consecutive layers are transferred to coordinates and fed to the SFF device, which 
processes them into a 3D construct in a layer-by-layer fashion. Some SFF techniques 
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have the possibility to operate outside of the conventional layer-by-layer methodology. 
This is for example the case with 2PP where a focussed spot can be scanned through 
a photo-crosslinkable solution in 3 dimensions. However, these also often apply layer-
by-layer fabrication to decrease production times and simplify CAD processing.220 An 
overview of the different categories of SFF techniques, including examples for each 
category, is presented in Figure 8 and the paragraphs below. 
 
 
Figure 8:Overview and classification of currently applied template fabrication techniques for indirect 
Rapid Prototyping8 
1.3.1.2.1. Irradiation-based systems 
Irradiation-based systems deliver energy via radiation to transfer a CAD to a certain 
material. A distinction can be made based on the purpose of the applied irradiation 
between local photo-polymerization systems (e.g.. SL, 2PP) and sintering systems 
which apply heat to locally fuse particles together (i.e. LS). A similar approach is digital 
light projection (DLP) or microstereolithography (MSTL), where instead of laser 
irradiation, a UV lamp is used combined with a micromirror array. Every layer is 
converted into a pixelated image and transferred to the micromirror array (digital 
micromirror device, DMD) where every pixel corresponds to one micromirror. 221 
Mirrors corresponding to areas which need to solidify reflect the UV light to the polymer 
solution, whereas the remaining mirrors reflect the light away.222,223 Consequently, 
each layer is generated in one flash in contrast to processes exploiting the scanning 
of a laser beam, which makes the technique faster than conventional SL.223 (Figure 9) 




Figure 9: Digital light projection/microstereolithography principle.  
Another irradiation-based technology is soft lithography. First, a pattern is generated 
via lithography on a robust photoresist. Next, poly(dimethylsiloxane) (PDMS) is “cast” 
onto the generated pattern, and the inverse pattern is transferred to the PDMS by 
hardening to generate a PDMS “stamp”.54 This soft “stamp” is then coated with the 
desired material followed by transfer of this material to a targeted surface, similar to 
conventional stamps coated with ink. The technique is referred to as soft lithography 
since lithography is applied as a master for a soft stamp material (PDMS). The 
technique cannot be considered a true SFF technique since only ‘2.5D’ single-layer 
patterns are generated through this approach. However, by introducing several single-
layer templates into the final material followed by template removal, 3D scaffolds can 
be obtained containing a stack of planar channels.54  
1.3.1.2.2. Nozzle-based systems 
Nozzle-based systems apply controlled X-Y movement of a material-depositing nozzle 
to generate each layer of the CAD. Increasing distance between the plotting head and 
plotting platform enables stacking of these layers to generate a 3D structure. A 
subcategorization can be performed based on the applied extrusion/dispensing 
mechanism. 
The most straightforward nozzle-based technique is fused deposition modelling (FDM). 
The method uses a thermoplastic polymer filament which is fed by rollers through a 
heated nozzle which melts the polymer material just before deposition.8,27,33,224 During 
deposition, the heat of the freshly deposited polymer softens the previous layer thereby 
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inducing interlayer attachment.225 FDM can generate structures with strut diameters in 
the range of several 100 micrometers which is mainly controlled by nozzle diameter 
and extrusion rate.225 The range of suitable materials for FDM remains limited since 
the materials have to be thermoplastic, exhibit suitable viscoelasticity and 
melting/solidification properties and have to be pre-processed into polymer filaments. 
For this technique, PLA is one of the most commonly applied materials. 
A variation to FDM is air pressure jet solidification (AJS) which applies air pressure 
instead of rollers to force solutions or melts through a nozzle, thereby removing the 
need for preformed thermoplastic polymer filaments. In contrast with FDM, a larger 
range of materials can be applied including hydrogels, polymer/ceramic sludges, 
etc.82,226,227 Similar to FDM, strut diameters can be obtained in the range of several 
100 micrometers.82 
Recently, the use of direct-write assembly was reported as a high-resolution variant of 
AJS. Via the combination of fine nozzle tips with fugitive inks, exhibiting specific 
viscoelastic properties, fine struts (down to 10 µm diameter) can be obtained by 
optimizing the pressure.228,229 These properties have to enable ink deposition under 
high shear conditions combined with sufficient shape retention after structuring.228,229 
Therefore, sometimes the ink is photo-crosslinked during deposition to ensure 
sufficient mechanical integrity.230 However, only a limited range of materials comply 
with these stringent viscoelastic properties, which is a restricting factor for many 
applications.231  
Recently, a variation to nozzle based SFF techniques referred to as melt 
electrospinning writing (MEW) has been reported which applies the principles of melt 
electrospinning in combination with fluid dynamics to obtain ultra-narrow strut 
diameters typically in the range of 5  to 50 µm.232,233  
1.3.1.2.3. Printer-based systems 
3DP applies selective deposition of a liquid binder on a powder bed to selectively fuse 
powder particles together into a single layer of the CAD.213,217,234,235 After completion 
of a layer, a roller distributes a new layer of powder onto the previous one and the 
process is repeated. Since infused powder acts as a support, complex 3D structures 
can be obtained with resolutions depending both on jet droplet and powder particle 
size, for iSFF resolutions in the range of 100 to 200 µm have been reported.213,234,236 
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When the complete structure is printed, unfused particles are blown away using 
pressurised air.217 Often, the constructs are very brittle and require infiltration with a 
polymer solution (e.g. polyethylene glycol) or PEG) to reduce brittleness.217 The 
material selection is limited, especially the use of synthetic degradable materials poses 
problems since organic solvents required for particle fusion dissolve most 
commercially available print nozzles.213,234  
In addition to 3D printing, other printer-based techniques apply an inkjet nozzle to 
directly deposit droplets of a build-material (e.g. wax) by using piezoelectric actuation. 
This technique is referred to as inkjet printing (IJP), drop-on-demand printing (DDP) or 
phase change 3D jet-printing.36,218,237 Upon impact, the droplets harden thereby 
forming beads which result in lines when adjacent beads overlap.36,237 The method 
benefits from a high resolution as a consequence of the inkjet principle.227 Often, two 
nozzles are applied to deposit two materials, being a build material to replicate the 
CAD and a support material to support overhanging struts during processing.238 
Application of a support material requires an additional support removal step by using 
a selective solvent before the final structure is obtained.85,227,238,239 Additionally, some 
systems increase precision by milling away the top of each layer to a well-defined 
height before the next layer is deposited.36,84–86,204,240 (Figure 10) Using this 
methodology, a layer height in the range of 10 to 20 µm can be obtained.227  
 
Figure 10: Principle of phase change 3D printing also referred to as drop on demand- or ink-jet printing 
principle.  
A small variation to IJP can be considered as a hybrid between printer- and irradiation-
based techniques. The technique is referred to as POLYJETTM and applies deposition 
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of photocurable droplets combined with immediate UV-curing, in this manner more 
robust structures are obtained in comparison to conventional IJP. Similar to IJP, the 
application of 2 nozzles enables the use of a support structure which can be selectively 
dissolved afterwards.207,241 
1.3.2. Indirect Solid Freeform Fabrication 
To overcome the limitations of conventional solid freeform fabrication techniques 
(limited material selection, brittleness and need for post treatment, low resolution and 
long optimization of new materials) 8,34,216–219 several research groups have been and 
are exploring a methodology which combines the benefits of SFF in terms of 
controlled, patient-specific design with the freedom of materials associated with 
conventional scaffold production techniques.210,223,227,242 This approach applies a 
construct, generated via SFF techniques as a sacrificial mould or template for the 
final construct.16 Therefore, the approach is referred to as “lost-mould technique”, 
indirect solid freeform fabrication, indirect rapid prototyping (iSFF), indirect additive 
manufacturing or indirect 3D printing.65,85,86,206,235 Here, the processing parameter 
requirements of the final scaffold material are of secondary importance, as a mould is 
generated using straightforward processing of well-established materials.34,242 To 
generate the template, SFF techniques can be applied with superior resolution 
compared to direct SFF of the desired material.227 By using high resolution 
techniques for template fabrication, for example SL, scaffolds with pore and strut 
sizes as low as 50 and 65 µm respectively can be obtained for materials unsuitable 
for direct fabrication using high resolution manufacturing methods.38 Consequently, 
well-defined 3D scaffolds can be generated in a straightforward manner from 
materials previously identified as being “unprintable” due to thermomechanical 
properties that do not match the often strict temperature and pressure requirements 
for direct rapid prototyping.37,82,85,213,219,238,239,243 Furthermore, less raw material is 
required since material consuming process optimization becomes superfluous. 
Additionally, only the volume of the final construct is required for scaffold production 
whereas most direct SFF techniques require excessive material amounts. For 
example, in SL, uncrosslinked material is washed away after shaping, in 3DP and LS 
unbound particles are blown away after structuring.219 Additionally, iSFF allows a 
straightforward combination of different materials within one scaffold, including 
bioactive compounds. This is achieved either via blending of materials, or via the 
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creation of zones with different mechanical properties for specific tissue function (e.g. 
interface between soft and hard tissue).219,238 Moreover, iSFF allows the creation of a 
hierarchical porosity in the final scaffold, since porous microstructures can be 
obtained inside the struts via conventionally applied techniques during or after 
casting.35,65,82,205,219,223,234,235,237–239,242  
Consequently, iSFF has proven to circumvent hurdles commonly associated with direct 
SFF techniques and opens up unprecedented opportunities towards new scaffolding 
strategies219 (sections 2.3. and 3). The combination of a large selection of SFF 
techniques with a vast variety of casting/template removal strategies results in a large 
range of diverse iSFF strategies. However, the generally applied methodology consists 
of three main steps35–37: (Figure 1) 
1. Mould fabrication through SFF 
2. Casting of the desired material + fixation of the final shape 
3. Mould removal. 
The design of the mould has to correspond to the inverse of the final construct.213,242 
Often this is accomplished in silico by generating an inverse 3D model.210 In some 
cases SFF techniques already apply a secondary material during printing to act as a 
support for the final design, which can be selectively removed afterwards. Hence, 
selective removal of the construct material rather than support material and application 
of the support structure as mould for iSFF has been reported.244 Consequently, the 
process of designing an inverse mould becomes redundant.244,245 Another approach 
to avoid designing an inverse mould is to generate a first structure via SFF exhibiting 
the design of the final scaffold. This structure is then used as a sacrificial mould to 
generate the negative sacrificial mould for the final construct.207,211,219,241 
To classify the range of approaches, a first categorization can be obtained by 
distinguishing between two main iSFF strategies. First, the combination of a sacrificial 
mould generated by SFF to control the macro-architecture (i.e. the external shape) of 
the final construct with conventional pore forming has been 
reported.35,211,212,234,235,239,246 In the present paper, these methodologies will be referred 
to as external indirect rapid prototyping (eiSFF).247 (Figure 11) 





Figure 11: Comparison of  the eiSFF and iiSFF approach 
Secondly, the application of SFF templates has been targeted to obtain a controlled 
microporous structure into the final scaffold.16,65,85,86,207,210,213,219,233,243  This 
methodology will be referred to as internal indirect rapid prototyping (iiSFF) (Figure 
11). Sometimes conventional techniques are applied in combination with iiSFF to 
generate a hierarchical microporosity, resulting in the generation of porous struts which 
follow the morphology of the template.204,213,219 Often also a combination of both 
approaches has been applied through which a desired outer contour is merged with 
well-defined inner architectures.82,210,213,242 
1.3.2.1. Mould or Template fabrication process 
1.3.2.1.1. Irradiation-based systems 
In the category of irradiation based systems, to date only photo-polymerization 
techniques have been applied for iSFF. In this respect, the best known technique is SL 
where a laser beam is scanned across the surface of a photo-curable resin or 
(pre)polymer solution, thereby locally polymerizing the material. After solidification of a 
complete layer, the platform moves downwards for processing of the next layer. After 
multiple iterations, unpolymerized material is removed leaving behind the polymerized 
template.30,210,248 
High resolution and precise architectural control render SL and DLP/MSTL ideal for 
complex porous templates suitable for iiSFF with high shape fidelity.210,222,243,249 
Currently, MSTL techniques enable generation of structures with (sub)-micron sized 
features.214 However, since the applied mould is photo-crosslinked, template removal 
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becomes less straightforward. Consequently, the method is generally used to generate 
ceramic scaffolds which allow template removal via pyrolysis.222,248 
1.3.2.1.2. Nozzle-based systems 
As FDM is one of the most popular SFF techniques, several research groups have 
utilized this technology for the generation of controlled microstructures in 
iiSFF.16,209,250,251 A key aspect is to select a filament material that can be selectively 
removed when using this method to create scaffolds for iSFF.  
Another template fabrication technique is direct writing. Due to the limited range of 
materials compatible with this technique, it is more suitable for iiSFF than for direct 
SFF.228,229,231 In a more specific example, the dynamic diameter control, generated 
by pressure variation, was exploited to create hierarchical vascular networks through 
iSFF.  
Other nozzle-based techniques apply a piston for the deposition of material. In one 
specific iSFF example, a liquid hydrogel precursor is sucked into a capillary using a 
piston.57 Next, physical gelation is induced into the capillary, followed by the deposition 
of the gel in a controlled area to obtain linear channels into a matrix of the final scaffold 
material with a diameter of 500 µm.57  
A last nozzle-based technique used for template fabrication is MEW. Although the 
technique is very recent, it has already been applied to generate microchannels in a 
hydrogel structure via iiSFF.233 
1.3.2.1.3. Printer-based systems 
The limited material selection for 3DP-techniques in combination with the poor 
mechanical properties make the technique more attractive for iSFF than direct SFF if 
template removal is possible.213,234 Therefore, Lee et al. used gelatin microparticles as 
a powder fused together with an aqueous solution to generate water-soluble 
templates.213 
Another popular iSFF technique is IJP. Since the applied material in this technology is 
mainly limited to specific waxes which can easily be dissolved, the technique has 
proven to be very popular for iSFF as it combines high resolution with straightforward 
template removal.83,85,226,240 
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1.3.2.2. Casting methods 
Following template generation, a casting step is performed to introduce the final 
scaffolding material. Since filling up the entire voids with the final scaffolding material 
can be difficult, several strategies have emerged in this respect. Applied methods 
include vacuum treatment, injection moulding and thermoforming. 
Vacuum can be applied to remove all air bubbles from a solution during scaffold 
infiltration.238 One strategy incorporates several templates into a solution of the final 
material followed by placing the entire container under vacuum.16 In another approach 
a syringe filter has been cut in half to which the template was secured. Next, the filter 
and template were placed into a solution containing the final scaffold material followed 
by generating a vacuum using the plunger of the syringe thereby resulting in suction 
of the solution into the entire template.240 (Figure 12) 
 
Figure 12: Casting via syringe-induced vacuum treatment. Reprinted from 240 with permission from 
Wiley. 
If the viscoelastic properties of a melt allow straightforward material handling, pure 
polymer melts are directly injected into the mould via a syringe.217,218 To this end, an 
extrusion chamber can be incorporated in the mould design. The chamber can be filled 
with a melt, followed by reproducible extrusion using a syringe plunjer.218 (Figure 13) 
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After template removal, the remnants of the extrusion chamber have to be removed 
manually. 218 
 
Figure 13: Principle of casting via injection moulding. In this approach the template 
contains a void for the final material before direct syringe injection. 
Some research groups have already applied a design for the sacrificial mould which 
incorporates an inlet where a syringe can be attached and an outlet to remove excess 
material and air. (Figure 14) As a result, the final scaffold material can simply be 
injected into the mould, similar to injection moulding.223,242 Consequently, scaffold 
generation is enabled in low tech environments (e.g. hospitals when it comes to 
scaffold production), if the templates are generated elsewhere.242 
 
Figure 14:iSFF principle including direct syringe injection casting step. The template contains an inlet 
for the syringe and an outlet for removal of excess material. 
As a final method, Sodian et al. have applied a technique where porous sheets of the 
scaffold material were heated, pressed against the negative mould and cooled to 
induce crystallization, thereby locking the final shape.246,252 As a consequence, 
complete heart valves could be obtained from a single porous sheet with a controlled 
porosity without the need for suturing.252 
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1.3.2.3. Mould or template removal process 
The final step in iSFF consists of template removal without damaging the final 
construct.242 The absence of chemical interactions between template and scaffolding 
material facilitates this process. In addition, elasticity and swelling/shrinking behaviour 
of both the template and material should be taken into account. For instance, if brittle 
scaffolding materials are applied, swelling of the template during dissolution can result 
in stress-induced cracks and deformations arising in the final construct.221 As a result, 
several techniques have arisen, including selective melting followed by evaporation, 
binder burnout and sintering, selective mould dissolution, selective mould degradation, 
and manual removal or aspiration.  
If the template material exhibits a melting point below the thermal stability threshold of 
the scaffold material (e.g. wax and poly-(glycolic acid)/poly-(lactic acid) or PGA/PLA), 
the template can be removed by selectively melting the template.219 To ensure 
complete template removal, a solvent can be applied to wash away any residue.219 
Sometimes melting alone is not sufficient for complete scaffold removal and often 
evaporation is necessary. In direct write assembly, the applied template material is 
often a fugitive ink. As a result, the template (vascular) structure can be removed by 
gentle heating to evaporate the ink.228,229 
When ceramics are applied as a scaffolding material, organic templates can be 
removed by burnout or pyrolysis prior to sintering.85,86,206,210,226,227,240,243,250,251 Pyrolysis 
followed by evaporation occurs when an organic material is heated to high 
temperatures (>400°C).206,240 As a result, even unsolvable crosslinked networks 
generated by irradiation-based techniques can be removed.206,222,249 As sintering at 
high temperatures is essential to remove the binder material applied for the ceramic 
slurry, template removal can occur without an additional step.36  
Selective mould dissolution (SMD) is predominantly applied if the final scaffold material 
is a (synthetic) polymer. A prerequisite of the technique is the availability of a solvent 
which selectively dissolves the template material without influencing the scaffold 
material.65,204,205,207,211,217–219,234,235,237–239,241,247 Therefore, the technique can be 
applied if the scaffold consists of crosslinked polymer networks which are unsoluble.16 
In addition, solvent mismatching systems can be an option (water versus organic 
solvents).82,213 The method is often applied to remove wax templates generated via 
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DDP/IJP techniques.83,84 Also, the removal of ceramic templates for the generation of 
scaffolds by using ceramic-specific solvents (e.g. RDO-APEX Engineering Products 
Corp) has been reported.219  
SMD is one of the few template removal techniques suitable for cell encapsulation in 
iSFF. This can be accomplished when a water-soluble template (e.g. gelatin) is 
combined with a crosslinked hydrogel material containing cells (e.g. collagen).54  
If the combination of high-resolution SL templates with thermally unstable scaffolding 
materials (e.g. (bio)polymers) is desired, pyrolysis and SMD are not possible for 
template removal.221 Therefore, the solution can sometimes be found in creative 
chemistry. Liska et al. reported on the use of a hydrolysable crosslinkable material 
(using methacrylic anhydride as a crosslinker) for SL template generation. After 
casting, the mould was selectively removed via hydrolysis of the anhydride bonds using 
an alkaline solution.221 Using this approach, high-resolution iiSFF and eiSFF scaffolds 
could be obtained from (PCL), poly(lactic-co-glycolic acid) (PLGA), poly-(L-lactic acid) 
(PLLA), chitosan, alginate and bone cement.242 
Aspiration is a technique through which the template is removed from the final 
scaffolding material using a low vacuum pressure. It is clear that this method can only 
be applied for the removal of template fibers which do not show adhesion to the final 
scaffolding material.57 The method can for instance be applied for the generation of 
blood vessels in labs on a chip (LoC) and organs on a chip.57 Consequently, the 
technique is restricted to the generation of simple unbranched channels, which limit 
tissue engineering applications. However, these properties are often sufficient for LoC 
devices. The method can be considered as the least invasive template removal 
strategy. 
SMD and aspiration have certain benefits over other scaffold removal methods, since 
they both allow the application of cell encapsulation via iSFF.54,55,57 Furthermore, the 
sacrificial scaffolds can be produced elsewhere as a ready-to-go kit. Consequently, 
cellularized scaffolds can be obtained without the necessity of SFF knowhow and 
infrastructure. This feature increases the potential for rapid technology adoption and 
swift transfer to the clinic.55 Consequently, iiSFF poses substantial benefits for the 
generation of vascular networks in comparison to direct SFF techniques.55  
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1.3.2.4. Overview of scaffold materials 
A range of indirect scaffold materials have been described in literature to date including 
biopolymers, synthetic polymers, ceramics and composites. Many authors have 
highlighted the versatile nature of the iSFF technique by casting a selection of 
(bio)polymers and ceramics. 57,55,253 In addition to (bio)polymers and ceramics, the 
iSFF technique can also be used for the construction of porous metal implants, 
enabling cellular ingrowth.236 Table 1 gives an overview of all iSFF approaches applied 
to date and contains information about the applied materials, the SFF technique, 
template material removal and the secondary pore creation strategy. 
1.3.2.4.1. Biopolymers in indirect rapid prototyping 
Extracellular matrix proteins are especially interesting for tissue engineering purposes, 
as they are inherently biocompatible, cell-interactive and do not result in toxic 
degradation products. However, they are often considered hard to process. Of 
considerable interest for tissue engineering purposes is collagen since it is the major 
constituent of the native human extracellular matrix.54,65,237,254 Fabrication of micro 
channels in a collagen matrix using conventional SFF techniques has been limited to 
simple geometries, such as cylindrical tubes. To generate collagen scaffolds with 
complex microfluidic channels, a gelatin mould developed by stacking several 
patterned layers obtained via soft lithography has already been applied.54 For some 
applications, the presence of micropores inside the scaffold can pose benefits with 
respect to diffusion-driven transport. When comparing critical point drying (CPD) and 
freeze drying for collagen scaffolds, CPD led to significantly higher shrinkage of the 
scaffold and could not result in a foam-like porous structure. Therefore, freeze drying 
is considered a more suitable technique for introducing microporosity in collagen 
scaffolds. 65 




Figure 15: Live/dead fluorescence images obtained of the scaffolds seeded with human foreskin 
fibroblasts (HFF) for both types of scaffolds after 1 and 5 days of cell culture including control image on 
tissue culture plastic. ( Scale bars represent 200 µm) Reprinted from source 16 With permission of 
Springer  
Gelatin is a material derived from collagen either by acidic or alkaline hydrolysis. It has been 
combined with microspheres in an iSFF approach to create channelled, microporous 
scaffolds.207 However, gelatin dissolves rapidly at physiological conditions and does not 
possess sufficiently high mechanical properties needed for many tissue engineering 
applications. Therefore, modification of the primary amine functions to obtain crosslinking 
functionalities (e.g. methacrylamides) is often performed.12,16,72,255–257Processing of low 
concentrations which are considered beneficial for cell viability via direct SFF becomes 
difficult.56 However, in contrast to direct SFF, iSFF has enabled the construction of self-
supporting scaffolds using polymer concentrations of 10 wt% and below (Figure 15).16,57  
Another applied biomaterial is silk fibroin, a silk-derived, protein-based material which 
is of specific interest for the engineering of ligaments, bones and cartilages. It consists 
of amino-acids and is water insoluble, in contrast to gelatin. Conventional fabrication 
methods only allow limited control over the internal architecture. Therefore, Liu et al 
combined iSFF with freeze drying to develop silk fibroin tissue engineering scaffolds 
with macro-channels and micro-pores thereby enabling optimal cell infiltration.239  
1.3.2.4.2. Synthetic polymers in indirect rapid prototyping 
Due to their mechanical properties and biodegradability, polyesters are often applied 
for bone tissue engineering. These materials are often processed using fused 
deposition modelling. However, this method does not allow the creation of a secondary 
pore structure, for example by including porogens during the casting step. By using an 
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indirect approach, nanofibrous PLLA scaffolds, mimicking the morphological functions 
of type I collagen, can be generated by applying phase separation in dioxane.212,247 
Phase separation can be combined with paraffin microspheres to generate a tri-porous 
structure.212 PCL is a biocompatible, semi-crystalline, slowly degrading polymer. It 
combines flexibility with robust mechanical properties, which makes it an attractive 
candidate for bone tissue engineering.223,258,259 In addition, PCL has also been applied 
in eiSFF for the generation of a carotid artery. To this end, a dip coating process was 
combined with salt leaching to create a porous construct.211 PLGA is another popular 
scaffold material for bone tissue engineering due to its robust mechanical properties. 
235,260,261  
 
Figure 16: Figure 9: a-c, Macroscopic images of scaffolds with villi architecture with different dimensions. 
d-f, Cryosectional images. (left to right: 0.5,1,0.5 mm;0.5,1,1 mm; 1,1,1 mm; villus diameter; height; 
intervillus spacing respectively). Reprinted from source235 with permission from Wiley Periodicals, Inc.  
To demonstrate the obtainable resolution of iSFF, Lee et al. fabricated villi-shaped 
scaffolds and the effect of scaffold design on smooth muscle cell response was 
evaluated (Figure 16). A higher cell density was observed for scaffolds with smaller 
villi-features (0.5 mm vs 1 mm). This supports the hypothesis that a larger boundary 
surface area will better support mass transport.235 Another polymer which has been 
applied for bone tissue engineering is poly(propylene fumarate) (PPF), an unsaturated 
linear polyester, which incorporates crosslinkable double bonds in its backbone. 
Furthermore, it has shown to support chondrocyte growth combined with matrix 
deposition. Rapid prototyping of unconventional polymers often requires tedious 
optimization of experimental processing parameters, which can be surpassed by using 
iSFF.  
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Poly-3-hydroxyoctanoate-co-3-hydroxyhexanoate and poly-4-hydroxybutyrate have 
been combined to create functional heart valves using the eiSFF approach, which 
allows the use of porogens 246,252 These materials are thermoplastic elastomers which 
are produced via a fermentation process.  
Poly(2-oxazolines),a versatile material class with great potential for biological 
applications, have been applied in combination with MEW to generate a construct with 
microchannels.233 
1.3.2.4.3. Ceramics in indirect rapid prototyping 
Porous ceramics are generally applied as scaffolding materials for bone defects and 
spinal fusion applications. In this respect, iSFF is very appealing since any organic 
mould can be removed during sintering or pyrolysis, thereby elegantly combining two 
processing steps. In addition, direct rapid prototyping of ceramic slurries is challenging 
and often requires a long optimization process. For bone tissue engineering, calcium 
phosphate is most often used under the form of tricalcium phosphate (TCP), a calcium 
salt of phosphoric acid. This material is commercially available for its use in medical 
and dental applications. To fill the iSFF mould, TCP particles are combined with a 
binder solution to obtain a ceramic slurry. After casting, the binder (and mould) are 
removed via sintering.83,84 To increase the scaffold potential, growth factors such as 
bone-morphogenic proteins (BMP) can be included in the scaffold post-sintering. 
Especially of interest is BMP-2, a bone matrix protein stimulating mesenchymal cell 
differentiation into chondrocytes and osteoblasts.83 
A second important ceramic material for tissue engineering purposes is hydroxyapatite 
(HA), a calcium phosphate and major component of human bones and teeth. It has 
been studied extensively as bone graft material, since it enables the culture of many 
types of osteogenic and bone marrow cells. Implantation studies have already shown 
its ability to support ingrowth of bone into porous implants 37,39,41,49,56,74,80,105–108 (Figure 
17). Often, a thermally crosslinked binder is used as a carrier for the HA particles, 
which can be removed during sintering.15,206,210,222,243,262 However, if instead of a binder 
a self-setting solution is used, sintering is not required and growth factors such as 
BMP-2 can be included in the scaffold during fabrication.82  




Figure 17: A-D, Confocal laser scanning microscope image of a cellular network grown on HA scaffold. 
E, Overlay of image B with a virtual drawing of the scaffold sector. Reprinted from source262 with 
permission from Wiley Periodicals, Inc  
When comparing HA and TCP or blends thereof as scaffold material, HA or HA/TCP 
blends prove to be superior to TCP in terms of cell viability, proliferation and osteogenic 
differentiation.85,86 In addition to these conventional ceramic materials, alumina 
ceramic powders have also been investigated as scaffold materials.250,251  
1.3.2.4.4. Composites and blends in indirect rapid prototyping 
The casting process offers the possibility of creating biphasic and composite scaffolds 
which exhibit zones with different properties for structural tissue interface engineering. 
An interesting example is the combination of ceramic and polymer composites. 
Material-related properties such as flexibility of polyesters and toughness of ceramics 
can be combined as a composite or for the creation of discrete zones within the 
scaffold.219 Inspired by natural bone, which is a composite of organic and inorganic 
compounds, Li et al. combined PLLA and chitosan with HA microspheres. PLLA is 
used for its high stability, while chitosan has a high biocompatibility. The addition of HA 
microspheres increases proliferation of pre-osteoblastic cells, resulting in an ideal 
scaffold for bone tissue engineering. (Figure 18).238  




Figure 18: Biphasic PLA/HA ceramic scaffold (top, yellow: PLLA; bottom, blue: HA). Reprinted from 
source 238 with permission from Elsevier 
By combining the synthetic polymer PPF, as described in paragraph 1.3.2.4.2 with β-
TCP, an interesting composite can also obtained. In addition to its osteoconductivity, 
the mechanical properties of the material can increase during the early stages of 
degradation as a result of continued crosslinking and by complexation of the polymeric 
carboxylic acid groups with calcium ions.263 
Besides biphasic scaffolds and blends, surface treatments can be applied to create 
multi-material scaffolds. For example, chitosan and PCL mandibular condyle shaped 
scaffolds were coated with apatite to increase osteoinductive properties.213  
1.3.2.5. Applications of indirect solid freeform fabrication 
Due to the versatile nature of the iSFF method, and the broad range of materials that 
can be applied, indirect scaffolds have been developed for different applications 
ranging from hard to soft tissues, tissue interfaces and the creation of vascular 
networks (Figure 19). By combining medical imaging with the 3D scaffold production 
methods, patient-specific and defect-specific tissue engineering implants can be 
developed. Furthermore, iSFF has been applied for the creation of microfluidic and 
vascular networks. However, since this topic is somewhat different from conventional 
tissue engineering it is discussed in a separate paragraph (1.3.2.5.3). 




Figure 19: Applications of iSFF in the engineering of hard tissue, soft tissue and tissue interfaces 
1.3.2.5.1. Hard tissue engineering using indirect rapid prototyping 
The main advantage of iiSFF is its rigorous control in terms of scaffold architecture. As 
a result, the natural morphology of bone tissue including the complex internal 
microstructure with Volkman’s and Haversian canals, can be carefully designed in the 
mould.82  
Pore size and shape greatly influence the mechanical properties of a scaffold and 
tissue ingrowth. Increased porosity will lead to a better ingrowth, but will decrease the 
implant stiffness. Via design optimization, scaffold microstructures can be designed to 
match the mechanical properties of the target tissue, while maintaining sufficient 
porosity for tissue ingrowth.210,243 In this respect, scaffolds with moduli and strength 
values in the range of human trabecular bone (compressive modulus of 10-900 MPa, 
yield stress of 0.2-14 MPa) could be generated using a casting method.260  
In addition to the mechanical properties, pore shape can also influence cell growth. By 
choosing different pore shapes this influence can be assessed. Channel surface area 
and local curvature have been shown to strongly influence the tissue growth rate. 
Round channels result in uniform growth of MC3T3-E1 cells, while in polygonal pores, 
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tissue growth typically starts in the corners, whereas cells on the faces initially 
remained in a resting state. As a result, over time, round pores are obtained regardless 
of the initial pore shape.208 (Figure 20). However, for identically shaped pores, with a 
size range of 350-800 µm, no significant effect on tissue ingrowth was observed in PCL 
even after 8 weeks of implantation.259 
 
Figure 20: Tissue formation depending on pore structure. Because of different cellular growth rates of 
cells located in the corner or on the face of the pore, a final round shape is formed regardless of the 
initial pore morphology. Reprinted with permission from The Royal Society publishing208. 
Detsch et al. compared bone marrow stromal cell cultivation on hydroxyapatite 
scaffolds generated via a direct dispense plotting method and an iiSFF method. They 
observed that for the iiSFF scaffolds a higher differentiation of the bone marrow stromal 
cells into precursor osteoblasts occurred while the direct printed scaffold exhibited a 
higher proliferation rate. They concluded that both scaffold types were suitable for 
tissue culture.226,227 
One of the targeted tissues to be regenerated using an iSFF approach is craniofacial 
tissue. Based on computed tomography (CT) or magnetic resonance imaging (MRI) 
scans the scaffold can closely mimic the architecture of the defect, for example the 
mandibular chondyle253 or the zygoma234. Human digit bone was reconstructed by 
combining a phase separation technique with an eiSFF method including paraffin 
spheres.212 
Aiming at cartilage tissue engineering an indirect PPF scaffold has been combined with 
a hyaluronic acid/collagen I hydrogel for cell delivery.264 These scaffolds combined 
load bearing qualities with enhanced tissue regeneration. Both cubic and ellipsoid 
shaped pores resulted in good tissue infiltration without any significant difference.  
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Moore et al. developed a bio artificial graft for the repair of spinal cord injuries. Tailoring 
to the complex nature of these injuries they developed an implant active both at the 
molecular, the cellular and the tissue level. An implant closely mimicking the 
morphology of the human spinal cord was fabricated using PLLA. Due to its specific 
architecture the scaffold could be seeded with multiple cell types mirroring the 
anatomical tissue locations. Schwann-cell loaded scaffolds were implanted in vivo and 
promoted axon regeneration (Figure 21). 261 
 
Figure 21: Histological images of tissue formed within the spinal cord scaffold, segmented axon 
bundles are clearly visible. Reprinted with permission from Elsevier261 
1.3.2.5.2. Soft tissue engineering using indirect rapid prototyping 
Using iSFF, complex structures with high resolutions can be achieved, which is 
demonstrated by printed scaffolds exhibiting a small villi architecture.213,234,235  
Another complex tissue that has been generated using iSFF is the heart valve. The 
design needs to be both functional as well as physiologically correct and was obtained 
based on x-ray computed tomography. The designs included human pulmonary and 
aortic homografts and were based on moulds fabricated using stereolithography 
followed by thermoforming of porous PPF sheets to obtain the final structure.246,252 
By combining eiSFF with dip coating and salt leaching, porous, patient-specific, 
bifurbicating blood vessels have been fabricated based on CT scans of a carotid artery 
(Figure 22) which exhibited a mechanical strength within the range of natural human 
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blood vessels (1-3 mPa). The biocompatibility of the scaffold was confirmed using 
human umbilical vein endothelial cells (HUVECs).211  
 
Figure 22: Bifurbicating  carotid artery, reconstruction (a) and macroscopic image of the PCL scaffold 
(b). SEM images of the surface (c and d).Reprinted from source 211 with permission from Elsevier.   
1.3.2.5.2.1. Indirect rapid prototyping as a solution for tissue interfaces 
The treatment of periodontal diseases involves the formation of new cementum, 
periodontal ligament and alveolar bone. This challenging multi-tissue interface inspired 
the combination of a biphasic scaffold with PGA as periodontal ligament and PCL to 
engineer the bone compartment. A mould was developed to perfectly fit a human tooth 
dentin slice attached to the PGA region of the scaffold (Figure 23). 244,258 
 
Figure 23: Polymer casted, hybrid scaffold for engineering the human periodontal tooth-ligament (PDL) 
interface. Left: 3D design, right: µ-CT images and 3D reconstruction. Scale bar is 50 µm. Reused from 
source244 with permission from Elsevier.  
1.3.2.5.3. Indirect templates for the formation of vascular networks 
1.3.2.5.3.1. Vascularized tissue engineering constructs 
Vascularization in tissue engineering constructs remains a key challenge as many 
different cell types need a constant supply of oxygen and nutrients. In the absence of 
blood vessels and capillaries, the thickness of most engineered tissues is limited to 
100-200 µm.265 This need is partially resolved by creating porous structures using 
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(direct) rapid prototyping techniques or other pore-creating methods. However, even 
with these porous scaffolds nutrient and oxygen supply is driven by passive diffusion. 
As a result, achieving cell densities close to physiological populations is extremely 
challenging since often necrotic areas are formed.55 The use of sacrificial templates 
offers an elegant alternative to conventional porous structures via the generation of 
multiscale, vascular-like channels in engineered tissue, which enables active transport 
of nutrients and waste. 
Natural vascularised tissues consist of three main components being the vascular 
lumen, the vascular wall lined with endothelial cells and a matrix of cells which surround 
the vascular channels. After removal of the vascular template the obtained channels 
can be perfused with endothelial cells to deposit a monolayer of cells. Consequently, 
hybrid cellularized scaffolds can be obtained exhibiting the presence of different cell 
types and a vascular network which closely mimics natural tissue.54,55,57 
To enable template removal in the presence of encapsulated cells template materials 
have to be carefully selected taking into account a number of requirements. They 
cannot be cytotoxic and need to be removed under mild conditions without relying on 
cytotoxic organic solvents. Examples of these materials include agarose57, gelatin54 
and carbohydrate-glass55. These can all be manually removed or dissolved by melting 
or dissolution in water or culture medium. An interesting approach to prevent 
leachables from entering into the matrix during template removal is the coating of 
vascular channels prior to casting. During selective dissolution this thin film prevents 
the leachables to enter the cell encapsulated hydrogel matrix while maintaining 
diffusion properties for biomolecules to the cells (Figure 24).  




Figure 24: a, Vascular unit cell. b, Patterned vascular channels supporting human blood flow. Scale 
bars: 1 mm (left) 2 mm (right). C, Encapsulated 10T1/2 cells in a filbrin gel, seeded HUVECs expressing 
mCherry. d, Two intersecting channels demonstrating endothelisation. e, Cross-section of a 
representative channel after nine days in culture. f, Single and multicellular sprouts formed by 
endothelial cells (arrowheads) Reprinted with permission from Macmillan Publishers Ltd: Nature 
Materials55, copyright (2012).  
1.3.2.5.3.2. Microfluidics 
Complex microfluidic channels are of interest for a range of applications in 
biotechnology, in sensors, lab on chips, organs on chips, chemical reactors and fluidic 
based computers. 228 They can be directly prototyped by (soft) lithography266–268, laser 
ablation269, deep proton writing270, micro-milling271 and ultra-precision diamond 
tooling272. Also, they can be produced at low cost in high volumes through replication 
techniques such as micro-injection moulding273, hot embossing274 or roll-to-roll 
printing275 . However, with these techniques the creation of bifurcating true three-
dimensional networks remains challenging. Direct writing with fugitive ink offers 
interesting perspectives in the creation of these microfluidic channels. For example, 
the creation of biomimetic vascular networks to study fluid transport efficiency has 
already been reported.231  
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Therriault et al. have used direct-write assembly with a fugitive ink to create channels with 
diameters ranging from 10-300 µm. An epoxy resin was cast and the ink was liquefied and 
removed forming a well-designed 3D epoxy network. By filling the channels with a 
photopolymerizable resin and selectively blocking some channels by using a filter before UV-
curing, a tower network was created to perform 1D, 2D and 3D mixing experiments (Figure 
25). 
 
Figure 25: a-c, Schematic representations and fluorescent microscope images of 1D, 2D and 3D 
microfluidic mixing experiments. Arrows indicate flow direction. Reprinted with permission from 
Macmillan Publishers Ltd: Nature Materials228, copyright (2003) 
1.3.3. Electrospinning 
Electrospinning is a method to create non-woven, porous fiber matrices which was  
discovered in the early 1930s.76 More specifically, a polymer solution or melt is guided 
through a metal needle and a large voltage (1 – 30 kilovolt) is applied between the tip 
of the needle and the grounded collector plate. As a result, the pendant drop becomes 
charged leading to the formation of a Taylor cone. When the charge repulsion 
overcomes the surface tension, a polymer jet is ejected from the Taylor cone. While 
the jet travels to the collector plate, the solvent will evaporate thereby creating solid 
fibers with a nano- to microscale diameter. If this process is continued during a 
sufficient time span (2-30 min depending on the flow rate), a mat of electrospun fibers 
will be formed. The setup is depicted in Figure 26.  




Figure 26: Electrospinning setup.  
As a result of their micro- or nano-structure, the fibrous scaffolds possess a high 
surface to volume ratio, which provides the cells with more surface area for attachment. 
Their porous structure enables efficient transport of nutrients and metabolites 
throughout the scaffold. In addition, the random fiber structure mimics the protein fibers 
present in the ECM. This renders electrospun scaffolds ideal for a range of applications 
including bone276, cartilage277,278, vascular279–282, neural283–286 and bladder287 tissue 
engineering. In addition, electrospun mats are highly investigated as wound bandages 
as their porosity enables gas exchange with the environment, while still offering a 
protective layer shielding the wound. In addition, the technique allows for the 
incorporation of antibiotic, antibacterial and other components promoting wound 
healing and preventing infection.288–291 
1.3.4. Other pore creation techniques 
In order to generate porous scaffolds, several other strategies than those mentioned 
above have been considered to date, such as critical point drying, freeze drying, 
porogen leaching, phase inversion, foaming and introducing gas forming agents 
Critical point drying implies the exchange of an organic solvent with liquid CO2 at room 
temperature at a controlled pressure. Next, the temperature is increased to 10° above 
the critical point of CO2 which converts liquid CO2 into gas, leaving behind a porous 
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network. The use of an organic solvent, often ethanol, is of crucial importance since 
liquid CO2 is not miscible with water. The obtained pores are generally about 50 µm 
large.65 
Freeze drying uses water (or another solvent) which is frozen to obtain ice crystals, 
followed by sublimation of these crystals. Consequently, empty pores are left with the 
morphological features of the ice crystals.65,204,292,293 When the solvent is water, the 
mean pore diameter is typically in the range of 100-200 µm.204  
In another approach, soluble salts or porogens can be incorporated into the scaffold 
material prior to casting. During template removal, the porogens are removed 
simultaneously, thereby leaving behind pores which exhibit the morphology and the 
size of the applied porogen.207,213,223,234,235,242,246 Tan et al. have applied uniform 
microspheres as porogens and arranged them in the most closely packed 
conformation via ultrasonic treatment. Using this method, a reproducible porous 
interconnective network can be obtained.207 
If a homogenous solution of two or more components (e.g. PCL in N-N-
dimethylacetamide) exists at a certain temperature, sometimes phase separation 
between the components can occur during cooling. After precipitation, the solvent can 
be washed away, leaving behind a porous structure in the precipitated compound (e.g. 
poly-ε-(caprolactone) or PCL).223,242,246,247 Under the right conditions (solvent system, 
cooling conditions), even nanofibrous structures can be generated which mimic the 
morphology of collagen fibers present in the ECM.212,247 
Another technique which has been explored is foaming. By vigorously stirring certain 
scaffold materials including gelatin, viscous foams can be obtained. When the scaffold 
material is cast into the mould followed by immediate freezing to lock the shape, a 
highly microporous material is obtained with pores revealing a spherical morphology 
and uniform distribution. The pore size can be controlled by varying the stirring speed 
during foam generation.241 
Another interesting approach to obtain micropores in a construct is the application of 
gas producing compounds. For example, when radical (photo-) polymerization is 
applied to lock the template shape into the final material, the use of azo-type initiators 
(e.g. VA-086) results in the generation of N2 gas during activation. This results in the 
formation of micropores inside the final construct.56  
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1.4. Phd outline 
In the present work, the aim was to explore different possibilities to circumvent the 
incompatibility of processing and crosslinking generally experienced with hydrogel 
building blocks. More specifically, in the second chapter, the development of a highly 
reactive hydrogel precursor was targeted to enable solid-state crosslinking thereby 
opening up unprecedented processing avenues. As the research was performed in 
close collaboration with an industrial partner (Allnex), the synthesis of the newly 
developed materials had to be readily translatable from lab-scale (mg to g range) to 
industrial scale (kg to ton range). As a result, the goal was to minimize the amount of 
synthesis and purification steps, and using industrially available reagents.  
In this second chapter, the solid state reactive prepolymers will be characterised using 
a variety of different techniques (1H-Nuclear Magnetic resonance spectroscopy, 
infrared spectroscopy, Gel permeation chromatography, photo-differential scanning 
caloremetry (photo-DSC) and rheology). In addition, three different processing 
possibilites will be explored: extrusion-based solid freeform fabrication from melt, 
electrospinning and two-photon polymerization in the solid state. In a final part of the 
chapter, a preliminary investigation into potential of these materials for tissue 
engineering will be investigated by seeding different cell types onto the scaffolds 
obtained by solid freeform fabrication.  
In the next chapter (chapter 3), the aim was to further characterise the prepolymers 
developed in chapter 2. Using different characterisation techniques, such as photo-
DSC, rheology and UV-Vis spectrophotometry a deeper look into the origin and kinetics 
of the solid state reactivity can be obtained. Furthermore, by synthesizing a range of 
different polymers, the versatility of this approach can be explored. In a final part, a 
model was developed to investigate the significance of the different termination 
reaction occuring during the solid state reaction.  
In addition, two more generally applicable hydrogel processing methods will be 
explored using the hydrogel precursors developed in this work. A first method, 
described in chapter 4, is indirect solid freeform fabriation, which applies conventional 
solid freeform fabrication techniques and materials to generate a template to be 
subsequently used to create scaffolds from a material of choice. With this technique, 
the drawbacks of conventional solid freeform fabrication, such as limited material 
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selection, brittleness and need for post treatment, low resolution and long optimization 
of new materials can be circumvented. 8,34,216–219  
For the second method, aqueous hydrogel solution that can be directly processed will 
be developed in chapter 5. Alltough many processing difficulties can be surpassed 
using a solid state reactive precursor, or by applying indirect rapid prototyping.. the 
composite material, described in Chapter 5, can be used as a solid freeform fabrication 
printing ink. The major advantage over the previously described methods is that this 
material could eventually be used to encapsulate cells during printing. To this end, the 
use of a silicate additive, inducing thixothropic behaviour and increasing the cellular 
response will be investigated in a second processing method to create a solid freeform 
fabrication ink suitable to generate 3D scaffolds for tissue engineering applications. 
The last chapter (chapter 6) will contain the major conclusions of the work and an 
outllook to future work. 
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Chapter 2:  
Flexible Oligomer Spacers as Key to 
















This chapter describes the synthesis and characterization of the solid state reactive 
materials developed. Parts of this chapter have been published as communication 
entitled “Flexible Oligomer Spacers as the Key to Solid-State Photopolymerization of 
Hydrogel Precursors” (Houben, A. et al. Flexible Oligomer Spacers as the Key to Solid-
State Photopolymerization of Hydrogel Precursors. Mater. Today Chem. 4, 84–89 
(2017)).1  
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As mentioned in the previous chapter, photopolymerization is an attractive technique 
to create tunable crosslinked polymer networks as it offers temporal and spatial control 
over the reaction.2,3 Furthermore, it is an energy-efficient process, as the 
polymerization can be initiated using low-energy UV irradiation. Therefore, this 
technique has been widely used to prepare crosslinked hydrogel networks starting 
from synthetic and natural polymers modified with photoreactive groups such as 
(meth)acrylates.4–6 Synthetic hydrogels are especially appealing as they can be 
prepared in a controllable and reproducible way, which in turn results in tailored 
mechanical and swelling properties.7  
Efficient crosslinking of conventional photoreactive hydrogel precursors relies on the 
mobility of the reactive groups and, hence, is typically addressed from the liquid state. 
To this end, solid precursors are processed from the melt at elevated temperature or 
after dissolution in a suitable solvent. However, this represents a limiting factor for 
many processing techniques (e.g. electrospinning, rapid prototyping, …) as these 
result in solid materials when processing is complete. This renders photocrosslinkable 
hydrogel materials hard to process into well-defined shapes with specific internal 
characteristics important towards their functional properties in e.g. biomedical 
applications. 8–12  
Herein, a model hydrogel precursor is introduced that overcomes this challenge using 
a prepolymer designed to enable successful crosslinking in the solid state. Not 
surprisingly, little has been reported on solid-state photopolymerization (SSPP) in 
literature as polymerization kinetics and functional group conversion are naturally 
expected to be inefficient. The few papers refer to monomer compounds (e.g. 
octadecyl (meth)acrylate),13–15 but so far, solid-state photopolymerization of 
macromolecular precursors and the concurrent technological benefit have never been 
described to the best of our knowledge.  
In the present approach, the hydrogel precursor is based on a polyethylene glycol 
(PEG) backbone which forms a semi-crystalline solid at room temperature. 
Photocrosslinking in the solid-state is promoted by the introduction of an oligomeric 
flexible spacer which separates the photoreactive acrylate groups from the immobilized 





PEG backbone polymer. Though spacers have already been applied to introduce cell- 
and protein interactive moieties in hydrogels,16–20 their use to provide motional freedom 
for reactivity enhancement has not been described to date.  
  





2.2. Materials and Methods 
2.2.1. Synthesis of model precursor 
Prior to the synthesis of the precursors, Poly(ethylene glycol) (MW 2000 g mol-1, 
Merck) (PEG2000) was vacuum dried under a N2 blanket in a double walled glass reactor 
equipped with a stirrer and connected to an oil bath heating system. Subsequently, the 
inhibitor 2,6-di-tert-butyl-4-methylphenol (BHT, Innochem GMBH) was added as a 
radical scavenger and phosphoric acid (H3PO4) was introduced to inhibit the reaction 
of the carboxyl groups present on the PEG (1.35 mmol g-1 ). The synthesis of 
PEG2000-OEOAcr occurred through a two-step process (see Figure 1). In a first step, 
PEG was linked to isophorone diisocyanate (IPDI) in a 1:2 stoichiometric ratio. 
Reaction between the hydroxyl groups of PEG and the isocyanates at  65°C was 
catalyzed by addition of 300 ppm bismuth neodecanoate which is proceeded by an 
exotherm occurring in a temperature range of 80-90°C. The urethane formation 
reaction further continued at T = 80°C. A potentiometric back titration allowed to 
monitor the progress of the urethane formation reaction. If the expected quantity of 
NCO groups is higher than 10%, the sample weight should be around 0.2 g. If the 
expected quantity of NCO groups is less than 2%, the sample weight should be around 
1 g. The sample is dissolved in 3 ml of a di-n-butylamine solution (64.5 g diluted to 1 L 
with N-methylpyrrolidone, NMP), and 50 ml of NMP is added. The excess of di-n-
butylamine is titrated potentiometrically using a 0.1 M HCl solution. A degree of 
conversion for the acrylate groups of 50 % after the first reaction step was targeted, 
corresponding with an NCO-value of 3.44 %. When the NCO-value decreased below 
the theoretical value, the selected end group (monoacrylated oligo(ethylene oxide) 
(OEOAcr, MW 336 g mol-1, GEO Specialty Chemicals), monoacrylated oligo(propylene 
oxide) (OPOAcr, MW 420 g mol-1, GEO Specialty Chemicals), monoacrylated oligo(ε-
caprolactone) (OClAcr, 334 g mol-1, Allnex) or hydroxyethylacrylate (HEA, 24 g mol-1, 
Allnex) was added dropwise under air atmosphere in the presence of 300 ppm bismuth 
neodecanoate. Next, the temperature was raised to 80°C. The reaction progress was 
monitored by measuring the NCO value via potentiometric titration. The reaction 
proceeded until the NCO value reached the theoretical value of 0.02 meq/g (value 
when half of the acrylate groups have reacted). After completion of the reaction, 500 
ppm phenothiazine (PTZ, Sigma Aldrich) and 500 ppm triphenyl phosphite (TPP, 





Sigma-Aldrich) were added as stabilizers and the reaction was completed by cooling 
to room temperature. Subsequently, the PEG2000-OEOAcr was filtered and 
transferred into a plastic container and stored at room temperature. Synthesis scale 
ranged from 100 g up to 5 kg.  
 
Figure 1: Synthesis scheme of the model precursor PEG2000-OEOAcr 
2.2.2. Gel permeation chromatography 
The number average molecular weight (Mn), the weight average molecular weight (Mw) 
and the polydispersity (PDI) were determined by conventional gel permeation 
chromatography (GPC) using polystyrene standards EasyCal from Polymer 
Laboratories (weight average Mw range: 200 – 400.000 g/mol). The polymer (PEG2000-
OEOAcr), its starting materials PEG2000, OEOAcr, IPDI and two PEG standards (MW 
1000 and 4000 g/mol) where dissolved (1.0% wt/wt) in tetrahydrofuran (THF)  
containing 0.5% toluene as flow rate marker. Analysis was performed by liquid 
chromatography (Merck-Hitachi L7100)  equipped with 3 PLGel Mixed-D LS 
polystyrene divinylbenzene GPC columns (300 mm X 7.5 mm, particle size 5 µm). The 
sample components were separated by the GPC columns based on their molecular 
size in solution and detected by a refractive index detector. Data were gathered and 
processed by Polymer Laboratories Cirrus GPC software. 











2.2.3. Nuclear magnetic resonance spectroscopy 
The 1H-NMR spectrum of the hydrogel precursors was recorded on a Bruker Avance 
500 MHz Spectrometer. Deuterated chloroform (CDCl3) was used as solvent. The 
number of scans was 16, the acquisition time was set to 3.17 seconds and the 
relaxation delay was 1.0 second. Spectra were analyzed using the Spinworks software 
(version 2.5).  
2.2.4. Infrared spectroscopy analysis 
Fourier Transform infrared spectroscopy was performed on a Bio-Rad FT-IR 
spectrometer FTS 575C operating in Attenuated Total Reflection mode. A diamond 
crystal with ZnSe crystal lens was used, with a refractive index of 2.4 at 1000 cm-1. 
Each spectrum is the result of 8 scans. The recorded spectra were analyzed using 
WIN-IR Pro software. 
2.2.5. Differential photocalorimetry 
DPC thermograms were recorded under nitrogen flow using a Mettler DSC823e with a 
Hamamatsu Lightningcure™ LC8 (L9588) unit. ). Aluminum crucibles (20 µL) were 
used for the experiments. The light source was a medium-pressure mercury-xenon 
lamp with prominent emission lines at 298, 302, 313, 365, 405 and 435 nm. The 
irradiance level in the UV-A range was adjusted to 15 mW cm-2 at the position of the 
sample crucible. The sample mass was typically 3 to 4 mg. An open empty aluminum 
crucible was placed at the reference location and the DSC cell was closed with an UV-
transparent quartz cover. Dry nitrogen was used as flow gas, unless mentioned 
otherwise (flow rate of 50 mL min-1). In order to compensate for the heat flow generated 
by the light source, reference and sample sides of the DSC cell were illuminated 
simultaneously. However, imperfect balance still led to a differential in evolved heat. 
Hence, to obtain the net reaction exotherm, photopolymerization was completed in a 
first step and the background heat flow was determined during a second one. The two 
heat flow signals were subsequently subtracted. Prior to irradiation, the samples were 
annealed at 60°C for 1 min, then cooled at a rate of -5 °C min-1 to the crosslinking 
temperature (20 or 50°C). After 10 minutes at the selected temperature, the two UV-
exposure cycles of 4 min were started. Maximum polymerization rate and double bond 
conversion were calculated according to literature procedures. 21,22 





2.2.6. Oscillatory photo-rheology 
The photopolymerization process of the precursor solutions was studied at 21°C using 
an Anton Paar MCR 300 rheometer equipped with an EXFO novacure 2000 UV-A light 
(intensity 140 mW cm-2) for sample irradiation from the bottom through a quartz plate. 
A parallel plate setup (ø 25 mm) was used. Frequency and strain sweeps were 
recorded to establish the linear visco-elastic range of the materials. A shear frequency 
of 1 Hz and an amplitude of 1 % were selected as they were well within this range. To 
study the effect of the network formation on the mechanical properties, the elastic 
shear modulus (G’) was monitored over time (gap 0.35 mm). UV light was switched on 
after 60 s during 10 min, followed by a 60 s measurement period without UV exposure. 
The photopolymerization followed for different concentrations (10 wt%, 30 wt% and 70 
wt%) with and without a photo-initiator 1-Hydroxycyclohexyl phenyl ketone (HCPK). 
2.2.7. Determination of the gel fraction and swelling degree 
Circular disks (thickness 2 mm, diameter 10 mm) were prepared from the appropriate 
solutions using glass plates covered by teflon release foil and separated by a silicon 
spacer. The precursor was dissolved in the appropriate amount of water, heated to 
40°C to decrease dissolution time. For the sample cured in the solid state, the 
precursor was molten at 60 °C and left to cool overnight. The samples were exposed 
from both sides to UV-A light for 20 minutes (300-400 nm, 2×8 mW cm-2). Samples 
were subsequently lyophilized (Christ alpha I-5) and weighed (wd0). The mass was 
again determined after equilibrium swelling in double distilled water at room 
temperature (ws). The final dry mass wdf was obtained after a second lyophilization 
step. The swelling ratio and the gel fraction were respectively calculated according to 
(ws-wdf)/wdf  and wdf/wd0.  
2.2.8. Electrospinning 
Electrospinning was performed using an in-house designed and developed device 
comprising a power supply (Glassman High Voltage, Inc, Model series EL50P00) 
capable of generating a potential between 0 and 50 kV and a 6 syringe motor driven 
pumping system (New Era Pump System, Inc, Model Multy-phase NE1600). For 
electrospinning experiments, an ideal composition was selected after optimization (as 
described in results and discussion) containing poly(ethylene glycol) (106 g/mol, 





Sigma) (2 wt% concentration) dissolved in a 1:1 water/ethanol mixture, to which 
PEG2000-OEOAcr was added (45 wt% concentration). A photo-initiator, Irgacure 2959 
(BASF) (2 mol% relative to double bond concentration), was added to obtain maximal 
crosslinking (see the following chapter). The distance between the needle and the 
collector plate was 15 cm, the flow rate was set to 1.5 mL/h and the potential difference 
was 15 kV. The electrospun fiber mats were crosslinked by UV-A illumination during 
20 minutes (300-400 nm) under N2 atmosphere. 
2.2.9. Fused deposition modeling 
Fused deposition modeling was performed using the BioscaffolderTM system (System-
Engineering, Hünxe, Germany) equipped with an extrusion head. PEG2000-OEOAcr 
was printed onto a cooled platform (13°C). Optimal processing parameters where 
selected after optimization (as described in results and discussion): a printing 
temperature of 57°C, a needle diameter of 160 µm, XY plotting speed of 220 mm min-
1, Z plotting speed of 700 mm min-1, layer thickness of 0.14 mm and a strut distance of 
1 mm. The obtained scaffolds were subsequently cross-linked via UV-A curing (300-
400 nm, 7,5 mW cm-2 from top and bottom, 20-60 min) and uncross-linked polymer 
was extracted in chloroform. 
2.2.10. Gelatin methacrylamide coating 
Gelatin-methacrylamide (GM) was prepared similar to a previously reported protocol. 
12,23 In brief, 100 g gelatin B was dissolved in 1 l phosphate buffer (0.1 mmolar, pH = 
7.4) at 40 °C. Under vigorous stirring, 3 equivalents of methacrylic anhydride, relative 
to the number of free primary amine functionalities in gelatin (38.5 mmol amines), were 
added. After 1h, the reaction was diluted with 1 l double distilled water followed by 24 
hours dialysis (Spectra/Por 4, MWCO 12-14 kg/mol) at 40°C. Finally, the material was 
frozen at -20°C and lyophilized to obtain a dry solid. The degree of substitution (DS), 
being 93%, was determined using 1H-NMR spectroscopy at 40 °C (D2O, Bruker WH 
500 MHz NMR spectrometer). The integrations of the characteristic signals of the 
methacrylamides at 5.75 and 5.51 ppm were compared to the Val, Leu and Ile 
reference signal present at 1.01 ppm as previously reported. 24 The obtained GM was 
applied as a coating by dissolving it in double-distilled water (1 wt% concentration) in 
the presence of 2 mol% Irgacure 2959 photo-initiator (BASF) relative to the 





methacrylamides. Next, the hydrogel scaffolds were swollen overnight in this solution 
at 5°C, to minimize potential hydrolysis of gelatin. Next, the scaffolds were crosslinked 
with UV-A light (300-400 nm, 2 x 8 mW cm-2 from top and bottom) for 1h and any 
uncrosslinked gelatin was dissolved in double distilled water for 1h at 40°C. The 
samples were subsequently lyophilized.  
2.2.11. Two photon polymerization  
The two-photon polymerization setup was used as described by Ovsianikov et al.25 A 
high power femtosecond laser oscillator (MaiTai eHP DeepSee, Spectra-Physics, 800 
nm, 60 fs, 90 MHz, <450 mW) was used and focused with a 32 × water-immersion 
microscope objective (Zeiss). For the positioning of the laser focus within the 
photosensitive resin, either a galvo scanner or a 3D piezo stage is applied. The CCD 
camera that is mounted behind a dichroic mirror is used for online monitoring of the 
2PP process.  
2.2.12. Biological evaluation 
Human adipose-tissue derived mesenchymal stem cells (ATMSC, P9, CryoSave) were 
cultured in DMEM GlutaMAX-1TM supplemented with 10% fetal bovine serum. Mouse 
calvaria preosteoblast cells (MC3T3-E1, P14, ATCC) were cultured in alfa-minimal 
essential medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine and 
0.5 vol% penicillin-streptomycin (104 U mL-1- 104 µg mL-1). Scaffolds were incubated 
in serum-free culture medium and ATMSC (250 000 cells/40 µl) and MC3T3 (150 000 
cells/40 µl) cells were seeded subsequently. After 3 hours, additional culture medium 
was added and the scaffolds were kept in culture (37°C, 5% CO2) for 23 days. Calcein 
AM/propidium iodide staining was performed after 1, 7, 14 and 23 days to evaluate cell 
viability by fluorescence microscopy (Type U-RFL-T, Olympus).  
2.3. Results and Discussion 
2.3.1. Synthesis and characterisation of the precursor 
To investigate the unique solid state reactivity, a range of precursors with different 
spacer groups (OEO, OPO, OCl, HEA) and a PEG backbone (MW 2000 g/mol), were 
synthesized at kilogram-scale following a solvent-free, two-step synthesis process in 
conditions relevant for up-scaled (kg to ton scale) industrial manufacturing. 11,26 For all 





precursors, the spacer group is attached to the backbone polymer using isophorone 
diisocyanate as depicted in Figure 1. The model compound, of which the molecular 
structure is shown in figure 2B, was the first polymer synthesized in the work and 
showed an excellent solid state reactivity. Therefore, no further optimization of the 
polymer structure was required.  
 
Figure 2. A: General structure of the solid state reactive polymers depicting the different building blocks. 
B: Model compound PEG2000-OEOAcr used for characterization and processing (n = 40, m = 6, x = 1-
3).  
2.3.1.1. 1H-NMR spectroscopy of the model precursor 
The 1H-NMR spectrum for the model precursor PEG2000-OEOAcr shown in Figure 
2B with an oligo-ethylene oxide spacer (OEO) is provided in Figure 3. The signals from 
0.85 to 1.9 ppm correspond to the methyl and cyclic methylene groups (g, h, i, k) of 
IPDI. The other protons of IPDI (e, j) can be observed at 2.9 and 3.25 ppm. Protons of 
the PEG-methyl in the spacer and backbone adjacent to the urethane (l’ and d”) can 
be found at 4.2 ppm, while the PEG-methyl protons next to the acrylate group (d’) are 
detected at 4.3 ppm. The signal from the urethane protons (m) can be observed 
between 4.7 and 5.1 ppm while the peaks at 5.85, 6.15 and 6.4 ppm correspond to the 
acrylate protons (a, b, c). An oxa-Michael addition reaction can occur as a side reaction 
between the hydroxyl groups of unreacted PEG and the acrylates of PEG2000-
OEOAcr 27,28 This is evidenced by the signal at 2.6 ppm (*) and will slightly reduce 
the acrylate concentration. The extend was determined by adding 3-nitroacetophenone 
as an internal standard, to determine the exact molar concentration of double bonds 
by comparing the peak of the internal standard and the signals assigned to the double 
bonds. The resulting value of 0.6256 mmol g-1 is in close correspondence to the 





theoretical value of 0.6421 mmol g-1, calculated based on the amount of monoacrylate 
PEG added during the synthesis (i.e. 0.80 mole monoacrylate PEG on a total mass of 
1246 g). Therefore, it can be concluded that the oxa-Michael addition reaction does 
not lead to a significant reduction in double bond concentration, and can be considered 
a minor side reaction. 
 
Figure 3: 1H-NMR spectrum of the precursor 
2.3.1.2. Gel permeation chromatography analysis of the precursor and reagents to 
assess the molecular weight and the composition 
For polycondensations, the polydispersity is controlled by using stoichiometrically 
unbalanced reactants (i.e. using an excess of one of the reagents to control the molar 
mass) and by limiting the removal of the formed by-product.29 However, this is not 
achievable in urethanisation reactions due to the impurity of the reagents (see below) 
and because in these reactions, no removable by-product is formed. Therefore, a 
controlled synthesis of polyurethanes is not straightforward.30 To increase the control, 
a diisocyanate with a primary and secondary isocyanate group (e.g. IPDI) can be 





combined with a selective catalyst (e.g. dibutyl tin dilaurate or bismuth neodecanoate) 
to obtained a more controlled two-step reaction.26 GPC analysis revealed the final 
composition of the product: by comparing the chromatogram of PEG2000-OEOAcr 
(black line) with the chromatograms of the raw materials (colored lines) in Figure 3, the 
different reaction products could be identified. Analysis of PEG standards (dotted lines) 
showed an excellent match between the measured molecular weight and the actual 
molecular weight. At position 1, a small fraction (1.6 mol%) of the diadduct of IPDI and 
PEG monoacrylate can be observed. This peak is quite broad due to the high molecular 
weight dispersity (3.8) of the PEG monoacrylate reagent shown in blue, caused by the 
variation of the number of ethylene oxide units, with an average value of 5. This low 
molecular weight product (number average MW is 1250 g mol-1) can be considered as 
a by-product of the synthesis.26 As a result, further purification steps (e.g. extraction) 
can be avoided what renders the precursor even more applicable and relevant towards 
industrial applications. The number of repeats of the PEG backbone, indicated by x in 
the molecular structure in Figure 1, is one for the peak at position 2, two for the peak 
at position 3 and three for the peak at position 4. While the aim of the synthesis was to 
obtain a polymer where the backbone repeats only once (z=1 in Figure 1), for some of 
the polymers the backbone will repeat multiple times. As explained higher, the 
urethanisation reaction is difficult to control. Here, PEG is reacted with IPDI, and 
because of the selectivity of the catalyst, only the primary isocyanate will react. 
However, as this selectivity is imperfect, for some of the IPDI molecules both 
diisocyanate groups will react, leading to the observed repeating backbone (1-3 
repeats). The number average molecular weight was calculated to be 3800 g mol-1 and 
the weight average 6740 g mol-1, which results in a polydispersity of 1.78.  






Figure 4: GPC chromatogram of the reagents used (PEG 2000, IPDI, PEG monoacrylate), the reaction 
product (PEG2000-OEOAcr) and 2 reference standards (PEG 1000 and PEG 4000) 
2.3.1.3. Infrared spectroscopy analysis of the precursor 
Characteristic bands for the urethane groups31 were observed in the ATR-FT-IR 
spectrum in Figure 5. including the stretching of NH groups (vN-H) at 3331 cm-1, the 
carbonyl stretch (vC=O) at 1718 cm-1, the amide II band (NH bending vibration) at 1530 
cm-1, the bending of C-H2 (δC-H2) at 1466 cm-1, the amide IV band at 1240 cm-1 and 
stretch bands of C-O-C at 1104 cm-1 and 1074 cm-1. The acrylate terminal groups show 
characteristic vibrations at 810 cm-1, 1410 cm-1 and 1640 cm-1. 






Figure 5: ATR-FT-IR spectrum of the precursor (PEG2000-OEOAcr). 
2.3.2. Investigation of the solid-state reactivity of the hydrogel precursors 
Upon crystallization of the precursor , the backbone polymer forms crystalline domains 
segregating the acrylate groups into structured zones as depicted schematically in 
Figure 6. As further suggested by optical microscopy, the crystalline domains are 
seemingly aligned as long strings building-up lamellae in spherulitic structures. 
Although other attempts have been made to visualize this phase separation (i.e. IR 
surface mapping, AFM), their resolution was not sufficient to detect the different zones. 
It can be anticipated that in such an immobilized structure, the polymerization can 
merely propagate along the acrylate-enriched zones following a reactive diffusion 
mechanism provided that functional proximity and motional freedom is sufficient. By 
incorporating a flexible spacer, the resulting prepolymers exhibit excellent solid state 
photo-reactivity at room temperature and, surprisingly, even in the absence of a photo-
initiator. Initiator-free polymerization avoids any potential toxic effects associated with 
the photo-initiator, eliminates pre-processing mixing steps as well as the need to find 
a photo-initiator suitable for the selected processing technique.25,32,33 This auto-
initiation will be investigated in more detail in the following chapter. The implemented 
strategy is here specifically demonstrated for a telechelic acrylated hydrogel precursor 
(Figure 2B) based on PEG with a molar mass of 2000 g mol-1 linked to a short 
oligoethylene oxide (OEO) spacer with an average ethoxylation degree of six.  






Figure 6: Optical microscopy image (scale bar 100 µm) and hypothetical drawing of the phase separation 
into PEG-rich, crystalline zones and acrylate-rich amorphous zones in the precursor solid state. 
Figure 7 compares the initiator-free photopolymerization of the model prepolymer 
(PEO2000-OEOAcr) in the solid and the molten state as determined by differential 
photocalorimetry. The top curves show the reaction exotherms upon UV-exposure for 
which the maximum of the heat flow hp,max provides a good index for the reactivity. The 
lower panel of Figure 7 represents the double bond conversion (DBC) during 
photopolymerization with a final value close to 52% in both the solid and the molten 
state. This was calculated from the total heat released ΔHp (J g-1):  
 
DBC (%) = 100 . ΔHp /(cacr.ΔH0,p)        (1) 
 
where ΔH0,p = 77.6 ± 1.1 kJ mol-1 is the molar reaction enthalpy of acrylate double 
bonds and cacr = 0.626 mmol g-1 is the concentration of acrylate double bonds of the 
model precursor estimated independently using proton NMR spectroscopy.21,22 The 
maximum polymerization rate rp,max can be estimated after proper scaling of hp,max 
according to:  
 
rp,max = hp,max/(cacr.ΔH0,p)         (2) 





Clearly, at the two temperatures the precursor exhibits significant polymerization in 
less than one minute but, remarkably, the reaction proceeds 2.5 times faster in the 
solid state as deducted from the rp,max values. An accelerating effect can be anticipated 
from the local concentration of acrylate groups in the periphery of the crystalline 
domains after solidification (cfr. Figure 6) as the rate of free radical polymerization is 
proportional to the double bond concentration. However, the immobilization of the 
precursor chains and the association of the double bonds must also significantly affect 
the reaction paths and the corresponding rate constants. For instance, propagation 
and termination controlled by translational diffusion of the growing polymer, typically 
resulting in the auto-acceleration step at early stage of the reaction in the liquid state, 
are completely inhibited in the solid-state. Reaction diffusion and monomolecular 
termination reactions (i.e. radical entrapment) are assumed to operate as the 
controlling mechanisms for propagation and termination in the solid-state reaction 
kinetics, as will be investigated in more detail in the following chapter.  
 
Figure 7: Heat flow profiles obtained by photocalorimetry (top) and double bond conversion (DBC, 
bottom) in the solid (20°C) and molten state (50°C) for PEG2000-OEOAcr. 
The importance of the nature of the spacer group on the polymerization kinetics in 
liquid and solid form is illustrated in Figure 8 where the maximum polymerization rate 
rp,max is compared for precursors with a short spacer of one ethylene oxide unit (PEG-
HEAcr) and flexible oligomer spacers with an average of six propylene oxide units 
(PEG-OPOAcr), three -caprolactone units (PEG-OCLAcr) and six ethylene oxide units 





(PEG-OEOAcrylate). In addition, this figure shows the versatility of this approach, as 
all polymers were reactive in the solid state. The various precursors are ranked 
according to a decreasing reactivity when photopolymerized in the melt without 
initiator. In the assumption of constant propagation in the early stage of the 
polymerization, the decrease of rp,max essentially reflects the decreasing ratio between 
initiation and termination. The auto-initiation process was investigated using photo-
DSC as depicted in Figure 8. In a first step, the different building blocks of the polymer 
were irradiated separately, in the absence of a photo-initiator. Only in case of the 
monoacrylate-PEG, an exotherm was witnessed as a result of auto-initiation. To further 
investigate where exactly in this molecule the initiation takes place, smaller segments 
of this molecule (i.e. hydroxyethyl acrylate and acrylic acid) were irradiated as well. 
Interestingly, even in the case of acrylic acid, a strong peak (7.8 W g-1) can be 
observed. Therefore, it can be concluded that the acrylate compound is the primary 
radical initiator showing a strong variation in efficiency depending on the chemical 
environment. 34,35 
 
Figure 8: Maximal polymerization rate (rp,max) for precursors with different oligomer spacers as studied 
by photo-DSC. 





Termination on the other hand is influenced by viscosity and both factors are assumed 
to control the reported rp,max value.2 In full contrast, the inversion of the trend for 
polymerization in the solid state now reveals a reactivity increase along the same 
series. This clearly demonstrates that the kinetic parameters are profoundly altered by 
the structural changes upon crystallization and that the spacing group has a prominent 
role. The polymerization rate increases with increasing spacer length, resulting in a 
local free volume gain.36 Additionally, the rate also depends on the chemical nature of 
the spacer. The three selected spacers (OPOAcr, OClAcr and OEOAcr) contain 
flexible units according to polymer stiffness parameters such as Flory’s characteristic 
ratio Cn, defined as the ratio of the mean square unperturbed end-to-end distance for 
a real chain to the value expected for an ideal (or freely jointed) chain with the same 
number of bonds. Recently, Kokubo and Vana reported very accurate Cn values for 
polyethylene oxide and polypropylene oxide, i.e. 3.96 and 5.76 respectively, 
quantifying the higher flexibility of the OEO spacer relative to the OPO one.37 Reliable 
values could not be found for PCL but typical Cn values for polyesters are in the same 
range.36  
 
Figure 9: Photo-DSC thermograms of the different building blocks enabling the investigation of the auto-
initiation process. 





The model precursor (PEG-OEOAcr) is readily soluble in water up to 90 wt%. The 
aqueous solutions can be photopolymerized in the absence of a photo-initiator yielding 
high gel fractions close to 100% for precursor concentrations between 20 and 100 wt%, 
as depicted in Figure 10. Only at the lowest concentration (10 wt%) and when 
crosslinking in the solid state, the gel fraction slightly drops to respectively 88.9 ± 
0.7 %.and 93.5 ± 1.2 %. 
 
Figure 10: Swelling ratio and gel fraction results for PEG2000-OEOAcr  in concentrations in water varying 
from 10 to 100 wt% in the absence of a photo-initiator (n=3).  
The photopolymerization process of different aqueous solutions of the hydrogel 
precursor was followed by oscillatory rheology in the linear viscoelastic regime.  Figure 
11 shows the build-up of the elastic shear modulus, G’, upon UV-exposure for the 
model precursor in the absence (dotted line) and in the presence (full line) of a photo-
initiator, i.e. 1-hydroxycyclohexyl phenyl ketone (HCPK, 1.5 mol% relative to the 
acrylates present). As anticipated, the results reveal that the presence of a photo-
initiator accelerates the network build-up, yet, with a negligible influence on the final 
moduli for concentrated (≥30 wt%) systems. In dilute conditions (<30 wt%), however, 
the final network exhibits a higher density of elastically active chains when polymerized 
with a photo-initiator as illustrated for the 10 wt% solution for which the final G’ reaches 
7.5 kPa compared to 5 kPa in initiator-free conditions. Similar values where obtained 
by Lin-Gibson et al for PEG dimethacrylates (MW 2000) g/mol, with a storage modulus 
for a 10 wt% concentration of 10 kPa.38 In addition, there is a clear effect of the 





concentration of the precursor on the rheological properties, both with and without a 
photo-initiator. Lower concentrations will result in a lower final storage modulus, which 
increases with increasing precursor concentration, up to 630 kPa for a 70 wt% 
concentration. 
 
Figure 11: Storage moduli monitored by photo-rheology for different precursor contents, in the absence 
(dotted lines) and in the presence (solid lines) of a photo-initiator (1.5 mol% HCPK) 
2.3.3. Investigation of the processing potential of the developed polymers  
2.3.3.1. Electrospinning of the solid state reactive polymer 
The exceptional solid state reactivity is particularly useful when dealing with polymer 
processing techniques for hydrogel applications. A first example is the manufacturing 
of a solid microfiber mat by electrospinning (Figure 12). Previously, fiber crosslinking 
using UV light has been attempted during formation, from the needle to the collector 
plate, when the solvent was still present. 39,40 However, substantial conversion levels 
were hard to achieve upon curing due to the short effective exposure time (i.e. < 1s).  
In contrast, with the solid-state reactive precursor, the fibers could be effectively 
crosslinked in a separate post-processing step following electrospinning.  






Figure 12: Dry electrospun fiber mat of the model precursor PEG2000-OEOAcr deposited randomly right), 
or in an aligned fashion (middle). 
To optimize the electrospinning process, a number of parameters can be varied, 
related to the composition of the electrospinning solution or to the electrospinning 
process. An overview of the evaluated parameters is provided in Table 1. For each 
parameter combination, the electrospinning process was evaluated visually (fiber 
formation, occurrence of drips, stable Taylor cone) and microscopically (fiber 
morphology and regularity, presence of beads, fiber size and variations in size). Some 
commonly observed fiber irregularities and defects, compared to regular fibers, are 
depicted in Figure 13. With regards to the solution, the PEG2000-OEOAcr concentration 
was varied between 5 and 45 wt%. As the polymer has a relatively low molar mass 
(Mn of 3800 g mol-1), the electrospinning process and fiber formation where not stable 
for the evaluated concentrations. Viscosity enhancement with high molar mass PEG 
(106 g mol-1) was required to enable fiber formation. Due to its high molecular weight, 
this additive increases the amount of chain entanglements (should be a at least 2.5 
entanglements/chain), resulting in stable fiber formation.41 The concentration of the 
high molar mass PEG additive was varied between 1 and 9 wt%.  






Figure 13: Top row: Regular fibers (left), electrospraying: no fiber formation (center), beaded fibers 
(right). Bottom row: incomplete solvent evaporation leading to fused fibers (left), large variations in fiber 
diameter (center), coiled fibers (right) 
For concentrations of 15 wt% PEG2000-OEOAcr or lower, at least 7 wt% of the PEG 
additive needed to be added. For concentrations of 20 wt% or higher, 2 wt% of the 
high molar mass PEG additive was sufficient to obtain a stable process. Although 
spinning with 1 wt% of PEG additive was possible as well, this was not always 
reproducible. Therefore, 2 wt% of the high molecular weight additive was selected. 
Regarding the PEG2000-OEOAcr concentration: as the ratio between the precursor and 
the additive increases, more crosslink points will be present in the fiber, leading to 
improved crosslinking. Therefore, the maximal PEG2000-OEOAcr concentration was 
selected. At a concentration of 50 wt%; fiber formation was not witnessed. Therefore, 
a concentration of 45% was used for further experiments.  
Table 1: Overview of evaluated electrospinning parameters, with the range that was evaluated and the 
optimal value. Process parameters in bold are for the sample in Figure 14. 
Parameter (unit) Evaluated range Optimal value  
PEG2000-OEOAcr (wt%) 5-50  45  
PEG 106g mol-1 (wt%) 1-9  2  
EtOH/H2O ratio 0/100 - 85/15 1/1 
Needle distance (cm) 15-20  15 - 20  
Flow rate (mL/h) 0.5 – 2.5  0.5 -1.5  
Potential difference (kV) 10-20 kV 12.5-  15  
 





Concerning the solvent selection, the volatility of the solvent is highly important: if the 
solvent is to volatile, it will start evaporate from the Taylor cone and eventually lead to 
needle blockage. This was the case when electrospinning in chloroform was 
attempted. Electrospinning in pure demineralized water was possible, but more regular 
fibers and reproducible results were obtained when a mixture of ethanol (EtOH) and 
water was used. Pure ethanol as a solvent was not possible, as the precursor and PEG 
additive did not dissolve in sufficiently high concentrations for electrospinning. A 1/1 
mixture of EtOH and demineralized water was selected as a solvent system. For this 
composition, high solubility and excellent fiber formation where be observed.  
In addition, for the electrospinning experiments a photo-initiator was added (2 mol% 
relative to the acrylate concentration of Irgacure 2959). As the fibers are quite small (in 
the range of 10µm), fewer crosslink points will be present in a fiber compared larger 
samples such as disks or 3D-printed constructs. In addition, the large surface-to-
volume ratio of these fibers will increase the effect of oxygen inhibition on the 
polymerization. To help increase the double bond conversion, a photo-initiator was 
added. The effects of a photo-initiator on the polymerization process will be explained 
in more detail in the following chapter. The presence of a photo-initiator will help to 
increase the stability of the fiber mats: without the photo-initiator, it was noticed that 
part of the fibers would dissolve or detach when immersed in water, while this was no 
longer an issue when a photo-initiator was added.  
For all electrospinning compositions, three process parameters where varied and their 
effect on fiber formation and morphology was studied: the distance from the needle to 
the collector plate, the flow rate of the polymer from the syringe and the applied 
potential difference. Another parameter that plays a major role in the electrospinning 
process is the air humidity. As the electrospinning device is not in an air-conditioned 
room, this parameter could not be controlled. This impacted the reproducibility of the 
results, especially the effects of the process parameters. Currently, a hygrometer is 
present to measure the air humidity during the experiment. Unfortunately, this was not 
available at the time of these experiments, therefore differences in air humidity could 
not be determined.  
A first process parameter is the needle distance. The needle distance will impact the 
evaporation of the solvent (longer distance gives more time to evaporate) and will have 





an influence on the electrical field (longer distance reduces field strength). As the air 
humidity also impacts the solvent evaporation, this will affect the influence of needle 
distance. For example, when looking at the effect of needle distance for all evaluated 
samples, a needle distance of 20 cm gave a slightly improved result compared to 15 
cm. However, for the samples in Figure 14, the best result was achieved with a needle 
distance of 15 cm. The second evaluated parameter was the flow rate, which was 
varied between 0.5 and 2.5 mL/h. Optimal results were observed for a flow rate 
between 0.5 and 1.5 mL/h, although this needed to be optimized for each experiment 
as small air bubbles or minor blockages in the needle and tubing will have an impact. 
The last parameter was the applied voltage, which was varied between 10 and 20 kV. 
Again, the voltage needed to be optimized for each experiment, however better results 
were observed for the lower voltages between 12.5 and 15 kV.  
In Figure 14, electrospun precursor fibers, obtained using the improved parameters 
discussed above (45 wt% PEG2000-OEOAcr, 2 wt% PEG additive, 2 mol% Irgacure 
2959, 1:1 EtOH/H2O mixture, needle distance of 15 cm, flow rate of 1,5 mL/h and 
potential difference of 15 kV) are shown before and after UV exposure and after 
swelling in water demonstrating the successful curing. Before water swelling, the fiber 
diameter was 7.70 ± 1.38 µm, which increased to 10.16 ± 1.30 µm after equilibrium 
swelling. The decrease in fiber smoothness after crosslinking is due to shrinkage 
phenomena during polymerization. This volume contraction is monomer dependent, 
and will occur when polymerizing acrylates and methacrylates.42  
 
Figure 14: From left to right: fibers after electrospinning, fibers after crosslinking and water swollen 
crosslinked fibers ( room temperature). 
2.3.3.2. Solid freeform fabrication of the solid state reactive polymer 





Another frequently used processing technique is solid freeform fabrication. Extrusion-
based printing of photo-crosslinkable hydrogel precursors is highly challenging and 
mainly uses thermo-responsive polymers or shear-thickening additives.5,43 The novel 
materials described herein could be printed by fused deposition modeling and again 
crosslinked in the solid state afterwards. To enhance the printing process, temperature, 
needle diameter, speed (in XY and in Z planes) and layer thickness where varied as 
summarized in Table 2. 
Table 2: Evaluated and optimal solid freeform fabrication parameters 
Parameter (unit) Evaluated range Optimal value  
Printing temperature (°C) 40-60  57 
Needle diameter (µm) 160-210  160 
XY-printing speed (mm min-
1) 
180-240  220 
Z-printing speed (mm min-1) 500-760 700 
Layer thickness (mm) 0.12-0.23  0.14 
The needle diameter will have a direct influence on the strut size: the precursor melt 
will more easily flow from a needle with a larger diameter, however the printing 
resolution will increase as the needle diameter decreases. Initially, a needle diameter 
of 210 µm was selected as printing with this needle was most straightforward. 
However, after optimization of the other printing parameters, the needle diameter could 
be reduced to 160 µm. Another important parameter is the printing temperature, which 
was varied between 40°C and 60°C. If the temperature is to low, the printing solution 
will not flow from the needle easily and blockages or interrupted struts will be observed. 
If the temperature is too high, the structure will not cool down fast enough and keep 
flowing after printing, as shown in Figure 15 (left). The XY speed will influence the 
thickness of the struts and was varied between 180 mm min-1 and 240 mm min-1. A 
higher speed will lead to thinner struts, however if the speed becomes too high, the 
struts will become interrupted. As thinner struts lead to a higher printing resolution, the 
maximum achievable speed was selected (220 mm min-1). 






Figure 15: Common defects observed during the optimization of solid freeform fabrication as a result of 
incorrect printing parameters. Left: printing temperature is too high. Center: layer height is too high. 
Right: Z printing speed is too low.  
The layer height influences the deposition of the struts. If the set value is too low, the 
printed layer will destroy the layer below as the needle moves through printed struts. If 
the value is too high, the deposited strut does not touch the strut below, leading to 
irregular shaped struts as depicted in Figure 15 (center). The Z speed is the speed at 
which the needle moves up after a layer is printed. If this speed is too high, the last 
part of the deposited strut will break and cause a defect. If the speed is too low, a 
droplet of material will be deposited on the edge of the scaffold, as shown in Figure 15 
(right).  
Using the selected printing parameters, regular scaffolds could be printed as shown in 
Figure 16A. The use of this technique has never been reported before for photo-
reactive hydrogel building blocks as it is mainly applied for thermoplastic polyesters. A 
pore size of 1 mm was selected, and the actual distance was determined to be 562 ± 
36 µm. This difference is due to the fact that the software assumes the needle distance 
will equal the strut size. For this scaffold, the needle diameter was 160 µm, while the 
strut size was 535 ± 108 µm. Clearly, the strut size is much larger compared to the 
needle diameter, explaining the difference in set strut size and printed strut size.  
As shown in Figure 16A, the printed structure becomes quite flexible after swelling in 
water. Clearly, the printed structure no longer dissolves, demonstrating the curing 
effectiveness. As the surface to volume ratio is much lower for these printed constructs 
compared to electrospun fibers, no photo-initiator needed to be added. Printing of 
larger and more complex shapes was also possible as illustrated in Figure 16B, where 
a printed meniscus is shown as a proof of concept that more complex shapes are 
attainable as well, based on a design from a magnetic resonance imaging (MRI) scan 
of a real human specimen.  






Figure 16: A: Magnified and overview image of the 3D-printed scaffold, and scaffold after incubation in 
water. B: From left to right: 3D model of a meniscus (32 x 25 x 12 mm3) based on an MRI scan of the 
patients meniscus, the 3D printed scaffold and a µ-computed tomography cross-section. 
  





2.3.3.3. Two photon polymerization in the solid state 
The last processing technique explored in this work is two-photon polymerization 
(2PP), a technique during which a tightly focused laser beam (voxel) is scanned 
through a photo-reactive material resulting in localized polymerization. The latter 
enables the creation of complex 3D-microstructures at sub-micrometer resolution.44  
However, there are some challenges associated with hydrogel optimization for 2PP 
purposes. Since hydrogel precursors are often processed in dilute conditions (< 20 
wt%), a loosely crosslinked network is usually obtained exhibiting structural distortions 
because of the lack of structural support.45 Furthermore, structuring in solutions can 
result in problems related to the support of ‘hanging’ structures during fabrication. 
Another limitation is the availability of biocompatible and water-soluble photo-initiator 
systems suitable for two-photon absorption.45,46 Obviously, the reported initiator-free 
solid state crosslinking approach eliminates problems related to photo-initiator toxicity 
and complex geometrical structures. In addition, the highly crosslinked network (gel 
fraction of 93.5 ± 1.2 % for circular disks in the solid state) leads to a low swelling 
degree (1.5 times its original dry weight), which will minimize structural distortions. To 
demonstrate the 2PP potential of the solid state reactive materials, a 3D Atomium 
model was printed, as illustrated in Figure 17. As can be observed, high shape fidelity 
was obtained, and the printed structure did not collapse, illustrating the supporting 
capacity of the solid state crosslinked hydrogel. 45  






Figure 17: Atomium model (top) used to create the 2-photon polymerization structures (bottom) from 
PEG2000-OEOAcr. 
2.3.4. Biological evaluation of fused deposition modelling scaffolds with and 
without gelatin methacrylamide coating 
The tissue engineering potential of PEG2000-OEOAcr was evaluated by seeding 
adipose-tissue derived mesenchymal stem cells (ATMSC) and mouse osteoblast cells 
(MC3T3) onto 3D-printed scaffolds. The developed precursor is PEG-based (see 
Figure 1), it can be anticipated that it will not be prone to cell adhesion.47 However, for 
applications for which cell adhesion is desired, a gelatin methacrylamide coating can 
be applied. As depicted in Figure 18, no cell adhesion was observed for the uncoated 
material over the duration of the experiment (i.e. 23 days). Conversely, the samples 
coated with modified gelatin showed excellent cell adhesion with cells displaying an 
elongated morphology as visualized by fluorescence microscopy (Figure 18) and SEM 
(Figure 19). Consistent with the seeding density, which was selected in relation to the 
expansion rate of the selected cell type (ATMSC: 250 000 cells/40 µl and 
MC3T3:150 000 cells/40 µl), the cells formed a confluent monolayer on the scaffolds 
at early times (d1 for the ATMSC’s, d7 for the MC3T3’s).48 Ideally, cell densities should 
be adjusted to reach confluency at the same timepoint. However, it is difficult to 
estimate the interactions between the material and the cells, therefore this was different 





for the 2 cell types. After a confluent layer was reached, the cells started to bridge the 
pores (visible from d7 at both timepoints. As evidenced from the vital staining images, 
the excellent viability of the adhering cells was maintained for 23 days, ascertaining 
the preliminary biocompatibility of these materials. A more quantitative analysis (e.g. 
metabolic activity assay) could be suitable here to determine the viability and indicate 
the amount of adhering cells, and proliferation at the different timepoints.48  
 
Figure 18: Cell adhesion and proliferation of ATMSC and MC3T3 cells on uncoated 
and 1 wt% gelatin methacrylamide coated scaffolds, studied by fluorescence 
microscopy of calcein-AM/propidium iodide stained cells. 
 
Figure 19: Cell adhesion and proliferation of ATMSC and MC3T3 cells on 1 wt% gelatin methacrylamide 
coated scaffolds, studied scanning electron microscopy of fixated samples 






In conclusion, for the first time, a solid-state reactive hydrogel precursor has been 
developed by linking an acrylate moiety, attached to a short (5 ethylene oxide or 2 ε-
caprolactone units) flexible oligomer spacer, to a semi-crystalline polymer backbone. 
The resulting prepolymers exhibited excellent photo-reactivity at room temperature, 
below their melting point and in the absence of a photo-initiator. This solid state 
reactivity can be explained by the structuring of the precursor into acrylate-rich 
amorphous zones and crystalline zones constituted by the polymer backbones. The 
introduction of a spacing segment with a low stiffness (Cn ratio of 3.96) has a clear 
positive effect on the reaction kinetics. A model PEG-based hydrogel precursor could 
successfully be processed and crosslinked using three techniques that are 
incompatible with conventional photo-reactive hydrogels; i.e. (i) electrospinning (with 
PI), (ii) melt-based additive manufacturing (without PI), both followed by a separate 
curing step, and (iii) 2PP in the solid state without PI, demonstrating the versatile 
application spectrum of the new precursor. Finally, using 3D-scaffolds, it has been 
shown that no cell adhesion takes place on uncoated scaffolds whereas excellent cell 
adhesion could be observed after application of a gelatin methacrylamide coating.  
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Chapter 3:  


















Herein, the kinetics of the solid state reactive materials developed in the previous 
chapter are more thoroughly analyzed based on photo-DSC experiments and by 
developing a model describing the solid state polymerization. In addition, the versatility 
of the solid state reactive polymers was explored by synthesizing a range of materials, 
and the effect of the different chemical structures on the material properties was 
determined.   
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Photo-initiated polymerization is a versatile polymerization mechanism that can be 
performed solvent-free (above the melting point) and at ambient conditions.1 It offers 
both spatial and temporal control, and is used in a number of applications such as 
dental materials, contact lenses2, coatings3 and tissue engineering matrices.4–7 
Although the photopolymerization procedure is fairly straightforward, the underlying 
mechanisms are quite complex. The free radical polymerization involves behaviors 
such as auto-acceleration and decelaration8, quenching9, radical entrapment10, volume 
shrinkage11, microstructural heterogeneity12 and incomplete functional group 
conversion.13  
A distinction can be made between linear and non-linear (crosslinking) systems, and 
in this specific case, between polymerization in the solid and in the liquid state (polymer 
melt or solution). The elementary reaction steps (i.e. initiation, propagation and 
termination) will not differ between the different systems and conditions, yet the kinetic 
aspects of the reaction will be significantly impacted.14 The different features of a 
crosslinkable photopolymerizable mixture and the network formed after completion of 
the photopolymerization process, are depicted in Figure 1. In this example, a 
bifunctional, macromonomer, also called prepolymer, is crosslinked in the melt using 
a photo-initiator to generate radicals. The most important kinetic aspects of a 
conventional free radical polymerization, valid for mono- and multifunctional monomers 
polymerized in the liquid and solid state are outlined in the following paragraphs. 
Differences between linear and crosslinkable systems, as well as polymerizations 
occurring in solid versus liquid state will be mentioned when relevant. 





Figure 1: Illustration of the photopolymerization process presenting the system before and after UV 
irradiation. In this schematic representation, the amount of crosslinking points is reduced compared to 
the actual situation, for reasons of clarity.  
Three main steps can be distinguished for free radical polymerizations including 
initiation, propagation and termination (see Figure 3).3,15 The diffusion reactions of the 
initiator, reactive groups (double bonds) and radicals significantly influence the 
observed reaction rates of initiation, propagation and termination reactions, and are 
influenced by viscosity, temperature, monomer structure and solvent.15 Three diffusion 
types can be considered in this respect, as shown in Figure 2:16–19  
- Translational diffusion: center of mass diffusion 
- Segmental fluctuation: reorientation of the radical-containing polymer segment  
- Reaction diffusion: diffusion of the radical through propagation 





Figure 2: Different diffusion types 
Therefore, the observed rate coefficients will vary as the reaction progresses. For 
polymerizations in the semi-crystalline state, it can be anticipated translational diffusion 
will be completely suppressed, and propagation and termination reactions can only 
occur through segmental fluctuation and reaction diffusion.  
 
Figure 3: Typical reaction steps involved in a free radical polymerization 
In free radical polymerizations, different types of initiating systems can be distinguished 
including photo-, thermal- and redox-initiation. In this work, the focus will lie on photo-
initiation, for which initiators can be classified according to two radical producing 




mechanisms.15 The type I photo-initiators generate radicals through a highly efficient 
α-cleavage process. In this category, benzoin ether derivatives, benzyl ketals, 
hydroxyalkylphenones, α-amino ketones and acylphosphine oxides can be found.15 
Type II photo-initiators act indirectly by hydrogen abstraction from a radical precursor 
containing a weak covalent bond. Examples include aromatic ketones, xanthones and 
thioxanthones, aromatic diketones and 3-keto-coumarins.15  
In case of a type I photo-initiator, initiation is a one-step process of which the rate Ri 
depends on the absorbed light intensity of the sample Ia and the efficiency of the photo-
initiator to generate radicals, which is expressed as the quantum yield Φi. The quantum 
yield expresses the amount of radicals produced for each absorbed photon.3 This 
results in the following equation for step (I) in Figure 3:3  
aii IR             (1) 
In the second step of the initiation, the radicals react with the monomer (step II), 
creating a new radical on the monomer group. When comparing the different reaction 
steps, the initiation reaction is least influenced by limitations associated with mass and 
heat transfer.1 To enable further propagation of the reaction, the radical will continue 
reaction with other monomers, thereby generating a growing polymer chain as shown 
in step III in Figure 3. The overall propagation reaction Rp is generally written as:3,15,20  
  MMkR pp            (2) 
where kp represents the propagation rate coefficient, [M] the double bond concentration 
and [M·] the radical concentration. The rate of the addition of a primary radical to a 
monomer (II) is different from the rate when a radical on a monomer reacts with another 
monomer (III). However, often the generation of the primary radical (I) and the first 
addition to a monomer (II) are combined into one expression for Ri. In addition, the 
bimolecular reaction rate is assumed to be chain length independent, although there 
is evidence that there can be an effect, especially when the monomer results in a more 
rigid polymer (e.g. methacrylates are more rigid compared to acrylates).17,21,22 The rate 
coefficient kp therefore encompasses a number of different reactions which are 
combined into one constant. In addition to the reaction of growing polymer chains with 
different lengths, these include reactions of pendant and monomeric double bonds and 
chain transfer reactions.23  




For crosslinking systems specifically, a difference in reactivity arises between free and 
pendant double bonds. As the reaction propagates, multifunctional monomers are 
incorporated in the growing polymer chain resulting in pendant double bonds. As a 
result, the reaction can either propagate by addition of the next monomer, or by 
reaction with one of these pendant bonds on the same polymer chain (intramolecular) 
or on a different polymer chain (intermolecular). As the concentration of these pendant 
bonds on the same chain is higher in the vicinity of the propagating radical, the 
intramolecular reaction will lead to cyclisation reactions and the formation of compact 
crosslinked regions called microgels.15 The occurrence of these cyclization reactions 
will decrease if the chain length between the double bonds increases (i.e. when 
polymerizing macromonomers).15,24–26 Furthermore, unreacted pendant double bonds 
as well as propagating radicals can become entrapped in the microgel regions and 
their reactivity decreases due to steric hindrance (see Figure 1). Upon percolation of 
these microgel regions, a space-filling crosslinked network is formed.15,23 The resulting 
structural inhomogeneity leads to internal stress, brittleness and a lower degree of 
conversion.1 
In free radical polymerizations, a range of different termination reactions can occur. 
The importance of each of these termination reactions depends on different factors, 
including the monomer type, the monomer functionality, the conversion degree, the 
atmosphere and the viscosity of the reaction mixture.15 For polymerization reactions in 
solution, the main termination reaction is assumed to be bimolecular, for which the 
radicals of two growing polymer chains react either through recombination (IV) or 
disproportionation (V).15 As both termination reactions don’t have specific effects on 
the polymerization kinetics, they can be combined in the expression for the bimolecular 
termination rate. The diffusion mechanisms for this bimolecular mechanism vary 
depending on the monomer type and reaction conditions.15 For linear systems in the 
liquid state, translational diffusion will have an important effect, especially in the first 
stages of the reaction. For crosslinking systems on the other hand, the larger polymer 
chains will become entangled or crosslinked in the network, thereby suppressing 
translational diffusion. Furthermore, in the solid state reactions center-of-mass 
diffusion is completely inhibited. Under these conditions, bimolecular reactions can still 
occur either through segmental fluctuation or reactive diffusion.15 The overall 
bimolecular termination rate can be expressed as: 3,15,20  




 22  MkR tBtB           (3) 
with RtB being the bimolecular termination rate and ktB the apparent termination rate 
coefficient. For this ideal behavior, no chain length dependence or radical trapping 
reactions (VI) are assumed. The latter type of reactions become more important as the 
reaction progresses and radicals cease to propagate and become “trapped” in the 
highly crosslinked regions. In addition, for polymers polymerized in the solid state 
specifically and for crosslinking systems in general, it can be anticipated that this 
monomolecular termination mechanism will be more important compared to liquid 
systems. As explained above, under both conditions, translational diffusion is 
suppressed or completely inhibited. Therefore, even from the onset of the reaction, 
radical entrapment will play a significant role. For all conditions, the monomolecular 
termination rate RtT can be expressed as: 3,15,20  
  MkR tTtT            (4) 
with ktT being the rate coefficient.  
In addition, radical scavenging by quenching molecules such as O2 can result in 
termination, especially when the polymerization is carried out under air atmosphere. 
These reactions will occur both at the interface of the sample and in bulk, as O2 
molecules can diffuse into the reaction mixture. These can react with a primary radical 
(VII) or with a radical on the growing polymer chain (VIII).15 The combined termination 
rate RtS is expressed using the scavenging rate coefficient ktS and the concentration 
[S] of the scavenging species: 3,15,20  
  SMkR tStS            (5) 
Often it is assumed that the radical concentration achieves a steady-state behavior 
(low and constant global concentration of macro-radicals) early in the polymerization 
process.14 Under this assumption, the rate of initiation Ri is equal to the rate of 
termination Rt.. For polymerizations under inert atmosphere for which bimolecular 
termination and radical entrapment are the predominant termination pathways, this 
leads to the following expression:3,15,20  
tTtBi RRR             (6) 





    MkMkI tTtBai
2
2          (7) 
The solution of this quadratic equation reads as 






1 2         (8) 
Combining equations (8) and (6) results in an expression for the polymerization rate 









2          (9) 
This can also be expressed as a function of the degree of polymerization (or double 
bond conversion) p:  









0        (10) 
In liquid polymerizations  of both linear and crosslinkable systems, an auto-
acceleration or gel effect can be observed at relatively low conversions after which the 
polymerization rate rapidly increases to several times its original value despite 
monomer consumption.15 This will lead to a maximum in the polymerization speed, 
followed by a deceleration when the reaction proceeds until vitrification sets in. This 
behavior is mostly governed by the termination reactions. The observed biomolecular 
termination rate is diffusion- controlled from the start of the reaction. The onset of this 
auto-acceleration will differ when comparing liquid and crosslinking systems. 
For linear polymerizations, translational diffusion will decrease with increasing 
conversion due to the increased viscosity, the increasing hydrodynamical volume (due 
to the increasing chain length) and the degree of crosslinking of the system.21 The 
segmental fluctuation on the other hand will increase as the polymer chain length 
increases. Initially, these two will be balanced and the termination rate remains 
constant. However, early in the reaction (e.g. around 20-25% conversion for methyl 
methacrylate),15 the translational diffusion starts to control the termination, while the 
propagation will stay unaffected. This leads to an increased radical concentration and 
an auto-accelerating effect on the overall reaction rate (gel-effect). As the conversion 




further increases, the translational diffusion decreases and the propagation speed 
becomes affected as well, resulting in deceleration. Near the maximum of the 
polymerization rate, the controlling mechanism changes from translational diffusion to 
reaction diffusion, effectively preventing an even larger decrease of the overall 
polymerization speed. 15 The reaction continues until the onset of vitrification, at which 
the reaction stops due to a complete lack of mobility.  
A similar rate profile can be observed for crosslinking reactions. However, the mobility 
of the macroradicals is restricted from the onset of the reaction because of the network 
formation. The gel point, which is the stage at which the microgel regions join to form 
a connected network, occurs at very low conversions of typically 1-2%. Therefore, the 
auto-acceleration step of crosslinking systems will occur at the onset (conversions < 
5%) of polymerization.15,27  
In this chapter, the kinetics of the solid state reactive polymers are investigated both in 
solution, melt and in the semi-crystalline solid state. In a first part, a qualitative 
description of the polymerization is provided. The auto-initiation and the effect of the 
atmosphere, the polymerization temperature and the thermal history are investigated. 
In addition, the versatility of the system is demonstrated by synthesizing and 
characterizing a range of polymers with different backbones and different molar 
masses. In a second part, a model is developed for the polymerization in the solid state 
of which the main focus will lie on the importance of mono- and bimolecular termination 
reactions.   




3.2. Materials and methods 
3.2.1. Polymer synthesis 
The polymers were synthesized as described in Chapter 2. Poly(ethylene glycol) with 
a molar mass of 2000 g mol-1, 4000 g mol-1, 8000 g mol-1, 10000 g mol-1 and 20000 g 
mol-1 and poly(ε-caprolactone) with a molar mass of 2200 g mol-1 were obtained from 
Merck. The molecular weight of the backbone is mentioned in the polymer code (e.g. 
PCL2200-OEOAcr was prepared using a PCL backbone of 2200 g mol-1). With 
increasing molar mass, the viscosity started to increase as well. For the polymer with 
a backbone of 8000 g mol-1, the viscosity after completion of the reaction became too 
high to remove the polymer from the reactor. Therefore, double distilled water was 
added (30 wt% on total mass in the reactor). This was subsequently removed using 
lyophilization (Christ alpha I-5).  
For the polymers with molar masses of 10000 g mol-1 and 20000 g mol-1, the viscosity 
was too high at the onset of the reaction, preventing effective stirring and reaction. 
Therefore, 2-butanone (Sigma-Aldrich) was added as an inert solvent (10 wt% on the 
total mass in the reactor). During the initial drying step, part of the 2-butanone 
evaporated (about 15% of the amount initially added). This was first replaced with fresh 
2-butanone, before continuing the reaction.  
Once the reaction was completed, double distilled water was added (30 wt% of the 
total mass in the reactor) and the 2-butanone was stripped until the amount of 2-
butanone that was initially added (10 wt% on the total mass in the reactor) was 
recovered. After synthesis, the polymers were dried in the vacuum oven at 80°C during 
24h to remove water and traces of 2-butanone. Although it can be anticipated that a 
significant part of the inhibitors will be consumed during this drying step, no stability 
issues were experienced with the polymers during use. Further stability studies can 
determine if the inhibitor amounts need to be adjusted to guarantee long-term stability. 
The theoretical acrylate concentration for each polymer can be calculated by dividing 
the amount of acrylates (in mole) by the combined mass of the backbone, the 
diisocyanate and the end group incorporated during synthesis. For example, when 
preparing 1.161 kg of PEG2000-OEOAcr, the double bond concentration can be 
calculated as follows: 0.745 mole of double bonds, divided by the total mass of 1.161 




kg (745 g PEG 2000 + 165.6 g IPDI + 250.3 g OEOAcr). This results in a theoretical 
acrylate concentration of 0.642 mmole g-1. 
3.2.2. UV absorption spectroscopy 
UV-VIS spectra were recorded on a Varian Cary 100 Bio UV-VIS spectrophotometer 
equipped with a Cary temperature and stir control. Samples were measured in quartz 
cuvettes with a path length of 1.0 cm in the wavelength range of 200 to 400 nm. The 
concentration of each sample was 0.5 wt% in acetonitrile. A baseline correction was 
performed and the absorbance of each spectrum was normalized to 1.  
3.2.3. Photo-DSC measurements 
The photo-DSC measurements were performed as described previously in Chapter 2 
(section 2.1.5). The effect of thermal history was investigated for two temperatures, i.e. 
isothermal crystallization at 20°C and dynamic crystallization with an end temperature 
of -20°C.  After crystallization, photoolymerization was conducted at temperatures 
ranging from -20  to 90°C, as indicated for each measurement. The 
photopolymerization rate and double bond conversion were calculated as mentioned 
earlier (section 2.1.5).   
For qualitative purposes, the measured heat flow profiles are shown and compared.  
However, for heat-flux DSC instruments as used in this work, the recorded signal does 
not reflect the true heat flow consumed or evolved from the sample but is actually 
smeared by the experimental system function, which is influenced by many factors 
such as instrument design, crucibles, atmosphere, etc.28,29 The smearing is 
mathematically expressed by a convolution integral and a deconvolution procedure is 
required to return to the true sample heat flow. The characteristic response time of the 
system is usually within the order of a few seconds and has a minor effect on thermal 
events which are slow enough (higher than the characteristic response time).However, 
the timescale of the initial acceleration step for the photopolymerizations studied herein 
is within the range of seconds and the instrumental response needs to be eliminated 
in order to recover the correct polymerization exotherm for subsequent kinetic 
modeling. The system function can be determined from the heat flow output resulting 
from a rectangular input signal generated by the simultaneous illumination of the 
sample and reference positions using a UV-light source controlled with a shutter. The 
deconvolution theorem was applied to solve the inversion problem for the system 




function which finally could be approximated using 
 /)( teAtth   with =2.7 and 
=0.71s. 
The latter function was then used to extract the corrected heat flow signal from the 
measured polymerization exotherm. 
The reproducibility of the photo-DSC measurements was high, evidenced by random 
repeat measurements which showed minor deviations of a few percentages. A slightly 
stronger effect was determined when measuring polymers from different batches, e.g. 
in chapter 2 and 3 two different batches were used, leading to a different double bond 
conversion in figure 7 (chapter 2) (around 50% without PI) and figure 7 (chapter 3) 
(around 65% without PI). As this technique is quite exact, the double bond conversion 
or polymerization kinetics were not checked using other techniques (e.g. ATR-FTIR).  
3.2.4. Swelling experiments 
Swelling experiments were performed as described in Chapter 2 (section 2.1.7).  
3.2.5. Mechanical tests 
The influence of the polymer backbone length on the mechanical properties of the 
crosslinked samples was evaluated by tensile tests using the Universal tester 10-KM 
(Hounsfield) with a load cell of 100 N. Dog-bone shaped samples with a length of 30 
mm were prepared from cross-linked hydrogel films (thickness 1 mm). The tensile 
properties of the hydrogel samples were determined immediately after UV-curing with 
their initial water content or after equilibrium swelling in double distilled water (swollen 
samples). All measurements were performed at room temperature. A preload force of 
0.3 N was applied and the specimens were deformed with a crosshead velocity of 10 
mm/min. The Young’s modulus was calculated from the slope of the initial, linear part 
of the stress/strain curves using the QMat software. 
3.3. Qualitative aspects of solid-state photopolymerization 
3.3.1. Investigation of the auto-initiation 
In a typical photo-initiation process, the initiator molecule absorbs one quantum of 
radiation to become energetically excited.30 It is important that the energy of the 
absorbed photon corresponds to the energy difference between the ground state and 
the excited state. Following intersystem crossing, a triplet state can arise from the 




excited singlet state. In case of type I photo-initiators, from this triplet state, radicals 
are formed by α-cleavage of the C-C bond or by hydrogen abstraction from a donor 
molecule for type II photo-initiators.30 
In Chapter 2, the auto-initiation capabilities of the materials developed in this work were 
demonstrated using photo-DSC. Auto-initiation of acrylates has been reported in 
literature, although this has been mainly observed at high energy UV light (λ < 230 
nm).31,32 Knolle et al proposed three initiation mechanisms based on quantum chemical 
calculations and absorption spectra, depicted in Figure 4. 31,32 The first structure (a) is 
the short-lived primary triplet state at which the double bond generates two radicals 
after irradiation. This state can further react by hydrogen abstraction, most likely 
intermolecular from the CH2 group next to the oxygen leading to structure (b). In 
addition, the triplet state acrylate can react with another acrylate in the ground state, 
leading to structure (c). 
 
Figure 4: Possible radical species formed by irradiation of  acrylates  
At 222 nm, tripropylene glycol diacrylate could be efficiently photopolymerized in the 
absence of a photo-initiator. At this wavelength, thin films (less than 1.5 µm) of 
tripropylene glycol diacrylate  and other acrylate monomers and oligomers were cured. 
However, at 313 nm (one of the most prominent emission lines of a medium-pressure 
mercury lamp), no reaction was detected for tripropylene glycol diacrylate.31 In 
contrast, Huang et al reported that hyperbranched acrylates could be cured at higher 
wavelengths using medium-pressure mercury lamps.33 They propose that the structure 
of their hyperbranched acrylates causes a red shift of the π-π* absorption, possibly 
due to overlap of π-π orbitals from neighboring acrylate groups. This red shift causes 
the absorption to shift towards the UV-A wavelength range, enabling the auto-initiation. 





Figure 5: Scaled UV absorption spectra for the model prepolymer (PEG2000-OEOAcr)), hydroxy ethyl 
acrylate (HEA), oligo(caprolactone) acrylate (OClAcr), oligo(ethylene oxide) acrylate (OEOAcr), 
oligo(propylene oxide) acrylate (OPOAcr) and acrylic acid (AAcid). The left image is the full spectrum, 
while the right image represents a magnification of a region of interest in the spectrum.  
In Figure 5, the UV absorption spectrum determined in acetonitrile for the model 
polymer PEG2000-OEOAcr is shown. In addition, absorption spectra were determined 
for the different end groups applied and described in Chapter 2 (hydroxy ethyl acrylate 
(HEA), oligo(caprolactone) acrylate (OClAcr), oligo(ethylene oxide) acrylate (OEOAcr), 
oligo(propylene oxide) acrylate (OPOAcr)) as well as for acrylic acid (AAcid). From 
these spectra, it is clear that the investigated (macro)monomers show a significant 
absorption above 300 nm. Although the absorption is dependent on experimental 
conditions such as concentration and solvent, these measurements clearly show that 
the π-π* absorption band is strongly influenced by the chemical environment of the 
acrylate. For the polymer (yellow plot) the absorption peak broadens and shifts towards 
higher wavelengths, which explains its auto-initiating capability. This can also be 
observed for the (macro)monomers, especially OEOAcr and HEA. The photo-DSC 
measurements of these compounds shown in Chapter 2 indeed show that they can be 
photopolymerized quite efficiently. Although no exact explanation was found for the 
absorption differences of these monomers, oligomers and prepolymers, it can be 
hypothesized that there will be an effect of hydrogen bonding.  
It can be anticipated that in the solid state, the auto-initiation of the acrylates will be 
influenced as a result of the structural changes. The phase separation into amorphous 
acrylate-rich zones and crystalline PEO-rich zones will result in areas with an increased 
concentration of acrylates. This will benefit the reaction of the short-lived primary 
radical state (a) in Figure 4 with a nearby acrylate to create structure (c) as their π-π 




orbitals can more easily overlap. This overlap will also shift the absorption maximum 
of the π-π* transition, resulting in more efficient initiation at lower energy irradiation. 
Therefore, it can be expected that the auto-initiation will be more efficient in the solid 
state compared to the molten state.  
3.3.1.1. Comparing the polymerization with and without a photo-initiator. 
In this work, 1-hydroxycyclohexyl phenyl ketone (HCPK) was selected as a photo-
initiator. For many years, α-hydroxyketones have been used as photo-initiators as they 
can efficiently produce benzoyl-ketyl radical pairs through type I cleavage upon UV 
irradiation (see Figure 6). Both radicals have a different reactivity. More specifically, for 
the reaction with acrylates, the rate coefficient of the ketyl radical was determined to 
be 1.3 x 107 M-1 s-1, while the benzoyl radical has a significantly lower rate coefficient 
of 2.7 x 105 M-1 s-1.34,35 
 
Figure 6: Photocleavage upon UV-irradiation of 1-Hydroxycyclohexyl phenyl ketone (HCPK)  
In Figure 7, the heat flow and double bond conversion of the model precursor PEG2000-
OEOAcr is shown with and without 2 wt% HCPK during the first 40 seconds of UV 
illumination. A first observation is that the reactivity and double bond conversion both 
increase upon addition of a photo-initiator. Indeed, the maximum heat flow increases 
from 3.4 W g-1 to 7.2 W g-1 in the solid state and from 2.1 W g-1 to 7.1 W g-1 in the 
molten state when a photo-initiator is added. The final double bond conversion (after 
max 260 s of irradiation) increases from 65 % to 76% in the solid state, and from 84% 
to 87% in the molten state. Based on equations (9) and (10), the polymerization speed 
is proportional to the square root of the initiation rate. As it is anticipated that the photo-
initiator will be more efficient in generating radicals than any self-initiation mechanism, 
adding a photo-initiator will result in a higher polymerization rate and double bond 
conversion. Similar results were obtained by Scherzer and Decker as an increase in 
photo-initiator concentration resulted in an increased polymerization rate and double 
bond conversion.36,37 





Figure 7: Photo-reactivity of the model precursor PEG2000-OEOAcr in the solid (20° C) and molten 
(50°C) state with and without a photo-initiator (0.2 wt% HCPK). 
Another interesting observation is that the maximum polymerization speed is almost 
equal (7.2 and 7.1 W g-1 respectively) in the solid and the molten state in the presence 
of the photo-initiator. If one assumes the radical generation of the photo-initiator is not 
significantly affected by the crystallization, the initiation rate will be similar in the solid 
or the molten state. Therefore, the reduced mobility for propagation in the solid state 
is compensated by the local packing of double bonds and suppresses termination 
through translational diffusion, leading to equal maximal polymerization speeds. The 
difference in double bond conversion (76% in the solid state and 87% in the molten 
state) can be explained by the increased mobility in the molten state, allowing the 
reaction to continue longer and reducing the amount of trapped radicals and double 
bonds. Without a photo-initiator, there is a difference in maximal polymerization speed 
at the two temperatures. More specifically, the increased solid state polymerization 
speed is likely due to more efficient initiation. As the double bonds are closer together, 
the π-π orbitals can more easily overlap as described above. As a result, more radicals 
will be formed in the solid state compared to the molten state.  





Figure 8: Gel fraction (circles) and swelling ratio (squares) as a function of precursor content for 
polymerizations with (right) and without (left) 0.2 wt% HCPK as photo-initiator 
Next, the auto-initiating efficiency was investigated using swelling experiments for 
aqueous solutions of AUP. More efficient crosslinking will lead to a higher network 
density. This results in an increased gel fraction and a decreased swelling ratio. Due 
to the unique solubility of the precursors, as described in the previous chapter, this 
could be determined over the whole concentration range. In Figure 8, the gel fraction 
and the swelling ratio are shown for concentrations ranging from 10 to 100 wt%, in the 
presence and absence of 0.2 wt% HCPK. Samples at a 100 wt% concentration were 
crosslinked in the solid state. The results show that there is no significant effect of the 
presence of a photo-initiator on the swelling ratio (See Figure 8). Regarding the gel 
fraction, values between 98 and 99% where obtained over the concentration range, 
with exceptions for the lowest concentration (10 wt%, gel fraction of 89%) and the 
highest concentration (100 wt%, i.e. in solid state). For the lowest concentration the 
auto-initiating capacity is decreased due to the dilute conditions which results in a 
reduced gel fraction . The results in solid state are in line with the observations made 
during the photo-DSC measurements. Indeed, when adding a photo-initiator, higher 
conversions were reached which results in a higher gel fraction. The gel fraction 
reached 93.5 ± 1.2 % in the solid state and increased to 100.1 ± 2.5 % upon addition 
of a photo-initiator. 
3.3.2. Effect of atmosphere on the photopolymerization  




It is well established that the presence of atmospheric oxygen has a detrimental effect 
on radical vinyl polymerizations.38 Indeed, the onset of the reaction is delayed and is 
accompanied by a reduction of both the final double bond conversion as well as the 
polymerization rate. Oxygen molecules can interfere in different steps of the photo-
polymerization.15,20,30 They can quench the excited triplet state of the initiator or react 
with propagating radicals resulting in the formation of oxygenated radicals. The latter 
are more stable and therefore less reactive towards double bonds and can further react 
to form hydroxyperoxides and carbonyl groups.30 Initially, the oxygen will quench the 
initiation, resulting in a delay of the polymerization. As a result, the onset of 
polymerization is delayed until most of the dissolved oxygen is consumed. However, 
as the small oxygen molecules can easily diffuse into the reaction mixture, they can 
cause further inhibition of the reaction in the vicinity of the surface. Oxygen inhibition 
is less pronounced in highly viscous compositions or near the end of the polymerization 
as the diffusion becomes more restricted.15 An increase in temperature will also reduce 
oxygen inhibition as it will decrease oxygen solubility.39 
 
Figure 9: Effect of the atmosphere on the photo-polymerization heat flow (upper panel) and the double 
bond conversion (lower panel) for the model precursor PEG2000-OEOAcr in the solid state (20°C) and 
the molten state (50°C). The green curves represent the polymerization occurring under inert nitrogen 
atmosphere, while the yellow curves show the polymerization in air. Full lines are photo-polymerizations 
in the presence of a photo-initiator (0.2 wt% HCPK), while the dotted lines represent the polymerization 
occurring without a photo-initiator. Only the first 20 seconds of the polymerization are shown. 
Figure 9 shows the effect of oxygen inhibition on the photopolymerization reaction in 
the solid state (20°C) and in the molten state (50°C) both with and without a photo-
initiator for the model precursor with a backbone of 2000 g mol-1. From these curves, 
it is clear that the typical effects of oxygen inhibition (delay in onset of polymerization, 
the reduced polymerization speed and reduced double bond conversion) were 




observed in this system. The presence of oxygen will cause a delay in the onset of 
polymerization and this effect is most pronounced for systems without a photo-initiator. 
As the radical concentration in these systems is lower, the inhibition effect will be 
higher. This is especially visible in the molten state, where the auto-initiation efficiency 
decreases and the time to reach the maximum polymerization speed increases from 
3.6 to 7.2 s in air atmosphere. In addition to the polymerization delay, the maximum 
polymerization speed and double bond conversion decrease as well. As a result of 
oxygen inhibition, for samples without a photo-initiator the maximum heat flow 
decreases from 3.39 to 2.7 W g-1 in the solid state and from 2.1 to 1.1 W g-1, while the 
final conversion decreases from 59 to 47% at 20°C and from 51 to 29%. Furthermore, 
the addition of a photo-initiator cannot sufficiently prevent the effects of oxygen 
inhibition, although it clearly improves the polymerization kinetics as explained earlier.  
3.3.3. Influence of the crystallization conditions and the polymerization 
temperature 
Temperature changes will significantly impact the kinetics of photopolymerization 
reactions, as propagation and termination processes typically follow an Arrhenius-type 
temperature behavior. In addition, there will be a severe influence on the different 
diffusion mechanisms. With an increase in temperature, viscosity decreases and 
diffusion mechanisms such as translational and segmental fluctuations will be 
enhanced. The overall effect of temperature on photo-initiated polymerizations is quite 
complex and not fully understood to date.15,40 For semi-crystalline precursors, another 
interesting aspect is the effect of the thermal history on the photo-reactivity. As 
discussed in Chapter 2 (section2.2.2), the solid state reactivity is related to the 
crystalline morphology developed upon crystallization. In Figure 10, the melting profiles 
for polymers that were cooled isothermally (20°C) and dynamically (-20°C) are shown. 
It is clear that the latter results in a large melting peak indicating a single predominant 
crystal shape (around 37°C) with a minor shoulder peak (around 29,5 °C). The former 
results in two distinct peaks (around 31°C and 37°C), indicating a significant presence 
of two different crystal shapes. This will undoubtedly affect the polymerization kinetics. 
The total melting enthalpy was 9.04 J g-1 for the isothermal crystallization, and 9.72 J 
g-1 for the dynamic crystallization. The exact degree of crystallinity cannot be 
determined from these values, as no reference material with a known crystallinity 




exists. However, based on the heat of fusion of 100% crystalline PEG 2000, which is 
188 J g-1, it can be estimated that the degree of crystallinity will be quite low.41  
 
 
Figure 10: Left: cooling peaks for dynamic (blue) and isothermal (red) crystallization. Right: Melting 
peaks after dynamic (blue) and isothermal (red) crystallization at 20°C. 
To investigate the effect of the crystallization conditions and polymerization 
temperature, a series of photo-DSC measurements were performed. For the 
crystallization of the polymer prior to polymerization, an isothermal crystallization was 
performed at 293 K (20°C) and compared to a dynamic crystallization for which the 
temperature is reduced to 353 K (-20°C). Secondly, the polymerization was performed 
with and without 0.2 wt% HCPK as photo-initiator. For these four conditions, the heat 
of polymerization was measured at 18 different temperatures ranging from 253 K (-
20°C) to 363 K (90°C). From the measured heat flow, the polymerization speed was 
calculated and plotted as a function of time and temperature as shown in Figure 11. 





Figure 11: Heat flow as a function of time and temperature for two different crystallization conditions 
(253 K and 293 K) and with and without 0.2 wt% photo-initiator. 
A first observation is that there is a distinct difference between the polymerizations with 
(bottom panel in Figure 11) and without (upper panel in Figure 11) a photo-initiator. 
Without a photo-initiator, the polymerization efficiency steadily increases to a maximum 
close to the melting point of the polymer, followed by a large drop in efficiency in the 
molten state after which it levels off. When a photo-initiator is present, the behavior in 
the solid state is quite similar to the behavior in the absence of a photo-initiator, as it 
increases to a maximum around the melting point. However, after this maximum is 
reached, the polymerization efficiency seems to remain at this maximum value as the 
temperature increases and the polymerization continues in the molten state.  
The effect of the crystallization conditions is more subtle. Evidently, this effect is only 
present in the solid state, as the thermal history will be erased when the polymer is in 
the molten state. When the crystallization is performed dynamically at 253 K (-20°C), 
the polymerization efficiency will display a sharper increase with temperature and a 
clear drop after the maximum is reached, in correspondence with the prominent melting 
peak observed in Figure 10. In contrast, for the polymer that was crystallized 
isothermally at a temperature of 293 K (20°C), the polymerization speed reaches a 
maximum, after which it starts to decrease until the polymer is completely molten. The 
effect of the crystallization conditions is quite similar in the presence and in the absence 




of a photo-initiator, although the overall polymerization rate is increased at all 
temperatures when 0.2 wt% HCPK is added. To further understand the interesting 
behavior of these polymers, the maximum polymerization rate and the final double 
bond conversion are plotted in Figure 12. 
 
Figure 12: Maximum polymerization speed and final double bond conversion as a function of 
temperature. 
The trends in Figure 11 can be clearly observed in the evolution of the maximum 
polymerization speed as a function of temperature (Figure 12). Without a photo-
initiator, the polymerization speed sharply decreases (from 6.2 mol g-1 s-1 to 2.8 mol g-
1 s-1 for dynamic crystallization and from 3.8 mol g-1 s-1 to 2.6 mol g-1 s-1 for isothermal 
crystallization) when the polymer is molten (from 303 K for dynamic crystallization and 
from 308 K for isothermal crystallization). This can be explained by a more efficient 
initiation in the solid state as the π-π orbitals show superior overlap due to the phase 
separation which will locally increase the acrylate concentration. Furthermore, 
translational diffusion is suppressed in the solid state, resulting in a decrease in 
termination rate. This will also lead to an increased polymerization rate for lower radical 
concentrations compared to the molten state. However, with a higher radical 
concentration (in the presence of a photo-initiator), termination through reactive 
diffusion and segmental fluctuations will increase and the decrease in termination rate 
will no longer compensate the mobility gain in the solid state. This will result in a lower 
rate compared to the molten state when a photo-initiator is present, as explained 
above. 




For the dynamic crystallization (blue curves, 253 K or -20°C), a large melting peak can 
be observed around 37°C, with a minor shoulder peak at 29.5 °C. For the isothermal 
crystallization (red curves, 293 K or 20°C), the maxima of two melting peaks are around 
31°C and 37°C. In the solid state, an exponential-like increase of polymerization rate 
for the dynamic crystallization (253 K) can be observed both with and without a photo-
initiator being present. The maximum value is reached just before the polymer is 
completely in the molten state, after which the rate drops in the absence of a photo-
initiator. This can imply that the reactivity is mostly influenced by the melting of the 
large peak, and that there is no observable effect of the smaller peak. Isothermal 
crystallization at 293 K will lead to a different behavior, as the polymerization speed 
reaches a maximum value and slowly starts to decrease before it reaches the molten 
state. This is likely a direct result of the presence of the two prominent melting peaks. 
Indeed, just before the first melting peak (around 304 K), the maximum polymerization 
speed ( 5.4 x 102  mol g-1 s-1) is reached. The polymerization starts to decrease to 3.8 
x 102  mol g-1 s-1 when the second melting peak is reached (around 310 K), after 
which the polymerization rate further decreases in the molten state (2.6 x 102 mol g-1 
s-1). 
As this behavior is observed both with and without a photo-initiator, it cannot be 
attributed to differences in initiation rate. The structural differences that occur when the 
crystallization is carried out under different conditions will affect termination and 
propagation, resulting in a different behavior as the polymerization temperature 
increases. For temperatures far from the melting point, the maximum polymerization 
speed will be higher (maximum difference of 1.2 x 102 mol g-1 s-1) when the 
crystallization occurs at higher temperature. However, close to the melting point, the 
maximum polymerization speed is higher for the system crystallized at lower 
temperature (6.2 x 102 mol g-1 s-1 at 303 K) compared to the system crystallized at 
higher temperature (5.4 x 102 mol g-1 s-1 at 298 K). 
In the molten state, the maximum polymerization speed seems to fluctuate around a 
constant value in the presence of a photo-initiator and even shows a slightly decreasing 
trend in the absence of a photo-initiator. An influence of the different initiators on the 
temperature-dependent behavior of the photopolymerization was discovered by 
Scherzer and Decker.40 At lower temperatures, the propagation dominates while the 
mobility of free radical chain ends increases with temperature which will affect the 




termination rate.40 For bimolecular termination, the reaction speed is proportional to 
the square of the radical concentration (see equation 3). At high radical concentrations, 
the extent of termination reactions will increase leading to a deviation from Arrhenius 
behavior upon temperature increase, where the rate of termination reactions remains 
constant or even decreases with increasing temperature.40 
An overall increase in double bond conversion can be observed with increasing 
temperature. With a rising temperature, the segmental mobility of the double bonds in 
the growing network increases, which makes them more accessible for 
polymerization.36 This can occur both in the solid state, for which the mobility of the 
spacer group increases, or in the molten state for which the mobility of both the spacer 
group and the larger molecular segments increases. Addition of a photo-initiator will 
increase the final conversion both above and below the melting point. Again, the effect 
of the crystallization conditions is visible both with and without a photo-initiator in the 
solid state (see Figure 11 and Figure 12). The dynamic crystallization will lead to a 
continuous increase with temperature, while the higher temperature creates a 
maximum, after which the conversion decreases with temperature until the melting 
point is reached. Above the melting point, a photo-initiator will result in an initial 
increase in conversion up to 343 K for which a maximum of 89% is reached. After this 
maximum, the polymerization drops to 84% after which it remains constant. Without a 
photo-initiator, a slightly decreasing trend in conversion can be observed going from 
an initial value of 80.1 % to 73.0 %. 
The dependence of the polymerization rate Rp can be expressed using an Arrhenius- 







ln            (11) 
With c being a constant and Ea,app the apparent activation energy for the 
polymerization. The latter is a highly complex function combining initiation, propagation 
and termination reactions. This equation is only valid when Rp is measured at a given 
conversion. Therefore, Rp was plotted as a function of 1/T at a set of given conversions 
(5-80%) in Figure 13. 





Figure 13: Ln Rp is plotted as a function of the inverse of temperature  at a set of given conversions (5-
80 %) (Arrhenius plot).  The upper panels indicate the photopolymerization without photo-initiator, 
while the bottom panels represent the photopolymerizationin the presence of 0.2 wt% HCPK. Left 
panels show samples crystalized at 253 K prior to polymerization while the right panels show samples 
crystalized at 295K.  
Below the melting point, similar observations as those discussed in the previous 
paragraphs can be made. The crystallization conditions affect the polymerization 
speed and the effects are more obvious in the absence of a photo-initiator. 
Interestingly, polymerization in the solid state shows a non-linear behavior as a function 
of temperature. Again, for the dynamic crystallization, the speed sharply increases to 
a maximum just before the melting point, while for the isothermal crystallization, a 
maximum is reached earlier after which the speed slightly decreases until the melting 
point is reached. 
  




3.3.4. Effect of the polymer structure on the solid state reactivity 
 
Figure 14: Overview of prepolymer structures applied: model prepolymer (PEO backbone, OEO spacer 
and acrylate end group, top); acrylate end group in the model polymer has been substituted with a 
methacrylate group (center); backbone in the model prepolymer has been substituted with a poly(ε-
caprolactone) backbone (MW 2200 g mol-1) (bottom) 
In Chapter 2, the effect of using different spacer groups on the solid and molten state 
reactivity was evaluated. To further investigate the versatility of the spacer-based 
approach enabling solid state polymerizations, two more variations with respect to the 
polymer structure were implemented. In a first adaptation, the acrylate group was 
replaced with a methacrylate group (PEG2000-OEOMA). It can be anticipated that this 
will lead to a reduced polymerization speed, as methacrylates are known to be less 
reactive compared to acrylates.11,15,27 Furthermore, it is likely that the change from 
acrylate to methacrylate will affect the auto-initiation, as this takes place within the 
acrylate group. 
Secondly, the backbone polymer was changed from poly(ethylene oxide) to poly(ε-
caprolactone) (PCL2200-OEOAcr). This is quite a drastic change for the system, as the 
phase separation that occurs during crystallization plays a major role in the solid state 
reactivity. By changing the polymer type, the crystal structure will change as well which 
could influence the solid state reactivity. In addition, the viscosity will change which will 
affect the kinetics in the molten state.  





Figure 15: Comparison of the maximum polymerisation rate in the solid (blue) and molten (red) state for 
the different polymers (PEG2000-OEOMAcr, PEG2000-OEOAcr, PCL2200-OEOAcr) 
Figure 15 shows the maximum polymerization speed of PEG2000-OEOAcr, PEG2000-
OEOMA and PCL2200-OEOAcr in the solid and the molten state in absence of a photo-
initiator determined using photo-DSC. The methacrylate polymer maintains an good 
reactivity in the solid state (rp,max of 3.2 x 102 mol g-1 s-1) although the maximum 
polymerization speed is lower compared to the acrylate polymer (5.4 x 102 mol g-1 s-1). 
This can be explained by the lower reactivity of methacrylates compared to acrylates, 
and possibly by a difference in auto-initiation capacity. Surprisingly, the molten state 
reactivity remains almost unaffected by the change in end group from acrylate to 
methacrylate (2.2 x 102 mol g-1 s-1 for PEG2000-OEOAcr versus and 2.4 x 102 mol g-1 s-
1 for the PEG2000-OEOMA). As the change from acrylate to methacrylate will affect 
initiation, termination and propagation reactions occurring in solution and in the molten 
state, it is not possible to determine the exact cause of this behavior. The prepolymer 
with a PCL backbone (PCL2200-OEOAcr) shows quite similar reactivity to the model 
prepolymer (4.9 x 102 mol g-1 s-1 at 20°C and 2.8 x 102 mol g-1 s-1 at 50°C) with a solid 
state reactivity that is just slightly lower. Possibly, this effect can be attributed to the 
different crystal structure. Surprisingly, whereas the backbone chemical structure has 
a profound effect on the final material properties, it does not significantly affect the solid 
state reactivity. 




3.3.5. Effect of the polymer backbone molar mass on the reactivity and physical 
properties 
 
Figure 16: Theoretical acrylate concentration as a function of backbone molar mass 
As the backbone molar mass increases, the concentration of acrylates in the system 
decreases, as shown in Figure 16. Based on the results described in the paragraphs 
above and in the previous chapter for solutions with a decreasing polymer 
concentration, it can be anticipated that a decreased initiation capacity is likely to result 
from an increase in backbone molecular weight. Therefore, it can be anticipated that 
from a critical molar mass, the polymerization will no longer be successful. In addition, 
the decreasing acrylate concentration will lead to a decreased network density, which 
will affect the swelling and mechanical properties of the polymers, as shown in the 
upcoming paragraphs. 
  




3.3.5.1. Effect of the backbone molar mass on photopolymerization 
 
Figure 17: Maximum polymerization rate (left) and double bond conversion (right) as a function of 
backbone molar mass. The red curves represent the results for polymerizations in the molten state 
(70°C) while the blue curves show the maximum polymerization rate and double bond conversion for 
polymerizations in the solid state (20°C). Open circles and dotted lines represent polymerization 
reactions without PI, Filled circles and full lines are polymerizations with 0.2 wt% HCPK.  
Since the melting point increases with increasing molar mass, the temperature was 
increased from 50°C to 70°C to compare the photo-reactivity of the polymers with 
increasing backbone molar mass in the melt by photo-DSC. In Figure 17, the maximal 
polymerization speed and double bond conversion are shown for the different polymers 
in the presence and in the absence of a photo-initiator. Even for backbone polymers 
with a molar mass of 10000 g mol-1, efficient crosslinking in the solid state remained 
possible. Moreover, swelling studies showed that even at 20000 g mol-1, the polymers 
could still be crosslinked in the solid state(samples swell and do not dissolve, proving 
the presence of crosslinks). However, the heat flow evolved from the polymerization of 
these precursors was too low to enable measurement using photo-DSC. The maximum 
polymerization speed without a photo-initiator decreased from 6.0 x 102 mol g-1 s-1 
(PEG2000-OEOAcr) to 2.8 x 102 mol g-1 s-1 (PEG10000-OEOAcr) in the solid state and 
from 1.6 x 102 mol g-1 s-1 (PEG2000-OEOAcr without PI) to 1.2 x 102 mol g-1 s-1 (PEG10000-
OEOAcr without PI) in the molten state. Similar trends can be observed for the 
polymerizations with a photo-initiator, although in the molten state there was an initial 
increase of the maximum polymerization speed going from 10.6 x 102 mol g-1 s-1 
(PEG2000-OEOAcr) to 12 x 102 mol g-1 s-1 (PEG4000-OEOAcr).  




3.3.5.2. Effect of the polymer backbone molar mass on the physical and 
mechanical properties of the crosslinked hydrogels 
3.3.5.2.1. Swelling behavior and gel fraction as a function of 
backbone molar mass 
In Figure 18 and Table 1, the swelling ratio and gel fraction are shown for the different 
polymers at various concentrations (from 10 wt% to 100 wt%(solid state)) and 
crosslinked in the absence of a photo-initiator. As the molar mass of the backbone 
increased from 2000 to 20 000 g mol-1, the solubility of the polymers decreased (data 
not shown), especially for the polymers with a backbone characterized by a molecular 
weight of 20 000 g mol-1 (PEG20 000-OEOAcr). Indeed, for the latter, a 10 wt% polymer 
concentration could not be dissolved. Therefore, the swelling degree and the gel 
fraction were only determined in the solid state for the latter sample. As anticipated, 
the swelling ratio decreased with increasing precursor concentration, and increased 
with increasing backbone molar mass. (e.g. for solid state crosslinking (100 wt% 
concentration), the swelling ratio increased from 1.3 for PEG2000-OEOAcr to 16.3 for 
PEG20000-OEOAcr) Similar results were obtained by Padmavathi and Chatterji who 
observed an increase of about four times for the swelling ratio at a 40 wt% 
concentration when the molar mass of PEG-diacrylate increased from 200 g mol-1 to 
3400 g mol-1.42 In addition, they observed that the swelling ratio for PEG-diacrylate 
(molar mass 1000 g mol-1) at 40 wt% was about two thirds of the swelling ratio at 20 
wt%.  
 
Figure 18: Left: Degree of swelling as a function of precursor concentration for the polymers with different 
molar mass (2 – 10 kg mol-1), as indicated by the different colors. Samples at a 100wt% concentration 
where crosslinked in the solid state. Right: Polymers with different backbone molar mass crosslinked in 
the solid state before and after equilibrium swelling in double-distilled water. 




In the solid state, the gel fraction remained above 80% for all polymers, demonstrating 
the excellent crosslinking efficiency even in the absence of a photo-initiator. For 
aqueous solutions, the gel fraction remained above 80% as well, except for the lowest 
polymer concentration evaluated being 10 wt%. Dilute conditions along with an 
increasing backbone length result in a decreasing gel fraction, ultimately dropping to 
56% for the polymers with a backbone molecular weight of 10000 g mol-1. In literature, 
similar trends where observed for PEG-diacrylates with molar mass between 600 and 
3400 g mol-1.42  
Table 1: Gel fraction (G.F) at different concentrations in water for polymers with a backbone molar mass 
ranging from 2 to 20 kg mol-1.  















30 wt% G.F.. (%) 97.99 ± 0.88 88.83 ± 0.42 95.26 ± 2.83 89.65 ± 1.11 n.a. 
50 wt% G.F.. (%) 98.36 ± 0.47 83.93 ± 0.38 85.54 ± 1.21 n.a. n.a. 
70 wt% G.F.. (%) 98.6 ± 0.63 101.59 ± 1.08 n.a. n.a. n.a. 
100 wt% G.F.. (%) 93.51 ± 1.18 85.33 ± 1.07 89.94 ± 1.73 81.6 ± 1.7 80.12 ± 1.63 
 
3.3.5.2.2. Tensile properties of the polymers with increasing 
backbone molar mass 
 
Figure 19: Young’s modulus and elongation at break for samples with different molecular masses, 
crosslinked in the solid state and equilibrium swollen in double distilled water (room temperature). 
In Figure 19, the Young’s modulus and elongation at break are shown for a selection 
of polymers with different molar masses, crosslinked in the solid state in the absence 
of a photo-initiator after equilibrium swelling. The increasing backbone molar mass 
results in a decreasing network density, which leads to a decreasing Young’s modulus, 




and an increasing elongation at break. For example, the Young’s modulus decreased 
from 2.4 MPa for PEG4000-OEOAcr to 0.04 MPa for PEG20 000-OEOAcr. The elongation 
at break on the other hand increased from 10% for PEG4000-OEOAcr to 71% for 
PEG20000-OEOAcr. This clearly demonstrates that the backbone molar mass can be 
used to tune the mechanical properties of the polymers developed. 
 
Figure 20 Young’s modulus and elongation at break for samples with different molar masses, 
crosslinked at concentrations ranging from 30 to 70 wt%. 
In addition to the backbone molar mass, the water content prior to crosslinking also 
influences the final mechanical properties. In Figure 20, the results are shown for 
samples with concentrations ranging from 30 to 70 wt% and molar masses varying 
between 2000 and 10000 g mol-1. Again, due to solubility issues with the higher molar 
masses, the samples with high molar mass and high precursor content could not be 
measured. Similar to the results in the solid state, upon increasing the molar mass, the 
Young’s modulus will decrease while the elongation increases. For example, at a 30 
wt% polymer concentration, the Young’s modulus decreases from 0.66 MP43a for 
PEG2000-OEOAcr to 0.15 for PEG10000-OEOAcr. The water content prior to crosslinking 
will have a strong influence on the elasticity modulus (for PEG2000-OEOAcr, the 
Young’s modulus increases from 0.66 MPa for a 30 wt% concentration up to 3.4 MPa 
upon increasing the concentration to 70 wt%). These values within the same range of 
those obtained in literature for PEG-diacrylate (e.g. 0.09 MPa for a 10 wt% hydrogel of 
PEG with a molar mass of 3400 g mol-1)44,45. However, the water content prior to 
crosslinking does not significantly affect the elongation at break. A similar observation 
was made in literature for a low molar mass PEG-dacrylate (508 g mol-1), where there 
was a 2% difference in elongation for a concentration increase from 65 wt% to 80 wt%. 
45,46For the samples with a high water content and a high molar mass, the sample 




becomes quite stretchable(around 37% for PEG2000-OEOAcr, up to 243% for PEG10000-
OEOAcr) with an ultimate elongation close to 250%.  
3.4. Kinetics of the solid-state polymerization: a scaling model 
3.4.1. Model development 
In this part of the work, a model is developed based on scaling laws to capture the 
structural dynamics behind the reaction kinetics of solid state photo-polymerization. 
Structural aspects associated with polymer properties are often expressed using 
scaling laws (e.g. network formation and gelation).47 As the solid state photo-
polymerization of macromonomers has never been described earlier in literature, 
kinetic models are not yet available. The various initiation, propagation and termination 
reactions occurring in the solid state will be different from those witnessed in solution 
or melt. However, the overall reaction profile is still quite similar, with the polymerization 
speed displaying an initial acceleration step, followed by a decrease until the reaction 
stops. In the molten state, this reaction profile is governed by bimolecular termination 
through translational diffusion (except in the later stages of polymerization when 
network formation reduces the mobility within the system). However, in the solid state, 
the translational diffusion mechanism is inhibited as the crystallinity restricts any 
translational movement. In the proposed model, three different mechanisms determine 
the reaction profile:  
- a zero-order initiation mechanism which is assumed to be independent of the 
macromonomer concentration 
- a first order monomolecular termination mechanism being for instance radical 
trapping 
- second order bimolecular mechanisms for propagation and termination, which 
are still possible in the solid state through reactive diffusion modulated by 
segmental fluctuations of the flexible spacers 
The dependence of the first and second order mechanisms on the structural changes 
occurring during polymerization is captured by scaling laws expressed in terms of the 
functional conversion p. Herein, a power law expression is applied for the structurally-
controlled dynamic rate constants. After determining the coefficients, information can 
be derived on the structural dependence of the different reaction mechanisms. 




The present modeling approach is based on a quasi-steady-state assumption for the 
polymerization leading to an expression for the polymerization rate as derived in 
equation (10) in the introduction of this chapter. In this equation, the first and second 
order termination mechanisms are included. Second order termination reactions are 
combined in a single bimolecular rate coefficient ktb, while ktT expresses first order 
termination. 









0        (10) 
which can rewritten in the simple parametrized form 






















           (14) 
If the second factor in Eq. (12) is constant, Rp should decrease linearly with conversion 




 down to zero. Obviously, other 
conversion-dependent factors control the overall polymerization rate to account for the 
experimentally measured acceleration-deceleration polymerization profiles. 
Using Eyring’s theory, the apparent (effective) rate coefficients for bimolecular 
propagation and termination (i = p, tb) can be expressed as a function of the chemical 
rate constant kc,i and a dynamic rate constant kd,i reflecting structurally-dependent 
dynamic changes (e.g. the different diffusion/fluctuation mechanisms occurring 











           (15) 
Assuming that the structural mechanisms effectively control the apparent reaction rate 
(
icid kk ,,  ), equation (15) can be reduced to: 
idie kk ,,             (16) 




Structural aspects affecting polymer properties are often expressed using scaling laws 
(e.g. network formation and gelation). Hence, a power law expression is introduced for 
the structurally controlled dynamic rate constants including a cut-off conversion pm;i. 
im
imididie ppkkk )/1( ,
0
,,,          (17) 
As the first order termination equation is assumed to be monomolecular, it has no 
chemical contribution and is only structurally controlled, i.e. 
tTm
tTmtTtT ppkk )/1( ,
0           (18) 
 
The cut-off value for the propagation, bimolecular termination and trapping can be 
approximated by the maximum conversion pmax 
max,,, pppp tTmtbmpm           (19) 
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MB            (24) 
tbptT mmm            (25) 
A priori, translational diffusion can be neglected in the solid state and both propagation 
and termination occur through similar mechanisms (reactive diffusion, segmental 
fluctuation). Therefore, it is reasonable to assume that both mp and mtb are of the same 




order of magnitude. As a result, the orders α and β (equations 23 and 24) can be 
approximated as 
tbptbp mmmm  2          (26) 
tTtbptT mmmm           (27) 
Therefore, the exponent α expresses the rate dependence for bimolecular 
mechanisms, while β expresses the dependence for monomolecular mechanisms. The 
polymerization rate as a function of conversion (equation 12) can now be expressed 
as a general equation with the four adjustable parameters:  
  )/1()/1()/1()1( max2max2max ppAppBppBpRp     (28) 
When applying this model, the polymerization speed is modelled as a function of the 
conversion p and the maximal conversion pmax (the specific pmax value for each set of 
experimental conditions (polymerization and crystallization temperature) was used). 
The photo-DSC data are fitted using 4 parameters α, β, A and B. The initial values for 
these parameters were estimated based on literature and experience to estimate their 
order of magnitude, and the Levenberg–Marquardt algorithm was used to obtain fitted 
values. The main strength of this model is that it gives an indication of the contribution 
of mono- and bimolecular termination reactions on the polymerization speed, through 
parameters α and β. However, A and B are a complex function of rate constants, initial 
monomer concentration and initiation efficiency. Therefore, these two parameters lose 
their physical relevance. As this model is specifically developed for solid state 
photopolymerization, it is not generally applicable to radical polymerization as there 
are a number of assumptions only valid under these specific conditions. Therefore, 
only photo-DSC data obtained in the solid state will be fitted using this model in the 
following paragraphs.   
3.4.2. Applying this model to the photo-DSC results 
Applying this model to the series of measurements described in section 3.3.3, resulted 
in an excellent fit of the experimental data (r2 ≥ 0.996). In Figure 21, the experimentally 
determined polymerization speed as a function of conversion is shown, with the 
resulting model for polymerizations occurring at 293 K (20°C) with and without a photo-
initiator and for the two different crystallization conditions. In addition, the experimental 




data and the fitting curves are shown for a range of different polymerization 
temperatures in Figure 22, for a polymerization in the solid state without a photo-
initiator after crystallization occurring at 293 K.  
 
Figure 21: Experimental polymerization speed (symbols) and fitting curves (lines) for precursors 
crystallized dynamically at 253 K (blue) and isothermally at 293 K (red) and polymerized at 293 K. The 
left graph represents polymerizations without a photo-initiator while the right graph is in the presence of 
0.2 wt% HCPK (corrected DSC thermograms, as described in materials and methods). 
 
 
Figure 22: Experimental polymerization speed (symbols) and fitting curves (lines) for precursors 
crystallized at 293 K without a photo-initiator. The colors represent the different polymerization 
temperatures going from 258 K to 293 K.  




Equation (28) describes the dependence of the polymerization rate on the monomer 
concentration (1-p), which is modulated using power law dependencies. The initial part 
of the polymerization curve showing the acceleration, is described by exponent β, and 
is governed by the monomolecular mechanisms. The last part of the curve before 
reaching the final conversion, is determined by bimolecular mechanisms expressed 
using the exponent α. In Figure 23, the variation of the fit exponents α and β is shown 
as a function of temperature. It is anticipated that there will not be a strong dependence 
of the exponents on the polymerization temperature, as the temperature dependence 
is already comprised in pre-factors A and B, which are a complex combination of the 
different rate coefficients. This is the case for exponent α, which remains between 1 
and 2 over the whole temperature range. This means that there is no strong 
dependence on structural changes for the bimolecular mechanisms. Furthermore, 
there is no effect of a photo-initiator nor of the crystallization temperature on α. 
 
 
Figure 23: Evolution of fit coefficients α (circles) and β (squares) as a function of temperature for the 
crystallization at 253 K (blue curves) and at 293 K (red curves) without (left) and with (right) 0.2 wt% 
HCPK. 
The exponent β on the other hand is significantly higher, indicating the monomolecular 
mechanisms are much more sensitive to structural changes during photo-
polymerization. Both with and without a photo-initiator, the coefficient is slightly higher 
for the prepolymers crystallized dynamically at 253 K ( e.g. for polymerizations at 20°C 
(293 K), β is 9.7 for isothermal crystallization and 11.3 for dynamic crystallization). In 
the presence of a photo-initiator, the coefficient continuously decreases with 
polymerization temperature (from 19.9 at 253 K to 6.5 at 308 K for polymerization after 




isothermal crystallization). Without a photo-initiator, the same trend can be observed 
(from 193 at 253 K to 8.8 at 303 K for isothermal crystallization). However, around the 
melting point, it starts to increase again (to 19.3 at 308 K for isothermal crystallization). 
The area close to the melting point can be considered a kinetic grey zone, because 
the system is neither completely molten, nor completely solid. For auto-initiated 
polymerizations, the polymerization rate will drastically drop after the melting point. In 
the presence of a PI, the rate maintains a more constant value, close to the maximum 
value in the solid state. This behavior which can be observed in Figure 12, is reflected 
in the variation coefficient β as a function of the temperature, close to the melting point 
with and without a photo-initiator. 
3.5. Conclusions 
In the current chapter, an in-depth analysis of the solid state reactive polymers, 
introduced in the previous chapter, was conducted. In a first part, the polymerization 
reaction was characterized based on a qualitative approach using photo-DSC. The 
results showed that the auto-initiation of the polymers can be attributed to radical 
generation by the acrylate groups. The absorption wavelength is strongly dependent 
on the chemical environment of the acrylates. Depending on the structure, it can shift 
to values within the UV-A range, as observed for the polymers developed in this work. 
In addition, the auto-initiation in the solid state is more efficient, as the π- π* orbitals of 
the acrylates can more efficiently overlap due to phase separation.  
Without a photo-initiator, the maximum polymerization speed will significantly drop 
when transitioning from the solid to the molten state (the maximum heat flow decreases 
from 3.4 W g-1 to 2.1 W g-1 ). In addition, it was shown that polymerization is less 
efficient under air atmosphere, both with and without a photo-initiator. As a result of 
oxygen inhibition, for samples without a photo-initiator the maximum heat flow 
decreased from 3.39 to 2.7 W g-1 in the solid state and from 2.1 to 1.1 W g-1. 
Furthermore, it was determined that an increase in temperature resulted in an increase 
in maximum polymerization speed until close to the melting point. Above the melting 
point, the polymerization speed remained constant. In addition, the crystallization 
conditions affected the solid state polymerization. The maximum polymerization speed 
and double bond conversion were slightly higher (maximum difference of 1.2 x 102 mol 
g-1 s-1) at the different polymerization temperatures when the crystallization occured at 
a higher temperature, except when approaching the melting temperature.  




The versatility of the polymers was demonstrated by synthesizing a series of polymers 
with a different backbone polymer (PCL versus PEO), a different end group 
(methacrylate versus acrylate) and an increasing backbone length (ranging from 2000 
to 20000 g mol-1). All polymers could be efficiently polymerized in the solid state. An 
increase in backbone length resulted in a reduction of the maximum polymerization 
speed and double bond conversion, as the acrylate concentration was reduced. The 
maximum polymerization speed without a photo-initiator decreased from 6.0 x 102 mol 
g-1 s-1 (PEG2000-OEOAcr) to 2.8 x 102 mol g-1 s-1 (PEG10000-OEOAcr) in the solid state 
and from 1.6 x 102 mol g-1 s-1 (PEG2000-OEOAcr without PI) to 1.2 x 102 mol g-1 s-1 
(PEG10000-OEOAcr without PI) in the molten state. 
The demonstrated versatility of this system offers the possibility to tune the mechanical 
properties of the polymers towards specific future applications. Another way to tune 
the properties was by varying the water content prior to polymerization. An increase in 
water content decreased the moduli and resulted in an increase of the swelling capacity 
of the hydrogels after crosslinking. For example, for solid state crosslinking (100 wt% 
concentration), the swelling ratio increased from 1.3 for PEG2000-OEOAcr to 16.3 for 
PEG20000-OEOAcr. 
In a final part of this chapter, a model was suggested to describe the solid state 
reactivity starting from a steady-state assumption. The model was based on the 
different monomolecular and bimolecular reactions occurring throughout the 
polymerization and uses scaling laws to describe the effect of the structural changes 
on the occurrence of these reactions. An excellent fit was obtained for the different 
reaction conditions. It was shown that the bimolecular mechanisms do not have a 
strong dependence on the structural changes and are independent of temperature. 
The monomolecular reactions showed a stronger dependence and were responsible 
for the auto-acceleration of the reaction. In addition, the monomolecular exponent 
decreased with increasing temperature.  
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This chapter describes an indirect approach to create three-dimensional scaffolds for 
tissue engineering purposes. Parts of this chapter were published as a research article 
entitled “Indirect Solid Freeform Fabrication of an Initiator-free Photocrosslinkable 
Hydrogel Precursor for the Creation of Porous Scaffolds.”1 (Houben, A. et al. Indirect 
Solid Freeform Fabrication of an Initiator-free Photocrosslinkable Hydrogel Precursor 
for the Creation of Porous Scaffolds. Maromolecular Biosci. (16, 1883–1894 (2016)).  
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As described in chapter 1, it is of crucial importance to generate a 3D environment that 
mimics the natural extracellular matrix (ECM) to achieve optimal support for cell 
adhesion and growth. 2–6 Ideally, a scaffold which provides mechanical support, is 
seeded with cells which then gradually substitute the scaffold material with ECM. 7,8 In 
this respect, hydrogels are ideal scaffold materials as they can closely mimic the water 
uptake potential and network structure of the native ECM.9–11 In this respect, synthetic 
hydrogels have the advantage that they can be produced in a controlled and 
reproducible way, resulting in tailored properties including elasticity and swelling 
behavior.  
Synthetic, urethane-based polymers are widely used due to their outstanding 
mechanical and chemical characteristics. Furthermore, their properties can be tailored 
by selecting the appropriate building blocks. Due to hydrogen bonding occurring 
between the nitrogen proton donor and carboxylic proton acceptor in the urethane 
bonds, elastic materials are obtained. The latter have already been extensively used 
in various biomedical applications of which an overview has been provided in the 
introduction (section 1.2.3.1.1). By incorporating hydrophilic segments (e.g. 
poly(ethylene oxide)), urethane-based hydrogels could be developed as described in 
chapters 2 and 3.12–16 The latter combine the favorable polyurethane characteristics 
with the ECM-similarity of hydrogels. However, because their hydrophilic surface has 
a low interfacial free energy in contact with body fluids, PEG-based materials are used 
for applications where cell and protein adhesion are not desired. (e.g. in PCL/PEG-
based materials or PLA/PEG based hydrogels)17–19 In contrast, natural hydrogels often 
show high cell adhesion, but show a large batch to batch variability in mechanical, 
biological and chemical properties as explained in the first chapter (section 
1.2.3.2).10,20–23  
Scaffold porosity is another important parameter to be considered during scaffold 
design, as it enables the diffusion of oxygen and nutrients towards the cells and 
drainage of waste products away from the cells. In addition, the porous network aids 
in achieving efficient and homogeneous cell seeding as well as cell distribution 
throughout the entire scaffold.24–26 In this respect, solid freeform fabrication (SFF) 
techniques have proven to be highly suitable as they offer superior control over both 
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macro- as well as microstructure compared to conventional scaffold production 
technologies.6,27 Processing of non-thermo-responsive hydrogels using SFF can be 
quite challenging. Therefore, the iSFF method, described in chapter 1 (section 1.3.2) 
is an ideal approach to process these challenging materials. In literature, a range of 
natural hydrogel materials such as collagen, gelatin, alginate have already been 
successfully processed into three-dimensional structures using iSFF. 8,23,28–31 Fewer 
papers report on the processing of synthetic hydrogels using iSFF. In this respect, the 
work of Bertassoni et al and Miller et al focusses on the use of PEG-based hydrogels 
for the creation of vascular networks.26,32  
Herein, a FDM-based iSFF approach has been optimized to generate tissue 
engineering scaffolds starting from the acrylate end-capped, urethane-based 
poly(ethylene glycol) precursor (PEG2000-OEOAcrP) developed in chapter 2. The solid 
state reactivity enables SFF of the pure polymer precursor (100 wt%), while iSFF is a 
broadly applicable methodology enabling processing of the precursor at various 
concentrations, thereby influencing the mechanical properties. In addition, it offers a 
method to create 3D scaffolds for other hydrogel materials that cannot be crosslinked 
in the solid state. Similar to the approach described in chapter 1, a gelatin-
methacrylamide (GM) coating was applied onto the PEG2000-OEOAcr scaffolds 
developed for tissue engineering applications.33  
 
Figure 1: Overview of the preparation steps required for scaffold production 
A scheme of the followed route towards scaffold development is depicted in Figure 1. 
Mouse calvaria preosteoblast cells (MC3T3-E1) were used to evaluate cell viability, 
adhesion and morphology on the different scaffolds developed.  
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4.2. Materials and Methods 
4.2.1. Synthesis of PEG2000-OEOAcr 
The synthesis of the hydrogel precursor PEG2000-OEOAcr was performed as 
described in chapter 2 (section 2.1.1.). Polyethylene Glycol (MW 2000 g/mol) was 
coupled to monoacrylate oligo(ethylene oxide) (MW 336 g/mol) using isophorone 
diisocyanate as a linker.  
4.2.2. Rheological Analysis 
Rheological analysis was performed according to the method described in chapter 2 
(section 2.1.6.) 
4.2.3. Determination of the Swelling Degree 
The swelling degree was determined gravimetrically, as described in chapter 2 (section 
2.1.7.) 
 
4.2.4. Tensile Testing 
For tensile experiments, hydrogel sheets were prepared with a thickness of +/- 1 mm, 
similar to those for the swelling tests, and cut into dogbone-shaped samples with a 
length of 50 mm and a central width of 4 mm. All tests were performed on a Universal 
tester 10-KM (Hounsfield) at an extension rate of 10 mm/min using a 100 N load cell. 
The Young’s modulus was derived from the stress-strain curves. Experiments were 
conducted both on samples containing their initial water content as well as samples 
after equilibrium swelling. 
4.2.5. Printing of the PCL Templates 
The templates were produced in a similar fashion as previously reported.2334 More 
specifically,  G-codes were obtained using in-house developed software written in 
visual basic for applications. Next, the G-codes were transferred to an Ultimaker 1 with 
a standard nozzle diameter of 400 µm via Cura 13.06.4 (Ultimaker, Geldermalsen, The 
Netherlands). PCL templates were produced in meander at 11 mm/s with a lay-down 
pattern of 0/90° and a layer height of 250 µm. The temperature ranged from 130 to 160 
°C while standard extrusion was set to 0.017 mm filament/mm deposited strut which 
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corresponds to a volume of 0.1009 mm³ PCL/mm deposited strut. To optimize the 
extrusion, a multiplication factor (extrusion rate) was applied varying between 1 and 
1.75 and the inter-strut center distance was set between 600 and 900 µm. The filament 
was a PCL filament obtained from Luxilon (Antwerp, Belgium) with a diameter of 2.75 
mm and a molecular weight of 130,000 g/mol with a polydispersity of 1.41 as 
determined by size exclusion chromatography. After optimization of the printing 
parameters, a standard extrusion rate of 1.2, a temperature of 120 °C and an inter-
strut center distance of 700 µm were selected to produce the samples for the biological 
evaluation. 
4.2.6. Preparation of the Hydrogel Scaffolds 
The hydrogel scaffolds were prepared by immersing the PCL templates in a solution 
of 60 wt% PEG2000-OEOAcr. The container containing the immersed templates was 
subjected to a vacuum treatment for at least 1 hour to ensure complete filling of the 
pores. Afterwards, the samples were removed from the solution and crosslinked for 1h 
using UVA light (300-400 nm, 2 x 8 mW cm-2 from top and bottom). After crosslinking, 
excessive material surrounding the PCL template was removed using a scalpel. Next, 
the PCL templates were dissolved in 10 ml of chloroform for 1 week, changing the 
chloroform solution daily. Finally, the obtained hydrogel scaffolds were dried using a 
vacuum oven at 30°C under reduced pressure (10 mbar). 
4.2.7. Micro-computed Tomography 
The 3D morphology of the scaffolds was determined using high resolution X-ray 
computed tomography (µCT). To visualize the sample containing both the hydrogel 
scaffold and the PCL template, 0.25 g/mL β-tricalcium phosphate (Sigma) was added 
to the hydrogel precursor solution to enhance contrast. The samples were scanned 
using the custom-designed system HECTOR at the Ghent University Centre for X-
ray Tomography (UGCT)35. During the scan, 2000 radiographic images were 
acquired at an exposure time of 1 s each, resulting in a total scan time of 36 minutes. 
The projection data were reconstructed to a 3D volume using an in-house developed 
software package: Octopus Reconstruction36 (Inside Matters, Belgium) and rendered 
using VGStudioMax2.2 (Volume Graphics, Germany). Using geometrical 
magnification, a reconstructed voxel size of 7³ µm³ was achieved on a 2000 * 2000 * 
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500 voxel grid. Edge enhancement effects from X-ray phase contrast were observed 
but left unprocessed as they do not hinder proper visualization and interpretation. 
4.2.8. Surface Texture Analysis 
Texturometry tests were performed in both dry and equilibrium swollen state using a 
Lloyd TA500 Texture Analyser, equipped with a 10 N load cell. When analyzing the 
equilibrium swollen hydrogel scaffolds, the samples were first removed from double 
distilled water, gently dipped with tissue paper to remove residual water and positioned 
on a flat bottom plate. On top of this bottom plate, a plate was placed with a round 
opening (Ø 5 mm) to prevent the sample from slipping away upon exposure to the 
applied force. A texture profile analysis (TPA) test was performed using a cylindrical 
probe (Ø 3 mm). During the measurement, the samples were compressed twice over 
a distance of 0.5 mm at a rate of 5 mm/min. The maximum force applied on the 
scaffolds is measured during the first and the second run. All samples were 
compressed in the longitudinal (Z) direction. 
4.2.9.  Gelatin Methacrylamide Modification and subsequent Hydrogel Coating 
The modification of Gelatin was performed as described in chapter 2. The scaffolds 
where coated using the modified gelatin as described in chapter 2 (section 2.1.10) 
4.2.10. In Vitro Biological Evaluation 
Both GM coated and non-coated samples, prepared from a 60 wt% PEG2000-OEOAcr 
solution, were evaluated. The samples were sterilized using ethylene oxide treatment 
(cold cycle, 35°C for 3 days). Mouse calvaria preosteoblast cells (MC3T3-E1) (ATCC) 
were cultured in alpha-minimal essential medium (Thermo-Fisher) supplemented with 
10% fetal bovine serum and 1% penicillin/streptomycin (both from Thermo Fisher) at 
37°C and 5% CO2. For each scaffold, 10,000 cells were seeded in 0.075 ml medium. 
After 1 hour, 0.5 ml medium was added. The medium was refreshed every other day.  
At different time points, an Alamar blue assay (Invitrogen) was performed by first 
washing the samples with PBS and subsequently adding 1% Alamar blue solution 
(diluted in PBS). After 1 hour, the absorbance was measured on a plate reader (Infinite 
M200, Tecan). Blank samples without cells were examined as a reference, to exclude 
any interference of the scaffold. The relative absorbance was calculated by dividing 
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the absorbance of the sample by the background absorbance of the blank reference. 
For visual evaluation, Carboxyfluorescein diacetate succinimidyl ester (CFDA) staining 
(Invitrogen) was used. After washing the sample with PBS buffer (T=37°C), 10 µM 
solution was added and the samples were incubated for 15 min. Next, medium was 
added (T=37°C) and the samples were incubated for another 30 min prior to analysis 
using fluorescence microscopy (Nikon Eclipse TE2000).  
Calcein-AM/propidium iodine staining (Sigma) was performed by washing the samples 
with PBS buffer (T=37°C) followed by the addition of 1 µM of calcein-AM solution and 
1 µM of propidium iodide solution. Prior to analysis by fluorescence microscopy, the 
samples were incubated for 30 min. Fluorescence microscopy was applied at  485 nm 
excitation and emission at 530 nm. For the picogreen assay (Invitrogen), lysis buffer 
(500 µl) was added to the samples and three freeze-thaw cycles were applied. The 
picogreen dye was diluted in PBS (5 uL/mL) and for each sample, 50 µl of reagent and 
50 µl of lysis buffer from the incubated sample were mixed and immediately analyzed 
on the plate reader.  
Statistical analysis was performed using PSPP (GNU Free Software Foundation). For 
comparison between multiple groups, ANOVA was performed with a Tukey Post-hoc 
test.  
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4.3. Results and Discussion 
4.3.1. Influence of the Hydrogel Precursor Concentration on the Material 
Properties 
One of the unique properties of the herein developed PEG2000-OEOAcr is that it is 
water compatible over almost the entire concentration range, from 10 – 90 wt%, with 
all concentrations resulting in the formation of a homogeneous network after UV curing. 
By varying the concentration, the final material properties can be tailored depending 
on the envisaged application. In addition, the material can be crosslinked efficiently in 
the absence of a photo-initiator, avoiding pre-processing mixing steps and potential 
toxic effects of the photo-initiator.37 To select the most appropriate hydrogel 
concentration for the scaffold fabrication, rheology, tensile and swelling tests were 
conducted. Samples of varying concentrations between 10 and 100 wt% were 
irradiated during 10 min with UV light and the final storage moduli obtained are plotted 
in Figure 2 (filled circles), giving an indication of the properties of the network formed 
after photopolymerization. An increasing trend in storage modulus, ranging from 6 kPa 
for the lowest concentration to 1410 kPa for the highest concentration, can be observed 
with increasing polymer concentration.  
 
Figure 2: Swelling ratio (open circles) and final value of the storage modulus after 10 10 min UVA 
illumination (filled circles) for different PEG2000-OEOAcr concentrations. 
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An inverse trend is observed for the swelling ratio (open circles) which ranges from 
7.16 to 1.3 times the initial dry weight. During the propagation of the polymerization 
reaction, molecules can either react inter- or intramolecular, the latter leading to 
cyclization reactions. This will result in the formation of so-called microgel structures, 
formed at the early stages of polymerization. Unreacted double bonds can become 
entrapped in the microgel regions, where sterical hindrance will reduce their reactivity. 
In further stages of the polymerization, these microgel regions will connect with each 
other, resulting in network formation on a macroscopic scale.38,39 With increasing water 
concentration, the probability of bridging between these microgel regions will decrease, 
and the number of intramolecular cyclization reactions will increase. This will lead to a 
more diluted and inhomogeneous network, with a higher concentration of unreacted 
acrylates. Therefore, by diluting the hydrogel precursor solution, the swelling of the 
crosslinked network increases, while the mechanical properties decrease, as is 
observed in these experiments. 
 
Figure 3: Young’s modulus for different PEG2000-OEOAcr concentrations for their initial water content 
and after equilibrium swelling. 
Furthermore, these differences in network properties are also reflected by the tensile 
properties of the samples with various concentrations as shown in Figure 3. The 
samples were evaluated both in the presence of their initial water content as well as in 
the equilibrium swollen state. Water swelling loosens the network, resulting in fewer 
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polymer chains per volume element thereby reducing the mechanical properties of the 
material. When evaluating the effect of the polymer concentration, similar trends can 
be observed before and after equilibrium swelling. With increasing polymer 
concentration, the Young’s modulus of the dry samples increased from 0.66 MPa for a 
30 wt% sample to 3.41 MPa for a 70 wt% sample. This can again be attributed to 
network dilution effects occurring with increasing water concentration. This reduces 
the concentration of elastically active chains, the polymer segments in between two 
crosslinks. After equilibrium swelling, a similar trend was observed with a Young’s 
modulus of 0.68 MPa and 3.10 MPa for the 30 and 70 wt% concentrations respectively.  
These values are quite high compared to alternative hydrogels composed of one single 
component.40 For example for crosslinked poly(ethylene glycol) diacrylate hydrogels in 
a similar molecular weight range (1-5 kg/mol), the tensile modulus remains below 1 
MPa over their whole solubility range (up to 40 wt%).41 Elongation at break was not 
significantly affected by the polymer concentration and was characterized by an 
average value of 25% for samples in the presence of their initial water content for the 
evaluated concentrations. After equilibrium swelling, this value increased to 37%.  
To select a suitable concentration, several factors have to be taken into account. 
Indeed, as the native ECM contains large amounts of water, a high water content and 
a high swelling degree are desirable. In addition, an increased diffusion of nutrients 
and metabolites is generally realized in high water content conditions. 42 In this respect, 
low polymer concentrations are preferential as they lead to a more loosely crosslinked 
network and a higher swelling degree. On the other hand, the scaffolds need to 
possess sufficient mechanical integrity to enable implantation and withstand the in vivo 
environment. 43 In a preliminary test, samples containing 30wt%, 60 wt% and 90 wt% 
were synthesized and their handling, swelling behavior and mechanical integrity was 
assessed. Samples with the lowest hydrogel concentration were fragile and difficult to 
handle. Samples with the highest concentration on the other hand were more difficult 
to prepare as the solution became quite viscous and efficient scaffold infiltration was 
difficult. Furthermore, due to the high crosslinking density, the scaffolds could become 
slightly brittle when equilibrium swollen. Based on the arguments mentioned above, 
and the practical evaluation of samples at different concentrations, 60 wt% was 
selected as the a good compromise for hydrogel concentration for scaffold fabrication. 
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4.3.2. Optimization of the Fused Deposition Modelling Parameters 
To obtain 3D hydrogel scaffolds, an iSFF approach was applied as indicated in Figure 
1. In a first step of the approach, PCL templates were generated via FDM. The 
influence of different processing parameters on the obtained template was assessed 
in terms of pore and strut size of the obtained template in Figure 4. A first parameter 
which was evaluated was the extrusion rate, which corresponds to the speed at which 
the filament is extruded relative to the movement of the extrusion head. The extrusion 
rate was  increased stepwise from 1 to 1.8, which implies that more filament is extruded 
to print the same strut length, resulting in the deposition of thicker struts. Lower 
extrusion rates result in the formation of thinner struts. The difference between the 
lowest and highest extrusion rate resulted in a difference in average strut diameter of 
about 200 µm (from 326 ± 37 µm to 523 ± 57 µm). The spacing between the centers 
of the struts remained constant, therefore a higher extrusion rate leads to a smaller 
pore size. A maximum difference in pore size of 200 µm (from 509 ±42 µm to 309 ± 62 
µm) was observed when comparing scaffolds produced at the lowest extrusion rate to 
those produced at the highest extrusion rate. This trend can clearly be observed in 
Figure 4 (left).  
 
Figure 4: Effect of the plotting parameters (poly(ε-caprolactone) (PCL) filament extrusion factor, 
printing temperature and set channel size) on the struts (filled circles) and channels (open circles) of 
the PCL templates. 
A second evaluated parameter was the extrusion temperature, which was varied from 
130°C to 160°C. Higher temperatures reduce the viscosity of the melt, which results in 
an increased polymer flow. A higher flow will again lead to thicker struts and smaller 
pores. An overall difference in strut size of about 110 µm (from 353 ±67 µm  to 462 ± 
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29 µm), and an overall difference in pore size of 120 µm (from 472 ± 59 µm to 352 ± 
35 µm) were observed.  
A final parameter which was assessed was the inter-strut center distance, the distance 
from the center of one strut to the center of the adjacent strut, which will determine the 
pore size. Inter-strut center distance was varied from 600 µm to 900 µm, resulting in a 
measured pore size ranging from 143 ± 29 µm to 452 ± 29 µm. A subtle decreasing 
trend in strut size, from 439 ± 18µm to 428 ± 17 µm can be observed with increasing 
pore size. This effect can be attributed to the distance the material needs to bridge 
between two struts. When the pores become larger, the struts bridging these gaps will 
start to deform, resulting in strut thinning.  
Based on these results, the optimal parameters were selected to create scaffolds for 
further experiments. In addition to the measured pore and strut size, the ease of 
printing and a visual inspection of the samples were also taken into account. An 
extrusion factor of 1.2 was selected (corresponding to the deposition of 0.121 mm³ of 
PCL/mm deposited strut) in combination with an extrusion temperature of 140°C. 
Higher and lower temperatures resulted in a higher frequency of printing problems 
associated with nozzle blockage and the production of flawed scaffolds. If the 
temperature is too high, the material will not cool down and crystallize fast enough, 
resulting in poor bridging of the gaps and finally, scaffold collapse. Conversely, low 
temperatures result in an increased viscosity of the material, often leading to nozzle 
blockage. Finally, an inter- strut center distance of 700 µm was selected, resulting in 
an average strut size of 385 µm and an average pore size of 294 µm.  
4.3.3. Fabrication and characterization of PEG2000-OEOAcr scaffolds 
In a next step, the templates were used to fabricate the PEG2000-OEOAcr hydrogel 
scaffolds. These templates were submerged in the hydrogel precursor solution and 
subjected to a vacuum treatment to ensure complete filling of the template. The 
PEG2000-OEOAcr solution was crosslinked using UVA illumination and the scaffolds 
were subsequently dissolved in chloroform. Using this procedure, a strut of the scaffold 
will become a channel in the final scaffold and vice versa. The vertical pores are formed 
in areas where two struts of the template overlap, which prevents infiltration of the 
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precursor solution in this area, which will result in the formation of longitudinal pores 
after template dissolution.  
 
Figure 5: Optical microscopy images of A) PCL template with large pores (top) and the resulting 
scaffold (bottom). The struts of the template will form channels in the scaffold, while the scaffold 
vertical pores are formed an area where two template struts overlapped. B) Template with small pores 
(top) and the resulting scaffold (bottom). C) Horizontal cross-section of the scaffold. D) Vertical cross-
section of the scaffold. 
As shown in Figure 5, the struts of the PCL template become the channels in the 
PEG2000-OEOAcr scaffold, while the pores exist in areas where the original PCL struts 
overlapped. The result of the PCL processing parameters on the channel and strut size 
of the PEG2000-OEOAcr scaffolds is depicted in Figure 6. The trends in pore and strut 
size of the PCL template are transferred to the PEG2000-OEOAcr scaffolds strut and 
pore size, respectively. As the channel and strut size were measured on dry samples, 
sample shrinkage was observed resulting in an average size reduction for the scaffold 
channels of 25 % relative to the template struts, and 10 % for the scaffold struts relative 
to the template pores. Equilibrium swelling of the scaffolds will affect these dimensions, 
however quantitative measurements on swollen samples were not possible due to the 
low contrast of the obtained images. 
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Figure 6: Effect of the plotting parameters (poly(ε-caprolactone) (PCL) filament extrusion factor, 
printing temperature and set channel size) on the struts (filled circles) and channels (open circles) of 
the PEG2000-OEOAcr hydrogel scaffolds based on the PCL templates. Note that a pore of the template 
will become a strut in the scaffold and a strut of the template will become a channel in the scaffolds. 
To further investigate the scaffolds, µCT images were recorded from a template with a 
scaffold and the final scaffold in the absence of the template Figure 7a shows the PCL 
template surrounded by a solution of 60 wt% PEG2000-OEOAcr. As the difference in 
contrast between PEG2000-OEOAcr and PCL is quite low on the µCT images, 2.5 
mg/mL CaP was added to the PEG2000-OEOAcr solution to increase contrast. After 
template removal, a porous scaffold was obtained from the PEG2000-OEOAcr solutions 
(Figure 7b). The cross-sections clearly show that the sample is effectively cured as 
uncross-linked polymer was extracted during the PCL dissolution step. Furthermore, 
the sample shows excellent porosity in both the vertical as well as the lateral planes, 
which is beneficial towards cell infiltration and - viability.  
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Figure 7: μ-CT images showing 3D cut-through, ZX and ZY cross-section of a) PEG2000-OEOAcr scaffold 
with added β-tricalcium phosphate to enhance contrast between the hydrogel and the PCL template, 
which is still present, b) PEG2000-OEOAcr scaffold. 
The different scaffolds were characterized both in the dry and the equilibrium swollen 
state using texturometry. As shown in Figure 8, a 1 mm indentation was applied to the 
sample, and the required force was measured to determine the sample hardness. 
Again, there was a clear effect of the processing parameters, both in the dry and the 
equilibrium swollen state. The hardness showed a decreasing trend from 43 N to 15.5 
N with increasing extrusion rate. Indeed, as the struts of the PCL template become 
thicker with increasing extrusion rate, larger channels are formed in the final PEG2000-
OEOAcr scaffold. Larger channels result in a higher compressibility of the scaffold and 
therefore, in a reduced hardness. A similar decreasing trend, from 9 N to 29 N, was 
observed upon increasing the extrusion temperature. Larger template struts result in 
larger empty channels for the final scaffold. Evidently, with increasing template pore 
size, the scaffold strut size increases, resulting in a higher hardness. When comparing 
the samples in the dry and swollen state, an average ten-fold reduction in hardness 
can be observed for the swollen samples. Similar trends with varying processing 
parameters can be observed in both the dry and in the equilibrium swollen state.  
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Figure 8: Effect of template plotting parameters, as determined by a texturometrical indentation test on 
the PEG2000-OEOAcr scaffolds in the dry (upper panel) and equilibrium swollen state (lower panel). 
4.3.4. In Vitro Evaluation of Selected Scaffolds 
For the biological evaluation, 3D hydrogel scaffolds with and without a gelatin 
methacrylamide coating were compared. A visual evaluation of the MC3T3 cells 
seeded onto these scaffolds at 10 or 12 days is depicted in Figure 9. A relatively low 
number of cells, 10,000 cells per scaffold, was selected as this is representative for 
cases with limited autologous cell availability.44–47 An example are osteoprogenitor 
cells for bone regeneration, where only a limited number of cells can be isolated from 
the periosteum using currently available techniques. Furthermore, by using a low 
seeding density, the interaction between the cells and the scaffold becomes more 
pronounced. Both CFDA-SE and Calcein-AM/PI staining were used. CFDA-SE was 
used as it is a non-toxic staining that allows fluorescent visualization of the cells over 
a time period of several days, while the latter was used only at the end point of the 
experiment (d12). For the PEG2000-OEOAcr scaffolds, infiltration of the cells into the 
different channels of the scaffold can be observed both with and without the GM 
coating. Quantitative analysis of the fluorescence microscopy and SEM images 
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showed a low amount of cells on the uncoated samples, while on the coated samples, 
a larger number of cells could be observed. Furthermore, the SEM images show a 
pronounced effect of the GM coating on the cell morphology. Indeed, without the 
coating, the cells show a more rounded morphology on the PEG2000-OEOAcr scaffold. 
Conversely, in the presence of the GM coating, cells show a flattened and more 
elongated morphology  
 
 
Figure 9: Analysis of the scaffolds after seeding with MC3T3 cells at 10 or 12 days (indicated on each 
image). Greyscale images have been obtained using SEM, images marked with * are brightfield optical 
microscopy images, + represent overlays of brightfield images with CFDA-SE stained fluorescence 
images, = depicts CFDA-SE stained fluorescence images and # shows live/dead stained fluorescence 
images. 
The qualitative observations were confirmed by quantitative analysis. At different time 
points, the metabolic activity of the samples was analyzed using an Alamar Blue assay. 
The absorbance is expressed relative to a blank sample, also prepared with or without 
GM coating,  to exclude any interference of the scaffold material. At the last time point, 
Chapter 4: Indirect Solid Freeform Fabrication of an Initiator-Free Photo-Crosslinkable Hydrogel 




the DNA content was determined using a picogreen assay, as depicted in Figure 10. 
A clear beneficial effect of the GM coating can be observed in both assays, confirming 
the optical microscopy and SEM results. Indeed, the metabolic activity shows a steady 
increase over the different time points for the coated hydrogel samples, which have a 
higher DNA content in comparison to the uncoated samples. While the differences in 
the metabolic assay were not statistically different, a similar significantly different (p < 
0.05) effect was observed for the DNA content.  
 
 
Figure 10: Left: Alamar Blue assay showing the absorbance of samples seeded with MC3T3 relative 
to the absorbance of a blank scaffold at different time points, indicating metabolic activity of the cells 
(uncoated scaffold in white, scaffold with gelatin methacrylamide (GM) coating in black).. Right: 
Picogreen assay showing the DNA content of the samples with and without Gelatin methacrylamide 
coating (GM) at d12 of the experiment. (results were significantly different at P < 0.05). 
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The hydrogel precursor PEG2000-OEOAcr developed in chapter 2 was successfully 
applied to create porous 3D scaffolds. The high reactivity of the material and its unique 
water compatibility were exploited to create a tunable network structure. The latter 
altered the rheological properties (from 10.6 kPa to 1410 kPa), swelling degree (from 
7.16 to 1.3 times the initial dry weight) and tensile properties ( from 0.67 MPa up to 3.1 
MPa). Indirect solid freeform fabrication has proven to be an elegant solution to 
circumvent processing limitations associated with the use of hydrogel materials and 
via this approach, 3D scaffolds could be generated starting from the hydrogel 
precursor. By varying the processing parameters of the PCL template such as the 
extrusion rate, the temperature and the inter-strut center distance, the properties of the 
final hydrogel scaffolds could be altered, both from a morphological as well as a 
mechanical perspective with the latter determined by texturometry. The presence of a 
completely interconnected porous network within these scaffolds was demonstrated 
using µ-CT. Biological evaluation of the samples using mouse osteoblasts showed that 
the cell adhesion and - proliferation were greatly improved by applying a gelatin 
methacrylamide coating.  
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Chapter 5:  
Development of a Synthetic 









This chapter describes the formulation of a 3D ink for solid freeform fabrication using 
a silicate nanoclay additive. Parts of this chapter will be published as a research article 
entitled “Development of a Synthetic Composite Hydrogel Ink for Solid Freeform 
Fabrication.” (Houben, A. et al. In preparation).  
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When targeting the regeneration of lost or damaged tissue, a conventionally applied 
approach is to develop a porous, three-dimensional (3D) scaffold that can be combined 
with cells. Upon combination, tissue can be regenerated by guiding the cells to produce 
their own extracellular matrix (ECM) and by providing a physical support for the growing 
tissue as introduced in the first chapter.1–4 Solid freeform fabrication (SFF) techniques, also 
known as 3D-printing or rapid prototyping, offer the possibility to produce scaffolds with 
high control over the geometry and morphology.5,6 A crucial aspect in this process is the 
selection of a suitable printing ink. The selected material has to lead to a final construct 
which is self-supporting, compatible with the available SFF technique and biocompatible. 
7,8 
Hydrogels are of great interest for the design of scaffolds, particularly when targeting soft 
tissue engineering, due to their good biocompatibility, their ability to absorb large quantities 
of water and their similarity to the ECM.7,9–11 However, only a limited number of cell-
interactive hydrogel printing inks are commercially available.8 These rely on the use of 
photo-crosslinkable gelatin (Gel4Cell® from Bioink solutions Inc and BioGel from Biobot) or 
combine a synthetic polymer with gelatin (Bioink® from RegenHU). However, despite their 
lack of cell adhesion sites, the use of synthetic hydrogels is advantageous as they have a 
straightforward, scalable and reproducible synthesis, which is associated with tunable 
physical properties of the final material.7,12,13   
In the previous chapters, a synthetic UV-curable acrylate-terminated urethane based 
poly(ethylene glycol) (PEG2000-OEOAcr) hydrogel precursor was developed and 
characterized.14,15 This PEG2000-OEOAcr hydrogel precursor is an attractive SFF ink 
candidate due to a range of interesting properties. It can be synthetized on an industrial 
scale using low-cost reagents.14 In addition, the material can be used over its entire 
concentration range (10-100 wt%), resulting in efficient hydrogel formation with excellent 
mechanical properties.14,16 Furthermore, the material can be UV-cured in the absence of a 
photo-initiator, which circumvents any possible toxic effects of  photo-initiators.17  
To increase cell interactive properties of synthetic materials, bulk modification or coating 
with biological molecules such as ECM proteins, peptide sequences and/or growth factors 
is a commonly used approach, as was applied in chapter 2 (gelatin methacrylamide 
coating).18–20 Alternatively, bioactive properties have been enhanced via the fabrication of 




composite hydrogels by the integration of inorganic compounds such as calcium 
phosphate or silicate-based materials into the hydrogel.13,21–25 The latter approach can be 
considered more advantageous due to the ease of fabrication resulting in composites with 
enhanced mechanical and biological properties, and the more cost-efficient character of 
the method.24  
In this approach, Laponite, a silicate nano-clay, was used as an additive as it conveniently 
improves both cellular response and the mechanical and rheological properties of the 
printing solutions and the printed constructs.26–28 It is composed of layered aggregates 
(nano-clay platelets) of magnesium silicate with the empirical formula Si8[Mg5.5Li0.4H4.0O24]-
0.7 Na+0.7. The material shows a thixotropic rheological behavior which is ideal towards 
extrusion-based SFF methods, as the printing material should easily flow from the needle, 
while the printed structure needs to be retained. 29,30 Furthermore, when the nano-clay 
platelets are combined with polymers, they act as multifunctional physical crosslinks 
between polymer chains leading to enhanced mechanical properties of the network, of 
which the crosslinks are reversible upon deformation due to adsorption/desorption 
phenomena of the polymer chains to/from the nano-clay platelets.31,32  
Besides favorable Laponite effects on the physical properties of polymers, its ability to 
promote cell response has also been reported using mouse osteoblasts, human 
mesenchymal stem cells and humane bone marrow stromal cells.11,26,33–35 Similar to 
bioactive glass, Laponite has dissolution products such as Mg2+ and Si(OH)4 which interact 
with cell integrins and stimulate collagen-I formation.33,36 On the other hand, protein 
adhesion is promoted in presence of the nano-clay materials on the surface, which 
subsequently results in improved cell adhesion.37 Chang et al. fabricated polyethylene 
glycol diacrylate (PEGDA)/Laponite composites and reported that the addition of Laponite 
improved cellular interactions with mouse osteoblasts.26  
In the present chapter, the aim was to develop a novel, low-cost, cell-interactive and fully 
synthetic (not protein based) 3D-printing ink. To this end, a recently developed PEG-based 
hydrogel material was combined with the nano-clay additive. The beneficial properties of 
Laponite have been described in literature (as mentioned above), however the 
development of a fully synthetic 3D printing ink for tissue engineering applications, 
evidenced by direct cell seeding on a printed scaffold has not been described. Calvert et 
al created cross-linked polyacrylamide and polyacrylic acid freeformed constructs by 




combining a monomer, a crosslinking agent and a catalyst with fumed silica and printing 
on a hot plate to induce polymerization.29 However, they do not describe cell seeding 
experiments on these scaffolds. Hong et al use laponite for 3D printing experiments, in 
combination with calcium-crosslinked alginate and PEG in a partly synthetic, partly 
biopolymer based ink.38. However, for the biological evaluation, they do not seed cells onto 
the printed scaffolds, but rather encapsulated them in a collagen solution which was 
injected into the pores of the printed scaffold. In this work, the properties of the ink solution 
before and after crosslinking were assessed using rheology, swelling tests, gel fraction 
experiments, tensile test and contact angle measurements. Next, the ink composition was 
optimized for SFF after which the resulting 3D-printed constructs where evaluated for their 
cellular response by seeding mouse osteoblast cells (MC3T3) directly onto the printed 
scaffolds.  
  




5.2. Materials and Methods 
5.2.1.  Polymer synthesis 
An acrylate-endcapped urethane-based poly(ethylene glycol) hydrogel precursor 
(PEG2000-OEOAcr)14–16 was synthesized by first reacting poly(ethylene glycol) (Mn 
2000 g/mol) (PEG 2000, Sigma) with isophorone diisocyanate (IPDI, BASF) at 75°C in 
a 1:2 stoichiometric ratio using 300 ppm bismuth neodecanoate (Shepherd) as a 
catalyst. In a second step, a monoacrylated PEG (Bisomer PEA 6, GEO Specialty 
Chemicals UK Ltd) was added together with 300 ppm bismuth neodecanoate and a 
temperature of  80°C was maintained until a residual NCO value below 0.02 meq g-1, 
determined by potentiometric titration, was considered for the reaction to be complete 
(after 3 hours). 
5.2.2. Preparation of composite ink solutions  
Three different types of nanosilicates, available under the commercial name Laponite 
(provided by BYK) were used herein. For initial characterization tests, Laponite RD and 
RDS were used (general purpose grade). The first purely consists of silicate nano-clay 
particles, while the latter also contained pyrophosphate groups to postpone gelation of 
the solution, enabling a more efficient mixing. For cell tests, Laponite XLS was used 
which has the same composition as Laponite RDS but of a higher purity (personal care 
grade: high purity, certified low heavy metal and low microbiological content). To 
prepare the precursor-nano-clay composite formulations, Laponite was dissolved in 
double distilled water at room temperature under heavy stirring. When Laponite was 
completely dissolved, the PEG2000-OEOAcr hydrogel precursor powder was added and 
the mixture was heated up to 50° C overnight under mechanical stirring until a 
homogeneous solution was obtained. The same protocol was followed for all 
compositions prepared and characterized in this study. 
5.2.3. Preparation of crosslinked hydrogel samples 
Thin hydrogel films, to be applied for swelling tests, mechanical characterization and 
static contact angle measurements, were prepared by film-casting the ink solutions 
containing the synthetic hydrogel building block (30-50 wt%) and  Laponite RD or RDS 
(0-3 wt%) in between two glass plates, as described in chapter 2. The samples were 




exposed from both sides to UV-A light for 20 minutes (LEDENGIN  LZ1-00U600  LED, 
Ultra Violet, SMD, 4.1 V, 365 nm, 2×8 mW cm-2).  
For printed hydrogels, samples were placed onto a glass plate and crosslinked using 
the same setup during 30 minutes to ensure complete curing of the sample.  
5.2.4. Rheological analysis of ink compositions 
The influence of shear on the viscosity of the polymer solutions with and without 
additives was studied by oscillatory rheology using an Anton Paar Physica MCR 300 
rheometer. A parallel plate setup was used with a top plate diameter of 25 mm. All 
measurements were performed at room temperature (21°C), after introducing 
approximately 500 µl precursor solution between the plates and setting a gap size of 
0.5 mm. The complex viscosity was measured as a function of the frequency (0.01 - 
100 s-1) and plotted on a logarithmic scale. 
Polymerization/cross-linking kinetics of the different ink compositions were studied by 
linear rheology using an Anton Paar Physica MCR 300 rheometer equipped with an 
EXFO novacure 2000 UVA light for sample irradiation from the bottom through a quartz 
plate (140 mW cm-2).  A parallel plate setup was used with a top plate diameter of 25 
mm. In order to study the network formation, the elastic shear modulus (G’) was 
recorded over time upon UV exposure. Frequency and strain sweeps were recorded 
to establish the linear visco-elastic(LVE)  range of the materials. A shear frequency of 
1 Hz and an amplitude of 1 % were selected as they were well within this LVE range. 
The gap was set at 0.35 mm. The UV-A light was switched on after 60 s and the 
samples were irradiated for 10 min followed by a 60 s interval without UV exposure to 
determine the final G’ value. 
5.2.5. Assessment of the swelling degree and the gel fraction of the crosslinked 
inks 
The effect of the Laponite content in the ink solutions on the crosslinking degree and 
the swelling capacity was evaluated gravimetrically, as explained in Chapter 2.  
Statistical analysis was performed using the Analysis ToolPack for Excel. A single 
factor analysis of variance was performed. For significantly different means, a F-test 
was executed. All variances were found to be unequal. Therefore two sample T-tests 




were performed assuming unequal or equal variances depending on the outcome of 
the F test.   
 
5.2.6. Mechanical characterization of the crosslinked inks 
The influence of the clay concentration on the mechanical properties of crosslinked 
inks was evaluated by tensile tests using a Universal tester 10-KM (Hounsfield) with a 
load cell of 100 N. Dog-bone shaped samples with a length of 30 mm were obtained 
from cross-linked hydrogel films (thickness 1 mm). The tensile properties of the 
hydrogel samples were determined immediately after UV-curing (samples with initial 
water content) and after equilibrium swelling in double distilled water (swollen 
samples). All measurements were performed at room temperature. A preload force of 
0.3 N was applied and the specimens were pulled with a crosshead velocity of 10 
mm/min. The mechanical tensile modulus was calculated from the slope of the first 
linear portion of the stress/strain curves. 
5.2.7. Bioplotting of Laponite-containing inks 
Three-dimensional porous scaffolds were fabricated via the Bioplotter technology 
starting from the different ink compositions, with an PEG2000-OEOAcr precursor 
concentration from 30 to 50 wt% in the presence of Laponite RDS (3 wt %). Printing 
with a lower or higher Laponite concentration did not result in reproducible scaffolds. 
Ink solutions were transferred into a syringe and inserted in the printing head of the 
Bioplotter. The optimization and selected printing parameters are described below. 
During the printing process, the 3D structure self-supporting character was further 
enhanced through scaffold cross-linking using 2 UV-A LED’s (365 nm) mounted on the 
printer head. For complete crosslinking, samples were also irradiated with UV light 
after the printing process (as described in section 2.3). The morphology of the samples 
was observed using a Axiotech 100 – Carl Zeiss with an Axiocam 105 Color from Zeiss 
and analysed using ImageJ software. 
5.2.8. Static contact angle measurements of cross-linked inks 
Static contact angle values of the samples were obtained by the sessile drop method 
using an OCA 20 (DataPhysics Instrument GmbH, Filderstadt, Germany) device, and 
analysed with SCA 20 (DataPhysics Instrument GmbH, Filderstadt, Germany) 
software. After placing 1 μl deionized water onto hydrogel discs, the drop was imaged 




via a micro camera and the contact angle was calculated via the circle fitting method. 
SCA values were recorded immediately and after 1 minute contact. 
5.2.9. Biological evaluation 
Mouse calvaria preosteoblast cells (MC3T3-E1, P14, ATCC) were cultured in alfa-
minimal essential medium supplemented with 10% fetal bovine serum, 2 mM L-
glutamine and 0.5 v % penicillin-streptomycin (104 U mL-1- 104 µg mL-1). The scaffolds 
were sterilized using ethylene oxide (cold cycle, AZ Sint-Jan hospital, Brugge). Prior to 
cell seeding, the scaffolds were incubated in serum-free culture medium for 1 hour to 
reach equilibrium swelling. After removal of the serum-free culture medium, MC3T3 
cells (300 000 cells/80 µl/scaffold) were seeded by drop-seeding. After 4 hours, 
additional culture medium was added and the cell/scaffold constructs were incubated 
(37°C, 5% CO2) for 21 days. Calcein AM/propidium iodide staining was performed to 
evaluate cell viability by fluorescence microscopy (Type U-RFL-T, Olympus). 
Statistical analysis was performed according to the methods described in section 2.5. 
 
  




5.3. Results and Discussion 
5.3.1. Combination of the shear thinning properties of Laponite and the UV 
photocrosslinking behavior  of the PEG2000-OEOAcr hydrogel precursor: a 
rheology study  
One of the Laponite key features is the shear thinning behavior. When dispersed in 
aqueous medium, platelet-like nanoparticles are formed.39,40 The dissolved 
nanoparticles crosslink trough ionic interactions, leading to a solution viscosity 
increase. When stress is applied, the gel structure is distorted resulting in a significant 
viscosity reduction. When the stress is removed, the re-orienting platelets result in 
gelation. This behavior was investigated using birefringence experiments, which have 
shown that upon applying shear stress, the clay platelets orient themselves along the 
direction of the applied shear.41 Furthermore, when a PEO-based polymer is present 
in the solution, the polymer chains adsorb to the clay particles through electrostatic 
interactions. This reversible binding results in shear thinning behavior, which is 
beneficial for extrusion-based solid freeform fabrication. In this first characterization 
section, the shear thinning effect of Laponite was characterized using a 30 wt% 
concentration of PEG2000-OEOAcr. As the aim was to understand the properties of 
Laponite, this was performed prior to the solid freeform fabrication experiments. 
Therefore, these concentrations are not optimized for solid freeform fabrication. 
Figure 1 (top left panel) represents the Laponite RD concentration dependent shear 
thinning properties of aqueous solutions. For the lowest concentration of 2 wt%, only 
minor shear thinning can be observed as the viscosity of the solution ranged from 0.72 
Pa·s to 0.04 Pa·s. The concentration of silicate nanodiscs is too low to enable 
significant ionic crosslinks. For a 3 wt% concentration however, a significantly higher 
viscosity increase of the solution to a value of 188 Pa·s was observed at the lowest 
shear rate of 0.01 s-1.The observed viscosity linearly decreases with an increasing 
shear rate to a value of 0.18 Pa·s. When the Laponite concentration is further 
enhanced, higher viscosities were obtained while maintaining the shear-thinning 
properties. 
In a next step, we were interested to study whether or not the Laponite shear thinning 
behavior is preserved in combination with the herein developed  PEG2000-OEOAcr 
hydrogel precursor. From figure 1 (top right panel), it is obvious that 30 wt%  PEG2000-




OEOAcr solutions reveal Newtonian behavior, characterized by a frequency 
independent constant viscosity. The figure further indicates that upon addition of 2-5 
wt% Laponite RD, a significant viscosity increase is observed at low frequency, with a 
decreasing trend at higher frequencies, confirming the prevalence of the Laponite 
shear thinning behavior when combined with  PEG2000-OEOAcr.  
 
Figure 1: Top: Complex viscosity as a function of the frequency for (left panel) varying concentrations of 
Laponite RD and (right panel) 30 wt% PEG2000-OEOAcr (indicated as prec. ) with a Laponite RD 
concentration ranging between 0 and 5 wt% as determined using rotational rheology. Bottom (left panel) 
Effect of Laponite (3 wt%) on the crosslinking behavior of 30 wt% PEG2000-OEOAcr solutions(prec.) and 
(right panel) effect of Laponite RD concentration (0-5 wt%) on the storage and loss moduli of 30 wt% 
PEG2000-OEOAcr solutions as determined using oscillatory photo-rheology. 
Next, we assessed a possible influence of Laponite RD (3 wt %) on the UV-curing of 
30 wt%  PEG2000-OEOAcr solutions.. Prior to UV crosslinking the storage and the loss 
moduli were about respectively 200 and 1500 times higher for the Laponite containing 
PEG2000-OEOAcr solution. The latter is the result of the crosslinking effect of the 
Laponite particles. Upon UV-illumination, both moduli rapidly increase, indicating the 
onset of effective curing and the excellent auto-initiation of the synthetic  PEG2000-




OEOAcr hydrogel precursor (i.e. in the absence of a photo-initiator). The slight increase 
once the plateau regime is reached corresponds to post-crosslinking reactions 
occurring in the gel.28 The original difference in storage modulus between solutions 
with and without Laponite decreases upon UV-curing. This is due to the elastic 
behavior of the hydrogel which is dominated by the chemical crosslinks formed.. As 
the viscous behavior of the sample is influenced by the Laponite-mediated reversible 
crosslinking of the PEG backbone of  PEG2000-OEOAcr, the loss modulus of the 
crosslinked sample was influenced to a greater extend by Laponite addition. As 
evidenced from Figure 1 (bottom right panel), a similar effect was observed upon 
increasing the Laponite concentration. Indeed, the storage modulus shows a slight 
increase upon Laponite addition, but remains unaffected at increasing Laponite 
concentrations. On the other hand, an increasing trend in the loss modulus was 
observed with increasing Laponite concentration. This confirms the elastic behavior is 
mostly governed by the chemical crosslinks, while the viscous behavior is affected by 
the reversible Laponite induced crosslinking. 
5.3.2. Optimization of the ink formulation: towards 3D printing of porous scaffolds 
After understanding the effect of Laponite on the shear thinning properties and UV-
curing of the PEG2000-OEOAcr - Laponite dispersions, the formulation was optimized 
for solid freeform fabrication prior to further characterization. During the optimization 
process, it was observed that especially for high Laponite concentrations or large 
sample volumes (over 10 g), it became increasingly difficult to obtain a homogeneous 
mixture. Therefore, the silicate particles were combined with tetrasodium 
pyrophosphate (commercially available as Laponite RDS). When dissolved, the 
pyrophosphate anions (P2O7)4- will associate with the positively charged edges of the 
Laponite crystal. As a result, both the surface as well as the edges of the Laponite 
particles have the same charge and the electrostatic repulsion will prevent the 
formation of a gel structure, as shown in Figure 2. Using Laponite RDS, a low viscosity 
dispersion is created that is more easily mixable with the polymer. When the polymer 
is added to this dispersion, this effect is rapidly overcome as the pyrophosphate anions 
are adsorbed in the polymer matrix due to the partial charges present (e.g. urethane 
bonds, ester and ether functions, …). As a result, the Laponite crystals will again 
interact and associate with themselves and the polymer, resulting in a viscosity 
increase. This allows for a more straightforward mixing procedure, resulting in 




homogeneous dispersions with identical printing properties to those prepared with 
Laponite RD. To enable full activation of the Laponite particles (i.e. viscosity build-up 
as a result of dissociation of the pyrophosphate anions with the Laponite particles and 
association of the Laponite particles with themselves and the polymer), the dispersions 
were stirred overnight prior to performing the 3D-printing experiments and the 
characterization assays.  
 
Figure 2: Schematic representation of the association and gelation of Laponite RD (top) and the effect 
of the pyrophosphate anions in Laponite RDS on these processes (bottom). . 
In Figure 4 the viscosity as a function of shear rate is compared for a 30 wt% dispersion 
and a 50 wt% dispersion of PEG2000-OEOAcr, both containing 3 wt% Laponite RDS. It 
can be observed that at all shear rates, the viscosity of the 50 wt% dispersion is higher 
compared to the 30 wt% dispersion. Both dispersions show the typical shear-thinning 
behavior due to the presence of Laponite. Because the exact shear rate during and 
after solid freeform fabrication cannot be determined as the device uses an air 
controlled dispense system, the effect of viscosity can be understood from a qualitative 
point of view. When designing a bio ink, it is important to have a low viscosity at higher 
shear rate, as this ensures that the polymer will easily flow from the plotting needle. 




However, if the viscosity after printing is too low this will drastically reduce the printing 
resolution as printed struts will fuse together. At low shear rates, both dispersions have 
a high viscosity, which will result in excellent structure retention of printed scaffolds. To 
have this ideal balance of the viscosities at different shear rates, the composition was 
optimized by increasing the  PEG2000-OEOAcr concentration from 30 up to 60 wt%. 
When the PEG2000-OEOAcr concentration was lower than 50 wt%, solid freeform 
fabrication was not possible as the flow of the material after deposition is too high, 
resulting in very broad and flat struts. When printing multiple layers, they fused 
together. This is evidenced by the viscosity at low frequency (0.1 s-1): the complex 
viscosity of the 30 wt% dispersion with 3 wt% Laponite RDS increases to 316 Pa s, 
while the 50 wt% dispersion with the same Laponite RDS concentration has a complex 
viscosity that is more than twice as high, 794 Pa s (see Figure 4). Furthermore, the 
slope of these curves is below -1, which indicates that some sedimentation occurs in 
the mixture. This implies imperfect dispersion of the laponite particles, so to have a 
more in-depth analysis of the solutions the mixing procedure should be optimized 
further. Over this PEG2000-OEOAcr concentration range, the Laponite concentration 
was varied from 1-7 wt%, but only solutions with 3 wt % had the ideal shear thinning 
behavior to flow easily from the needle, while retaining the structure after printing. In 
conclusion, a dispersion of 50 wt% PEG2000-OEOAcr combined with 3 wt% was 
determined to be ideal for solid freeform fabrication.  
 
Figure 4: Complex viscosity as a function of the frequency for a 30 wt% and a 50 wt% PEG2000-OEOAcr 
dispersion with 3 wt% Laponite RDS. 




To maximize the printing resolution, the samples were illuminated with 2 UVA-LED’s 
during printing, resulting in a partial crosslinking of the acrylate groups, further 
increasing the structure retention of the printed samples. Complete crosslinking of the 
samples was achieved post processing by irradiating (t = 30 min) the samples using 
UVA lamps. The solid freeform fabrication process was optimized by selecting an 
appropriate layer thickness, speed in the XY plane, speed in the Z direction, pressure 
and strand distance. An overview of these parameters, with the evaluated range and 
the selected value is described in Table 1. 
Table 1: Optimized parameters during solid freeform fabrication 
Parameter (unit) Evaluated range Optimal value  
Pressure (bar) 0.5-5 1-1.2 
Temperature (°C) 10-25 10 




 (mm min-1) 
500-1200 500 
Layer thickness (mm) 0.2-0.25 0.2 
Strand distance (mm) 1-1.4 1.2 
 
A first optimized parameter is the pressure, which was varied between 0.5 and 5 bar. 
The pressure will determine the speed at which the printing ink flows from the syringe. 
If the pressure is too low, the ink will not be extruded due to the shear thinning behavior 
of the dispersions. The pressure, XY and Z speed and temperature all need to be 
optimized together: when the pressure increases, the flow will increase. Therefore the 
XY and Z speed need to be increased to maintain thin struts. A decreased temperature 
will increase the viscosity of the solutions, and the pressure will need to be adjusted 
together with the XY and Z speed. The optimal value for the printing pressure was 
determined to be 1-1.2 bar. Imperfect sealing of the plotting syringe led to small 
variations in the applied pressure and the actual pressure (typically between 0.1-0.7 
bar), therefore the pressure needed to be optimized each time the printing syringe was 
changed. It was observed that high viscosities aided the printing process and led to 




better structure retention. Therefore, the temperature was set to the lowest possible 
value of 10°C. 
As mentioned, the optimization of the printing pressure and temperature are closely 
related to the optimization of XY and Z speed. After the pressure was set to obtain a 
continuous and regular flow of the ink from the needle, the XY speed was optimized. 
When the speed becomes too low, the struts will become thicker, eventually leading to 
pore blockage. If the speed is too high, the struts will no longer be continuous, leading 
to incomplete layers. The ideal XY speed was determined to be 600 mm min-1. As 
illustrated in the previous chapter, the Z speed is the speed at which the needle moves 
up after a layer is printed. If this speed is too high, the last part of the deposited strut 
will break and cause a defect. If the speed is too low, a droplet of material will be 
deposited on the edge of the scaffold (see chapter 2, section 2.2.3.2). For the selected 
ink composition, the ideal Z speed was 500 mm min-1. After optimization of the plotting 
parameters, the structural parameters (layer height and strut distance) could be 
optimized. By printing multiple layers, measuring the height of the construct and 
dividing this by the number of printed layers, the actual value of the layer height could 
be determined, which was 0.2 mm on average. Finally, the strand distance was set to 
1.2 mm, to obtain a regular porosity throughout the scaffold. 
With these optimized plotting parameters, regular scaffolds were printed starting from 
these dispersions, as depicted in Figure 5. An average strut size of 575 ±111 µm and 
pore size of 684 ±99 µm were obtained. The sum of the measured strut size and 
measured pore size is in close accordance to the set strand distance (1.2 mm), 
indicating a good match between CAD and CAM. In addition, a 3D meniscus shape 
(width 31.52 mm, length 1.39 mm and height 2.79 mm) was printed as a proof of 
concept demonstrating the ability of the ink to be used for the printing of larger 
constructs. 





Figure 5: Photographs (left) and optical microscopy images (middle) of 3D scaffold starting from a 50 
wt% PEG2000-OEOAcr dispersion containing 3 wt% Laponite RDS. Right: Human meniscus scaffold 
(31.52 mm x 1.39 mm x 2.79 mm) printed as a proof of concept.   
5.3.3. Further characterization of the selected ink composition 
Further optimization of the solid freeform fabrication ink was performed based on the 
optimized concentration of 50 wt%  PEG2000-OEOAcr and 0-3 wt% Laponite RDS. 
Samples were prepared by photo-initiator free UV initiated polymerization and the gel 
fractions and swelling degrees of the obtained gels were determined (depicted in 
Figure 3). The gel fraction remained unaffected in the investigated Laponite 
concentration range and was above 99% for all concentrations. This indicates that 
even without the addition of a photo-initiator, a strongly crosslinked network was 
formed. Furthermore, there is no significant impact of Laponite on the crosslinking 
efficiency. For the swelling ratio, a statistically significant decrease was observed with 
increasing Laponite concentration. The additional crosslinking thus decreases the 
water uptake of the samples. Similar results were obtained by Chang et al. for PEGDA 
crosslinked with various concentrations of Laponite.26 





Figure 3: Swelling degree and gel fraction of a 50 wt% PEG2000-OEOAcr hydrogel in the presence of 0-
3 wt% Laponite RDS. All gel fractions did not reveal statistical differences, whereas all swelling ratios 
where significantly different (p < 0.5) 
The mechanical characterization of crosslinked hydrogel sheets was performed both 
in the presence of the initial water content and after equilibrium swelling for scaffolds 
starting from  50 wt% polymer concentration containing 0-3 wt% Laponite RDS (see 
Figure 6). Although a decreasing trend could be observed, there was no statistically 
significant difference in elongation upon applying different Laponite concentrations (p 
< 5). An average value of 29% was obtained for the samples with their initial water 
content, which decreased to an average value of 23 % after equilibrium swelling in 
water. Initially, an increase of both the Young’s modulus (from 2.2 MPa to 2.6 MPa ) 
and the tensile strength (from 0.60 to 0.68 MPa) could be observed which can be 
attributed to the additional crosslinking of the samples due to the presence of Laponite, 
similar to what was observed in literature.26,30,33  





Figure 6: Young's modulus, tensile strength  and elongation at break for a 50 wt% dispersion of 
crosslinked PEG2000-OEOAcr hydrogels containing a Laponite RDS concentration ranging between 0 
and 3 wt%. Inset image: air bubbles present in the sample containing 3 wt% of Laponite  
However, for Laponite RDS concentrations exceeding 2 wt%, a decreasing trend in 
tensile properties was observed due to the presence of air bubbles trapped in the 
samples, weakening the mechanical properties. These air bubbles (ranging in size 
from 10 to 300 µm), as shown in a crosslinked sample (see inset image in Figure 6) 
could not be removed because of the viscous nature of the mixture. Different mixing 
methods, including vacuum treatment and heating were explored with no effect. For 
the dispersions containing 3 wt% Laponite RDS, the Young’s modulus for samples with 
their initial water content was reduced from 2.2 MPa for the Laponite free sample to 
1.9 MPa. After equilibrium swelling, the Young’s modulus was reduced from 1.6 MPa 
to 1.2 MPa.  
5.3.4. In vitro biological evaluation of 3D-printed scaffolds 
The increased cell interactivity in the presence of Laponite has already been reported 
previously in literature: in addition to the release of dissolution products that stimulate 
collagen production, an increased protein adsorption on the surface of the 
nanocomposites further enhances cell adhesion. 23,33,37 In addition to the change in 
chemical composition of the surface, the presence of Laponite will also affect the 
hydrophilicity of the surface, which can be beneficial for cell adhesion.42 This effect 
was characterized by measuring the contact angle of crosslinked hydrogel sheets 
starting from ink dispersions with 50 wt% PEG2000-OEOAcrand 0-3 wt% Laponite RDS 
(see Figure 7). A decreasing trend in SCA, both immediately after droplet deposition 
and 1 minute later, can be observed. This indicates the effect of Laponite on the 




surface properties of the material: the SCA decreases, indicating an increased surface 
wettability by water. The change is SCA will contribute to the cell adhesion properties 
of the material. Research performed by Tamada et al has already shown that a 
moderately hydrophilic material, with a contact angle between 60° and 80°, results in 
maximal cell adhesion.42 Upon addition of Laponite, the static contact angle of the 
material reaches this region, as the SCA after contact is reduced from 101° for the 
sample without Laponite, to 80° for the sample containing 3 wt% Laponite RDS. In 
literature, a similar decrease in SCA was observed for agar-based films with increasing 
nanoclay content.43 
 
Figure 7: Static contact angle measurements of crosslinked samples of 50 wt% PEG2000-OEOAcr with 
0-3 wt% Laponite RDS. The SCA is measured immediately and 2 minute after deposition of the 
droplet.  
Qualitative analysis using live/dead staining (see 8 and 9) revealed the effect of 
Laponite on MC3T3 adhesion and viability. Since SFF was not possible in the absence 
of Laponite, hydrogel discs with and without Laponite were used to evaluate the effect 
on the cell adhesion and viability. As this experiment was performed prior to the solid 
freeform fabrication experiments, the initially selected PEG2000-OEOAcr concentration 
of 30 wt% was used to assess the effect of Laponite on cell adhesion. For the 
experiments with 3D scaffolds, the optimized concentration of 50 wt% was used, as 
printing with the 30 wt% dispersion was not possible. Although cell adhesion still occurs 
on the samples without Laponite, most likely due to protein adsorption, a clearly 




beneficial effect of Laponite can be observed. Especially at d1, a significant difference 
in cell viability of about 46% can be observed. After three days, the cell viability on the 
scaffolds without Laponite has recovered from 54% to 94%, while the viability on the 
scaffolds with Laponite has further increased from 90% to 98%. Furthermore, as can 
be observed on the fluorescence microscopy images (figure 8 right part) cells seeded 
on the Laponite disks have formed a confluent monolayer after three days, while this 
is not the case for the hydrogel only scaffolds.  
 
Figure 8: Left: Mouse calvaria preosteoblast cell (MC3T3-E1) viability for scaffolds with and without 
Laponite XLS after one and three days of culture. Results at both time points were significantly different 
at a P < 0.05. Right: vital staining images of MC3T3 cells seeded on 30 wt% PEG2000-OEOAcr disks 
with (A) and without (B) 3wt% Laponite XLS after one day (d1) and three days (d3) of incubation. 
Similar results were obtained on the Laponite-containing 3D printed scaffolds depicted 
in Figure 9. After 24h of contact, the cells on the 3D printed scaffolds show excellent 
viability and an elongated morphology, indicating a good adhesion between the cells 
and the scaffold. Furthermore, after 7 days the cells formed a confluent monolayer on 
the 3D scaffold, which was maintained throughout the duration of the experiment (23 




days). At this timepoint, in some areas a typical bridging behavior can be observed, 
where adjacent cells act as support to allow growth into the pores of the scaffold. 44 
 
 
Figure 9: Vital staining of mouse calvaria preosteoblast cells (MC3T3-E1 as a function of time on 
3D scaffolds containing 50 wt% PEG2000-OEOAcr and 3 wt% Laponite RDS. Arrows indicate areas 
where cells are starting to bridge the pores of the scaffold. 
  




5.4. Conclusion and future perspectives 
In conclusion, the proposed composite synthetic ink is an ideal addition to the 
biopolymer based solid freeform fabrication inks currently available. By combining the 
synthetic PEG2000-OEOAcr hydrogel precursor with the Laponite silicate nanoclays, 
ideal ink properties were obtained, including technical capability and cell interactive 
properties. For the final composition, a concentration of 50 wt% for the synthetic 
hydrogel building block, and 3 wt% for the nanosilicate clay were selected. The desired 
shear thinning behavior was observed as the viscosity decreased from 24.0 Pa·s at a 
shear of 0.3 s-1 to 0.2 Pa·s at a shear rate of 100 s-1 for this dispersion. Excellent 
mechanical properties of the crosslinked ink hydrogels were obtained, with a Young’s 
modulus of 1.9 MPa for the selected ink composition. Furthermore, the addition of 
nanosilicate promotes cell adhesion and enhances cell viability, as evidenced by cell 
seeding experiments on 2D discs and 3D-printed scaffolds. Future perspectives 
include the evaluation of these materials for cell encapsulation, with the aim to develop 
the material into a cell-containing bio-ink. This can lead to scaffolds containing 
encapsulated cells rather than seeding the cells after printing, to maximize the 
(autologous) cell content into (patient-specific) scaffolds. 
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6.1. Conclusions  
In a first part, a novel, solid state reactive hydrogel building block was developed by 
introducing a short, flexible spacer separating the reactive acrylate end groups from 
the semi-crystalline backbone, based on poly(ethylene glycol) with a molecular weight 
of 2000 g/mol. This prepolymer could be synthesized on a large scale (up to 5 kg) and 
solvent-free. During crystallization of the prepolymer, phase separation occurs 
between the acrylate groups and the backbone polymer. The flexible spacer provides 
the acrylates with sufficient mobility to crosslink with excellent reactivity in the solid 
state, even in the absence of a photo-initiator. This auto-initiation, which is more 
efficient in the solid state, can be explained by a shift in absorption maximum of the 
acrylates from the UV-B and UV-C range towards the UV-A range. Due to the phase 
separation, in the solid state, the π-π orbitals of the acrylates can overlap better, 
leading to an increased efficiency of the auto-initiation (maximum photo-DSC heat flow 
increased from 2.1 W g-1 (melt) to 3.4 W g-1 (solid state)). Furthermore, the 
prepolymers could be dissolved over almost the entire concentration range (up to 90 
wt%) in water. The latter enables to tune hydrogel properties such as swelling behavior 
(going from 1.5 to 8.2 times the original dry weight) and mechanical properties (from 
0.66 MPa at a 30 wt% concentration to 3.41 MPa at 70 wt%). 
In addition, the properties of the polymers could be tuned by varying the different 
building blocks. A first example is by changing the molecular weight of the backbone 
polymer. This was varied from 2000 g mol-1 up to 20,000 g mol-1, without losing the 
solid state reactivity. The swelling ratio of the samples crosslinked in the solid state 
increased from 1.47 up to 16.03 times for the lowest and highest molecular weight 
respectively, while the Young’s modulus decreased respectively from 0.66 MPa to 0.15 
MPa for 30 wt% samples. Another approach was to change the backbone chemical 
structure from poly(ethylene glycol) to poly(ε-caprolactone), which resulted in a 
polymer that is still solid state reactive, being biodegradable and no longer water-
soluble. Furthermore, end group variations from acrylate to methacrylate were realized 
as a decrease in the toxicity of uncrosslinked polymers can be anticipated. Finally, 
different spacer groups were used (e.g. oligo(ε-caprolactone) and oligo(ethylene 
glycol)) to tune the degradation of the crosslinked hydrogels, as it can be anticipated 
that an ε-caprolactone spacer will be more susceptible towards hydrolysis.  




Based on a series of photo-DSC experiments, the reaction kinetics of the polymers 
were thoroughly characterized. Adding a photo-initiator results in a accelerating effect 
on the reaction kinetics, increasing the maximum polymerization speed and double 
bond conversion in the solid and in the molten state. Indeed, the maximum heat flow 
increases from 3.4 W g-1 to 7.2 W g-1 in the solid state and from 2.1 W g-1 to 7.1 W g-1 
in the molten state when a photo-initiator is added. The final double bond conversion 
(after max 260 s of irradiation) increases from 65 % to 76% in the solid state, and from 
84% to 87% in the molten state. The presence of oxygen on the other hand has a 
detrimental effect reducing the polymerization speed and conversion in both the solid 
as well as the molten state. For samples without a photo-initiator the maximum heat 
flow decreases from 3.39 to 2.7 W g-1 in the solid state and from 2.1 to 1.1 W g-1, while 
the final conversion decreases from 59 to 47% at 20°C and from 51 to 29%. 
Furthermore, it was observed that an increase in temperature increases the 
polymerization speed from 0.3 mol g-1 s-1 at 253 K up to 5.4 mol g-1 s-1  at 298 K in the 
solid state (except at temperatures close to the melting point), while there was no 
significant temperature effect in the molten state. Similar effects were observed when 
adding a photo-initiator. The temperature at which the polymers are crystallized also 
played a profound role. Crystallizing the polymer at a lower temperature (from 293 K 
to 253 K) reduces the maximum polymerization speed and double bond conversion 
(maximum difference of 1.2 x 102 mol g-1 s-1) except at temperatures close to the 
melting point. To further understand the solid state reactivity, a model was developed 
using scaling laws to describe the effect of structural changes on the mono- and 
bimolecular reactions occurring during photopolymerization. The results showed that 
the auto-acceleration was mainly caused by monomolecular termination reactions and 
that the latter are much more sensitive to the structural changes and to temperature 
compared to the bimolecular propagation and termination reactions.  
Using a range of different strategies, processing difficulties associated with hydrogel 
building bocks have been successfully surpassed. The solid state reactive polymers 
developed in this work could be successfully processed by melt-based solid freeform 
fabrication, a method never used before for hydrogels. When printing was complete, 
the structures were cross-linked by UV-A irradiation in absence of a photo-initiator. The 
printed constructs were quite flexible after crosslinking and subsequent swelling. No 
cell adhesion occurred on the printed constructs, while excellent cell adhesion and 




proliferation were observed after applying a gelatin methacrylamide coating. 
Furthermore, the prepolymers could be used to create electrospun fibers, followed by 
a separate UV-crosslinking step. For the electrospinning experiments a photo-initiator 
was added, as the fibers are quite small (10µm range), fewer crosslink points will be 
present in a fiber compared larger samples such as disks or 3D-printed constructs. In 
addition, the large surface-to-volume ratio of these fibers will increase the effect of 
oxygen inhibition on the polymerization. To help increase the double bond conversion, 
a photo-initiator was added. Finally, an alternative processing technique, being two-
photo-polymerization, was used to create microstructures in the solid state, in the 
absence of a photo-initiator.  
In a last part of the polymer processing work, two additional universally applicable 
processing methods were applied starting from the prepolymers developed in this 
work. The first method was indirect solid freeform fabrication, which is used to create 
three-dimensional constructs from materials that are generally difficult to process. This 
method was successfully applied to create scaffolds with an interconnective porous 
network, as revealed using µCT. Using this approach, scaffolds with tunable 
mechanical (compression force for 1mm indentation between 9 N and 43 N) and 
swelling properties (between 1.30 and 7.16 times the initial dry weight) could be 
developed by changing the template printing parameters (extrusion rate from 1.0 to 
1.8, temperature from 130 °C to 160 °C, strut distance from 600 µm to 900 µm) and/or 
the hydrogel concentration (from 10-100 wt%). Again, the cell adhesion and 
proliferation on these scaffolds was improved by applying a gelatin- methacrylamide 
coating.  
Although the materials developed herein are very promising for a range of applications, 
they are not cell-interactive. Therefore, the second method included the development 
of a solid freeform fabrication composite ink based on the silicate nanoclay Laponite in 
aqueous solutions of the hydrogel precursor. In addition to its cell-interactive 
properties, the nanoclay results in shear-thinning behavior ideal for solid freeform 
fabrication purposes. The formulation was optimized towards a concentration of 50 
wt% polymer and 3 wt% Laponite, which resulted in excellent mechanical properties 
and straightforward printing procedures. Excellent cell-adhesive properties were 
obtained on two- and three-dimensional discs and scaffolds respectively.  
  




6.2. Future perspectives 
The unique solid state reactivity and its advantages towards hydrogel processing hold 
great potential. To gain more insight in the phase separation into amorphous, acrylate 
rich zones and crystalline, backbone rich zones other techniques could be explored 
such as solid state NMR and XRD. Furthermore, the effect of crosslinking density and 
crystallinity on the mechanical properties could be further investigated. However, as 
the crystallinity will also affect the network formation during photopolymerization (as 
shown in Chapter 3), it is difficult to separate these effects from each other. A first step 
towards this would be to evaluate the mechanical properties of polymers with different 
conversion degrees and crystallinities. On a material development level, it can be 
interesting to further explore the limits of the solid state reactivity, on the one hand by 
selecting different building blocks such as semi-crystalline poly(esters) and 
poly(ethers), or by using temperature- or pH-responsive backbone polymers. 
Examples include poly(lactides), poly(glycolides) and poly(lactide-co-glycolide) to tune 
the degradability of the materials and the mechanical properties, or Pluronics® (ABA-
block copolymers of poly(propylene oxide) and poly(ethylene oxide)) to achieve 
temperature responsive behavior. On the other hand, it will be interesting to explore 
the limits of the elaborated system. Currently, the PEO backbone molecular weight can 
be increased up to 20,000 g mol-1 without losing the solid state reactivity. However, 
with increasing molecular weight, the double bond concentration will further decrease. 
So, it can be anticipated that from a certain molecular weight threshold, the polymers 
will no longer be solid-state reactive.  
Furthermore, the ease of processing opens up unprecedented opportunities towards 
applications in the biomedical and non-biomedical field. Due to their processing 
capabilities, they are ideal solid freeform fabrication resins, compatible with different 
techniques such as solid freeform fabrication from the melt, 2-photon polymerization 
or even as a bio-ink by combining the PEG-based materials with Laponite. When used 
as a bio-ink, cells will be encapsulated in the material prior to printing. Therefore, it is 
relevant to evaluate the capability of the materials to encapsulate cells. These 
experiments are currently ongoing in a collaboration with the University of New South 
Wales (Sydney, Australia) .  
Regarding the indirect solid freeform fabrication approach, another advantage of the 
technique is that constructs which combine zones of different materials can be used. 




For example, a scaffold could be created which is partially cell-interactive by combining 
the polymer with Laponite and partially non-cell-interactive by using the material as 
such. Alternatively, different prepolymers can be selected to create zones with different 
mechanical properties. Another relevant aspect would be the assessment of the 
technique to be used to create scaffolds with a more complex shape, although the 
dimensions of the construct might be limited by the limited penetration depth of UV-
light.  
In the field of tissue engineering, a fascinating application can be meniscus 
engineering, as the mechanical properties of meniscus scaffolds are highly important. 
In addition, to replace a meniscus, the scaffold needs to mimic the two zones of the 
meniscus, the outer red zone (vascular) and the inner white zone (avascular). With the 
solid state reactive materials, one of the main advantages is that they are highly 
tunable by either varying the different prepolymer building blocks, or by changing the 
water content prior to cross-linking. Furthermore, due to their ease of processing, the 
implants can be tailor made for each patient, by printing a scaffold from a CAD-model 
based on scans of the initial defect. In addition, by changing the building blocks of the 
polymers, the properties of the vascular and avascular zone can be represented in the 
scaffold. Therefore, these materials are ideal candidates for meniscal tissue 
engineering.  
Another potential application involves coatings. The molten polymer can be applied as 
a coating using spraycoating, spincoating or dipcoating. As the coating can be 
crosslinked after solidification, the coating and crosslinking can be performed in two 
different steps, after solidification of the coated layer. For some coating-related 
applications, cell and protein adhesion is not desired, e.g. stents (blood contact area). 
It was demonstrated that no cell adhesion occurs on the PEG-based materials after 
crosslinking in the solid state. Therefore, these materials are ideal candidates for this 
type of applications. Furthermore, after the coating has been applied, selected zones 
can be crosslinked by applying masks prior to UV crosslinking. As a result, a patterned 
coating of the surface can be achieved, which can be interesting for applications that 
require regions where cell or protein adhesion is required, in combination with areas 
where this is unwanted.  
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Om het tekort aan donoren te bestrijden voor gevallen waar orgaantransplantatie nodig 
is, en om gangbare problemen met protheses en getransplanteerde organen te 
voorkomen (bvb. verschil in mechanische eigenschappen of afmetingen, infecties, 
afstoting, …)1–3 is gedurende de laatste  decennia weefselregeneratie een steeds 
populairdere tak geworden in het biomedische onderzoeksdomein. 4 
Weefselregeneratie heeft als doel om biologische substituanten te ontwikkelen die 
weefselfunctie herstellen, onderhouden of verbeteren.2 In dit verband zijn hydrogels 
een belangrijke materiaalcategorie, omdat hun eigenschappen (zacht, elastisch 
gedrag, netwerkstructuur en een hoog watergehalte) sterk lijken op die van de 
extracellulaire matrix. 5–8  
Hydrogels kunnen worden gedefinieerd als gezwollen, drie dimensionele netwerken. 
Afhankelijk van hun samenstelling kunnen ze tot duizenden keren hun oorspronkelijk 
droog gewicht aan water opnemen. De aard van het netwerk kan zowel fysisch als 
chemisch zijn. Fysische vernetting is reversibel en kan tot stand komen door middel 
van microkristallijne zones, ionische bindingen, waterstofbruggen, van der Waals 
interacties of combinaties van deze interacties. Chemische vernetting anderzijds wordt 
gecreëerd door het vormen van covalente bindingen. Hydrogels kunnen zowel van 
natuurlijke oorsprong zijn (bvb gelatine methacrylamide)9 of van synthetische 
oorsprong (bvb poly(ethyleen glycol) diacrylaat)10.  
Voor weefselregeneratie is het belangrijk dat er een 3D cultuuromgeving wordt 
ontwikkeld die de cellen ondersteunt op vlak van biomechanica en biologische 
eigenschappen om zo implantaten te ontwikkelen met behulp van cellen van het 
beschadigde weefsel.11–17 Om dit te bereiken worden de cellen gecombineerd met 
zogenaamde “scaffolds” of draagstructuren. Bij het ontwikkelen van deze scaffolds is 
het belangrijk dat deze gebaseerd zijn op niet toxische materialen en voldoende 
poreus zijn. Zo krijgt het gevormde weefsel voldoende ruimte om te groeien, en is een 





Een populaire techniek om deze scaffolds te ontwikkelen is 3D printen. Met deze 
techniek worden structuren gecreëerd door de sequentiële toevoer van energie en/of 
materiaal volgens een computer gestuurd ontwerp (‘computer-aided design’, CAD).7 
Met deze techniek kan op een reproduceerbare en homogene manier een scaffold 
ontwikkeld worden met een hoge mate van controle over de macro- en microstructuur. 
19–22 Het belangrijkste nadeel van deze techniek is dat slechts een beperkte selectie 
aan materialen compatibel is met een gekozen 3D-print techniek. Vooral wat betreft 
hydrogels zijn deze vaak moeilijk te verwerken met 3D-print technieken.7  
Een gangbare techniek om covalent gebonden hydrogels te creëren is 
fotopolymerizatie.23 Hierbij wordt een foto-initiator gebruikt, die radicalen genereert bij 
blootstelling aan UV-licht. Deze radicalen reageren dan met functionele groepen die 
aanwezig zijn op het polymeer (bvb acrylaten) om zo een netwerk te vormen. Het 
belangrijkste nadeel van deze techniek is de functionele groepen voldoende mobiel 
moeten zijn, daarom wordt de reactie steeds uitgevoerd in vloeibare toestand. Daarom 
is deze methode incompatibel met een groot deel van de verwerkingstechnieken (bvb 
3D printen of electrospinnen), aangezien de gecreëerde structuren na verwerking in 
de vaste toestand zijn.7,24–27  
In dit werk werd daarom een nieuw materiaal ontwikkeld dat nog steeds kan vernet 
worden met UV-licht in de vaste, semi-kristallijne toestand. Dit materiaal werd 
ontwikkeld door een semi-kristallijn, hydrofiel polymeer te linken met acrylaat 
eindgroepen, waartussen een kort, flexibel oligomeer werd geplaatst. Wanneer dit 
materiaal kristalliseert, zal er een fasescheiding optreden tussen de eindgroep en het 
semi-kristallijne polymeer. Hierdoor komen de acrylaten in een gescheiden zone 
terecht, en het oligomeer tussenstuk geeft de acrylaten nog net voldoende mobiliteit 
om te reageren met elkaar. Dit tussenstuk speelt dus een belangrijke rol, die werd 
onderzocht door een serie polymeren te synthetiseren met verschillende 
tussenstukken: 6 ethyleen oxide eenheden (PEG2000-OEOAcr), 6 propyleen oxide 
eenheden (PEG2000-OPOAcr), 2 ε-caprolacton eenheden (PEG2000-OClAcr) en 
tenslotte ook een polymeer met een zeer kort tussenstuk van slechts 1 ethyleen oxide 
eenheid (PEG2000-HEAcr).  
De verschillende polymeren werden gekarakteriseerd met behulp van foto-differentiële 
scanning calorimetrie (DSC) metingen. Daaruit bleek dat de polymerisatie ook efficiënt 




eventuele toxische effecten van de foto-initiator worden vermeden, dienen er geen 
extra mengstappen uitgevoerd te worden, en moet er geen foto-initiator gezocht 
worden die compatibel is met de geselecteerde verwerkingstechniek. 28–30 Uit de foto-
DSC metingen bleek dat het referentiepolymeer PEG2000-OEOAcr zelfs 2.5 keer 
sneller reageerde in de vaste toestand (20°C) dan in de gesmolten toestand (50°C). 
Verder bleek uit de metingen ook dat een flexibel tussenstuk een positief effect heeft 
op de reactiviteit in vaste toestand. Dit was het geval voor PEG2000-OEOAcr en 
PEG2000-OClAcr, die beiden erg flexibel zijn (met een karakteristieke ratio van 
ongeveer 4). Een kort of niet flexibel tussenstuk, zoals bij PEG2000-HEAcr en PEG2000-
OPOAcr leidt tot een verlaagde reactiviteit in vaste toestand.  
Door zijn hoge reactiviteit in vaste toestand, kon PEG2000-OEOAcr verwerkt worden 
met verschillende technieken. Een eerste techniek was extrusie-gebaseerd 3D printen, 
wat tot op heden enkel werd gebruikt voor thermo responsieve polymeren of waarbij 
additieven werden toegevoegd om dilatatie te creëren.5,31 Voor deze techniek werd het 
polymeer eerst verwarmd tot boven zijn smeltpunt, en door afkoeling onmiddellijk na 
het printen werden vaste structuren gecreëerd. Deze konden vervolgens na het printen 
met UV licht vernet worden. Deze scaffolds werden ook gebruikt voor de cultuur van 
cellen (osteoblasten van een muis, en menselijke stamcellen afgeleid van vetweefsel). 
Aangezien het materiaal zelf niet cel-interactief is, werd een coating van gelatine 
gemodificeerd met methacrylamide zijgroepen aangebracht op de scaffolds. Uit de 
celtesten bleek dat voor de materialen met coating de cellen uitstekend vasthechten 
aan het materiaal, en een hoge viabiliteit behielden gedurende het experiment (23 
dagen). Zonder de coating echter werd geen cel adhesie geobserveerd.  
Een tweede verwerkingstechniek die werd toegepast was electrospinnen. Met deze 
techniek worden micro- en nanovezels gecreëerd door een hoog potentiaalverschil 
aan te leggen tussen een naald waardoor een polymeeroplossing wordt gepompt, en 
een collecteerplaat. Hierdoor wordt de druppel polymeeroplossing geladen, en 
ontsnapt een vloeistofstraal aan de druppel. Deze vloeistofstraal zal vervolgens naar 
de collectorplaat worden getrokken, waarbij het solvent verdampt. Op deze manier 
wordt een mat van vaste vezels gevormd op de collecteerplaat. Door de reactiviteit in 
vaste toestand, konden de vezels na het electrospinnen nog steeds vernet worden. 




voor zwellen in water, en 10.16 ± 1.30 µm na zwellen in water) te verkrijgen, was het 
noodzakelijk  een foto-initiator toe te voegen (2 mol% Irgacure 2959). 
Een laatste techniek die werd toegepast is 2-foton-polymerizatie (2FP). Hierbij wordt 
een laserstraal doorheen een foto-reactief materiaal gescand waarbij lokaal de foto-
polymerisatie wordt geïnitieerd. Zo kunnen structuren worden gecreëerd met een sub-
micrometer resolutie.32 Deze techniek werd voor hydrogels nog nooit toegepast in 
vaste toestand. Verder is het ook moeilijk om een foto-initiator te vinden die absorbeert 
bij de exacte golflengte van de laser, maar toch nog steeds biocompatibel is.33,34 Dit is 
geen probleem meer voor de materialen ontwikkeld in dit werk, die konden verwerkt 
worden met 2FP in de vaste toestand en zonder foto-initiator. Dit werd geïllustreerd 
door een 3D model van het atomium te printen, met een afmeting van slechts 100 µm.  
Vervolgens werden de kinetische aspecten van de ontwikkelde polymeren verder 
gekarakteriseerd met behulp van foto-DSC experimenten. Hieruit bleek dat de auto-
initiatie mogelijk is door het ontstaan van radicalen op de acrylaat groepen tijdens UV 
belichting. Door de acrylaten met de verschillende eindgroepen (die eerder 
beschreven werden) te analyseren met UV-spectrofotometrie, bleek dat de 
geabsorbeerde .golflengte sterk afhankelijk is van de chemische omgeving van de 
acrylaten. Afhankelijk van de structuur, kan deze verschuiven naar de UVA-
golflengtes, waardoor de auto initiatie mogelijk wordt. Dit proces wordt efficiënter 
wanneer het polymeer zich in vaste toestand bevindt, en de π- π* orbitalen van de 
acrylaten beter kunnen overlappen. Zonder foto-initiator, daalt de maximale 
vrijgekomen warmte bij fotopolymerisatie van 7.2 W g-1 naar 3.4 W g-1 bij overgang van 
vaste naar gesmolten toestand. Verder werd ook aangetoond dat de 
polymerisatiesnelheid in vaste toestand zal toenemen met toenemende temperatuur, 
maar constant blijft boven het smeltpunt.  
De veelzijdigheid van de in dit doctoraatswerk ontwikkelde materialen werd 
aangetoond door polymeren te synthetiseren met een verschillend type centraal 
polymeer (poly(ε-caprolacton of PCL)) of een verschillend moleculair gewicht van het 
centrale polymeer (PEG2000 – 20 000 g mol-1). Al deze polymeren konden efficiënt 
gepolymeriseerd worden in de vaste toestand. Verder werd ook aangetoond dat de 
mechanische eigenschappen en zwellingsgraad van de polymeren konden beïnvloed 
worden door het moleculaire gewicht van het centrale polymeer te wijzigen. De 




gewicht van 2000 naar 20 000 g mol-1. Dit kon ook worden bereikt door de hoeveelheid 
water toegevoegd voor fotopolymerisatie te variëren. Als deze hoeveelheid verhoogt, 
zal ook de zwellingsgraad verhogen. Voor de polymeren met moleculair gewicht van 
het centrale polymeer van 2000 g mol-1 was de zwellingsgraad 8.18 voor een 10% 
concentratie, en 1.47 voor een 100% concentratie.  
In een volgend hoofdstuk werd een scafffold productiemethode ontwikkeld die 
toepasbaar is op materialen die moeilijk rechtstreeks te verwerken zijn met behulp van 
3D-printen. Alhoewel dit mogelijk is voor het polymeer vanuit de smelt, lukt dit niet voor 
waterige oplossingen van het polymeer. De ontwikkelde methode maakt gebruik van 
indirect 3D-printen: een materiaal dat gemakkelijk kan geprint worden (e.g. PCL) wordt 
gebruikt om een initiële templaat te maken. Deze templaat wordt dan gevuld met de 
polymeeroplossing die vervolgens vernet wordt. Ten slotte wordt de PCL templaat 
opgelost in chloroform, waardoor de scaffold in het uiteindelijke materiaal overblijft. 
Door de concentratie van het polymeer te variëren, konden de reologische 
eigenschappen gewijzigd worden: de opslagmodulus stijgt van 10.6 kPa tot 1410 kPa 
voor een concentratietoename van 10 – 90 m%. De zwellingsgraad zal dalen als de 
concentratie verhoogt, van 7.16 naar 1.3 keer het oorspronkelijke droge gewicht. De 
Young’s modulus zal dan weer toenemen als de concentratie stijgt, van 0.67 naar 3.1 
MPa.  
Met de indirecte aanpak konden op een efficiënte manier 3D scaffolds gecreëerd 
worden vertrekkende van precursoroplossingen met verschillende concentraties. Door 
de printinstellingen voor het printen van de PCL templaat te variëren (extrusiesnelheid, 
temperatuur, poriegrootte), konden ook de eigenschappen van de finale scaffold 
beïnvloed worden. Zowel de morfologie als de mechanische eigenschappen werden 
hierdoor beïnvloed, wat gekarakteriseerd werd door middel van optische microscopie 
en texturometrie. Vervolgens kon met behulp van µ-CT metingen aangetoond worden 
dat ook binnenin de scaffold een geconnecteerd poreus netwerk aanwezig was. Ten 
slotte toonde de biologische evaluatie aan dat de cel adhesie en proliferatie op de 
scaffold sterk kon verbeterd worden door een gelatine methacrylamide coating aan te 
brengen. 
In het laatste hoofdstuk ten slotte werd een inkt ontwikkeld voor 3D printen door het 
ontwikkelde polymeer te combineren met een additief bestaande uit een silicaat 




dispersie veroorzaakt, waarbij de viscositeit hoog is bij lage afschuifsnelheid, en laag 
bij hoge afschuifsnelheid. Dit is ideaal voor 3D-printen: het materiaal kan gemakkelijk 
uit de naald vloeien, maar zal zijn vorm behouden eens geprint. Daarnaast zorgt het 
additief er ook voor dat cellen goed adheren, waardoor een gelatine methacrylamide 
coating niet langer noodzakelijk is.  
Na optimalisatie werd een polymeerconcentratie van 50 m% gecombineerd met een 
Laponiet concentratie van 3 m%. Voor deze oplossing werd met behulp van 
reologiemetingen een thixotroop gedrag waargenomen waarbij de viscositeit daalde 
van 24.0 Pa s bij een afschuifsnelheid van 0.3 s-1 tot 0.2 Pa s voor een afschuifsnelheid 
van 100 s-1. Ook de mechanische eigenschappen van deze inkt waren goed: na 
fotopolymerizatie werd een Young’s modulus van 1.9 MPa bekomen. Verder werd met 
behulp van celcultuur op 2D en 3D scaffolds aangetoond dat het Laponiet inderdaad 
de celviabiliteit ten goede komt. Een volgende stap is het printen van deze inkt waarbij 
cellen reeds tijdens het printen worden toegevoegd, en zo dus ingekapseld kunnen 
worden in de scaffold. Zo kan uiteindelijk de (autologe) celinhoud gemaximaliseerd 
worden om patient-speciefieke scaffolds te creëren voor weefselregeneratie. 
Overige toekomstperspectieven voor dit werk zijn onder meer de effectiviteit van de 
reactiviteit in vaste toestand verder opzoeken, door de bouwstenen verder te variëren, 
bvb door poly(lactides) of pluronics te gebruiken als centraal polymeer, of door het 
moleculair gewicht van het centraal polymeer verder te laten toenemen. Zo kan de 
limiet gevonden worden tot waar het materiaal nog steeds reactief is in de vaste 
toestand. Ook naar verwerking toe zijn er verschillende mogelijkheden voor de 
materialen. Allereerst zijn het natuurlijk ideale grondstoffen voor 3D-printers: zowel 
voor extrusie-gebaseerde printers (in de vaste toestand), als in oplossing (met 
Laponiet) of voor 2-foton polymerisatie. Deze 3D-print technieken kunnen worden 
gebruikt voor het creëren van scaffolds voor weefselregeneratie, bijvoorbeeld voor het 
creëren van een meniscus implantaat dat specifiek op maat van de patiënt wordt 
gemaakt. Met behulp van de indirecte methode kunnen ook scaffolds gemaakt worden 
die bestaan uit verschillende zones met verschillende materialen, om zo het autologe 
weefsel zo goed mogelijk na te bootsen. Ook kan het creëren van meer complexe 
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List of Abbreviations 
 
ECM    extra-cellular matrix 
SFF    solid freeform Fabrication 
2D    two dimensional 
2PP    two photon polymerization 
3D    three dimensional 
3DP    three dimensional printing 
µm    micrometer 
AJS    air jet solidification 
AM    additive manufacturing 
BMP    bone-morphogenic proteins 
CAD    computer aided design 
CAM    computer aided manufacturing 
DDP    drop on demand printing 
DLP    digital light projection  
CPD    critical point drying 
CT    computed tomography 
DMD    digital micromirror device 
ECM    extra cellular matrix 
eiRP    external indirect rapid prototyping 
FDM    fused deposition modelling 
HA    hydroxyapatite 
h-MSC   humane mesenchymal stem cells 
HFF    human foreskin fibroblasts 
IJP    ink-jet printing 
iiRP    internal indirect rapid prototyping 
iRP    indirect rapid prototyping 
LoC    lab on a chip 




MEW    melt electrospinning writing 
mPa    millipascal 
MPa    megapascal 
MRI    magnetic resonance imaging 
MSTL    micro stereolithography 
PCL    poly-(ε-caprolactone) 
PDL    periodontal ligament 
PDMS   poly(dimethylsiloxane) 
PEG    poly-(ethylene glycol) 
PGA    poly-(glycolic acid) 
PLA    poly-(lactic acid) 
PLGA    poly-(lactic-co-glycolic acid) 
PPF    poly-(propylene fumarate) 
RP    rapid prototyping 
SFF    solid freeform fabrication 
SLA    stereolithography 
SLS    selective laser sintering 
SMD    selective mould dissolution 
TCP    tricalcium phosphate 
UV    ultra violet 
HUVECs   human umbilical vein endothelial cells 
LCST    lower critical solution temperature 





List of Materials 
Below, an overview of the materials developed in this work is provided. The first 
material is the reference material, used in the majority of characterization and 
processing experiments. Adaptations made to this material are indicated in bold in 
the table below. 
Name Backbone 
(g mol-1) 
Diisocyanate Spacer End group 
PEG2000-OEOAcr PEG 2000 IPDI Oligo(ethylene 
oxide) 
Acrylate 
PEG4000-OEOAcr PEG 4000 IPDI Oligo(ethylene 
oxide) 
Acrylate 










PEG 20000 IPDI Oligo(ethylene 
oxide) 
Acrylate 
PEG2000-OPOAcr PEG 2000 IPDI Oligo(propylene 
oxide) 
Acrylate 
PEG2000-OClAcr PEG 2000 IPDI Oligo(ε-
caprolactone) 
Acrylate 
PEG2000-HEAcr PEG 2000 IPDI Hydroxyethyl Acrylate 
PEG2000-
OEOMAcr 
PEG 2000 IPDI Oligo(ethylene 
oxide) 
Methacrylate 
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SAFETY DATA SHEET
Revision date  2017-01-04 Revision number  1.05
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE
COMPANY/UNDERTAKING
1.1  Product identifier  
Product name BISOMERÒ PPA 6
Product code 745786
Synonyms Polypropylene glycol monoacrylate
1.2  Relevant identified uses of the substance or mixture and uses advised against  
Recommended use [RU] Monomer for special polymers
Cross-linking agent
Uses advised against None known
1.3  Details of the supplier of the safety data sheet  
Responsibility Statement For further information, please contact  safety-data-sheet-fp@geosc.com
1.4  Emergency telephone number  
Emergency telephone 24 Hour Emergency Phone Number
GEO Specialty Chemicals UK Ltd
+44 (0)23 80891806
2. HAZARDS IDENTIFICATION
2.1  Classification of the substance or mixture  
Classification according to Regulation (EC) No. 1272/2008 [CLP]  
Skin sensitization Category 1
Acute aquatic toxicity Category 2
Chronic aquatic toxicity Category 2
2.2  Label elements  
Labeling according to Regulation (EC) No. 1272/2008 [CLP]  
_____________________________________________________________________________________________
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Supplier
GEO Specialty Chemicals UK Ltd
Charleston Road, Hardley, Hythe
Southampton, Hampshire SO45 3ZG
United Kingdom
Phone: +44 (0)23 80894666
Fax No: +44 (0)23 80243113
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745786 -  BISOMERÒ PPA 6 Revision date  2017-01-04
Signal word  WARNING
Hazard statements  
H317 - May cause an allergic skin reaction
H411 - Toxic to aquatic life with long lasting effects
Precautionary statements
P262 - Do not get in eyes, on skin, or on clothing
P280 - Wear protective gloves
P302 + P352 - IF ON SKIN: Wash with plenty of soap and water
P273 - Avoid release to the environment
Hazard components for labeling  Polypropylene glycol monoacrylate.
2.3  Other Information  
None known
3. COMPOSITION/INFORMATION ON INGREDIENTS
3.1  Substances  
Component EU EINECS weight-% Classification according to Regulation





Not applicable >= 70% Skin Sens. 1 (H317)




247-118-0 < 5% Acute Tox. 3 (H301)
Acute Tox. 3 (H311)
Acute Tox. 3 (H331)
Skin Corr. 1B (H314)
Skin Sens. 1 (H317)
In compliance
For the full text of the H-Statements mentioned in this Section, see Section 16.  
3.2  Mixtures  
Not applicable
4. FIRST AID MEASURES
4.1  Description of first aid measures  
General advice
In case of adverse health effects seek medical advice.
Eye contact
Remove contact lenses, if worn. Immediately flush with plenty of water for at least 10 minutes, holding eyelids apart to ensure
flushing of the entire surface. Seek medical advice immediately.
Skin contact
Immediately wash thoroughly with soap and water, remove contaminated clothing and footwear.  Wash clothing before reuse.
Get medical attention if irritation should develop.
_____________________________________________________________________________________________
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Ingestion
If swallowed, give 1-2 glasses of water, but do not induce vomiting.  Do not give anything by mouth to an unconscious or
convulsing person.  Get medical attention. If vomiting should occur spontaneously, keep airway clear.
Inhalation
Remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical attention.
4.2  Most important symptoms and effects, both acute and delayed  
Most important symptoms and effects
No information available.
Chronic effects
Repeated or prolonged exposure may result in liver or kidney damage.




5.1  Extinguishing media  
Suitable extinguishing media
Water spray jet, Alcohol-resistant foam, Extinguishing powder, Carbon dioxide.
Extinguishing media which must not be used for safety reasons
High pressure waterjet.
5.2  Special hazards arising from the substance or mixture  
Special Hazard
Formation of toxic gases is possible during heating or in fires.  The product may undergo spontaneous polymerization at high
temperatures.  Polymerization is exothermic and may cause damage to the container and/or release of thermal decomposition
products.
5.3  Advice for firefighters  
Special protective equipment for firefighters
Firefighters should wear self-contained breathing apparatus and full firefighting turnout gear.
Firefighting measures
Cool exposed containers with water spray after extinguishing fire.
6. ACCIDENTAL RELEASE MEASURES
6.1  Personal precautions, protective equipment and emergency procedures  
Personal precautions
Wear suitable protective clothing and gloves.
6.2  Environmental precautions  
Environmental precautions
Do not empty into drains/surface water/ground water. Inform authorities in the event of product spillage to water courses or
sewage systems.
6.3  Methods and material for containment and cleaning up  
_____________________________________________________________________________________________
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Methods for cleaning up
Remove with liquid-absorbing material (sand, peat, sawdust). Dispose of contaminated material as waste according to Section
13.
6.4  Reference to other sections  
See Section 12 for additional Ecological Information
7. HANDLING AND STORAGE
7.1  Precautions for safe handling  
Advice on safe handling
Avoid contact with eyes, skin and clothing
Avoid breathing vapor or mist
Use only in well-ventilated areas
Personal protective equipment comprising: suitable protective gloves, safety goggles and protective clothing.
Wash thoroughly after handling
Ensure that eyewash stations and safety showers are close to the workstation location
7.2  Conditions for safe storage, including any incompatibilities  
Technical measures and storage conditions
The product is stabilized against spontaneous polymerization before delivery.  However, if the permissible storage time or
storage temperature are greatly exceeded the product may polymerize.
Keep only in the original container in a cool, well-ventilated place
Store at temperatures not exceeding 25  °C/ 77 °F
Store in a dry place
Store away from direct heat or sunlight.
Tanks should preferably contain no dead spaces where the product can be trapped and polymerize. Internal structural
members should therefore be kept to a minimum and tanks should be welded.
Storage tank vents, especially those fitted with flame arrestors, should be inspected regularly for polymer fouling which can
arise from vapor phase polymerization.
Do not store together with reductants.
Do not store together with oxidants.
7.3  Specific end use(s)  
Specific use(s)
 Not applicable
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
8.1  Control parameters  
Occupational exposure limit value  
Component European Union United Kingdom Spain Germany Turkey
2-Hydroxypropyl acrylate
 25584-83-2
NAV NAV NAV NAV NAV
Component Austria Belgium Switzerland Poland
2-Hydroxypropyl acrylate
 25584-83-2
NAV NAV NAV TWA: 2.8 mg/m3
Skin
STEL: 6 mg/m3
Biological limit values  
Component European Union United Kingdom Spain Germany Turkey
2-Hydroxypropyl acrylate
 25584-83-2
NAV NAV NAV NAV NAV
_____________________________________________________________________________________________
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Legend
NAV - Not available
8.2  Exposure controls  
Personal Protective Equipment 
Eye/face Protection
If splashes are likely to occur: Chemical Goggles.
Hand Protection
Polychloroprene gloves.  Coating thickness 1.1 mm.  Level 5 > 240 min breakthrough time.
Skin and body protection
Wear suitable protective clothing.
Respiratory protection
Filter A2 is recommended in cases of prolonged exposure.
Other personal protection data
Eyewash fountains and safety showers must be easily accessible.
Hygiene measures
Handle in accordance with good industrial hygiene and safety practice.
Environmental exposure controls
No information available.
9. PHYSICAL AND CHEMICAL PROPERTIES





Odor threshold No information available
Property  Values  Remarks  
pH No information available No information available
Melting / freezing point No information available No information available
Boiling point / boiling range No information available No information available
Flash point  128  °C  /  262.4  °F PMC D93A
Evaporation rate No information available No information available
Flammability (solid, gas) No information available No information available
Flammability Limit in Air
Upper flammability limit No information available No information available
Lower flammability limit No information available No information available
Vapor pressure No information available No information available
Vapor density No information available No information available
Specific gravity No information available No information available
Solubility (water) emulsifiable No information available
_____________________________________________________________________________________________
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9.2  Other information  
Bulk Density No information available
Explosive properties Can polymerize violently.
Oxidizing properties The substance or mixture is not classified as oxidizing.
Softening point No information available
Molecular weight 420  g/mol
Volatile Organic Compound (VOC) content, wt.% No information available
Percent Volatile, wt.% <  0.5  %
10. STABILITY AND REACTIVITY
10.1  Reactivity  
Reactivity
Polymerizes readily unless inhibited. Polymerization is highly exothermic and, if not controlled, may be violent.
10.2  Chemical stability  
Chemical stability
Stable under normal conditions of handling, use and transportation. Periodic air sparging in storage will assist long term
stability.
10.3  Possibility of hazardous reactions  
Hazardous polymerization
May occur if inhibitor is depleted or if exposed to high temperature.
10.4  Conditions to avoid  
Conditions to avoid
This product contains a peroxidation inhibitor. To maintain inhibitor activity, oxygen must not be eliminated from the
atmosphere above the product. Avoid radical forming substances (metal-ions, peroxides). Avoid heating. If prolonged
excursions above the recommended storage temperature occur, then the rate of inhibitor depletion could accelerate, leading to
an increased risk of polymerization. In these circumstances it is recommended that the inhibitor level be checked periodically
using ASTM procedure D 3125, and more inhibitor added if depletion is observed.
10.5  Incompatible materials  
Materials to avoid
Reaction with reducing agents. Reaction with oxidants. Acids or alkalies. Free radical producing initiators. Primary and
Secondary Amines.
10.6  Hazardous decomposition products  
Hazardous decomposition products
Carbon monoxide. Carbon dioxide. Irritating vapors.
Solubility in other solvents No information available No information available
Partition coefficient: n-octanol/water No information available No information available
Autoignition temperature No information available No information available
Decomposition temperature No information available No information available
Kinematic viscosity  46.00  mm2/s  @ 25 °C ASTM D 445-97
Dynamic viscosity No information available No information available
Density  1.0220  g/cm3
_____________________________________________________________________________________________
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11. TOXICOLOGICAL INFORMATION
11.1  Information on toxicological effects  
The product is a tested preparation with following data:
Acute health hazard  
Eye contact
May cause slight irritation.
Skin contact
May cause slight irritation.
Ingestion
May be harmful if swallowed.
Inhalation
Inhalation of mist or vapor may cause respiratory tract irritation.
Acute toxicity 
Oral LD50 > 2,000 mg/kg
Method: OECD Test No. 401: Acute Oral Toxicity
Dermal LD50 No information available
Inhalation LC50 No information available
Skin corrosion/irritation
Slightly irritating, does not require labelling
Method: OECD Test No. 404: Acute Dermal Irritation/Corrosion
Serious eye damage/eye irritation
Slightly irritating, does not require labelling
Method: OECD Test No. 405: Acute Eye Irritation/Corrosion
Sensitization
Dermal sensitization: sensitizing







Specific target organ toxicity - Single exposure
No information available
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12. ECOLOGICAL INFORMATION
12.1  Toxicity  
• The ecological evaluation of the product is based on data from the raw material and/or comparable substances.
Acute aquatic toxicity  
Fish LC50 > 1 - <= 10 mg product/l.
Crustacea No information available
Bacteria toxicity EC0 > 1- <= 10 mg product/L.
Algae/aquatic plants No information available




The total of the organic components contained in the product achieve values below 60% BOD/COD or CO2 liberation, or below
70% DOC reduction in tests for ease of degradability. Threshold  values for ' readily degradable' (e.g. to OECD method 301)
are not reached.
12.3  Bioaccumulative potential  
Bioaccumulative potential
No information available
12.4  Mobility in soil  
Mobility
No information available.
12.5  Results of PBT and vPvB assessment  
PBT and vPvB assessment
No information available
12.6  Other adverse effects  
Other information
No other ecological studies have been carried out on this product.
13. DISPOSAL CONSIDERATIONS
13.1  Waste treatment methods  
Disposal of wastes
Waste incineration with the approval of the responsible local authority.
Contaminated packaging
Packaging that cannot be cleaned are to be disposed of in the same manner as the product. Disposal must be made according
to official regulations.
_____________________________________________________________________________________________
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14. TRANSPORT INFORMATION
US DOT  
14.1. UN number  UN3082
14.2. UN proper shipping name  ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (Polypropylene glycol
monoacrylate)
14.3. Transport hazard class(es)  9
14.4. Packing group  III
14.5. Environmental hazards
14.6. Special precautions for user
ERG Number  171
Land transport (ADR/RID)  
14.1. UN number  UN3082
14.2. UN proper shipping name  ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (Polypropylene glycol
monoacrylate)
14.3. Transport hazard class(es)  9
14.4. Packing group  III
14.5. Environmental hazards
14.6. Special precautions for user
ADR/RID-Labels  9
Classification code  M6
Hazard identification number (Kemler No.)  90
Tunnel restriction code  (E)
Inland waterway transport (ADN)  
14.1. UN number  UN3082
14.2. UN proper shipping name  ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (Polypropylene glycol
monoacrylate)
14.3. Transport hazard class(es)  9
14.4. Packing group  III
14.5. Environmental hazards
14.6. Special precautions for user
Classification code  M6
Air transport (ICAO-TI / IATA-DGR)  
14.1. UN number  UN3082
14.2. UN proper shipping name  ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (Polypropylene glycol
monoacrylate)
14.3. Transport hazard class(es)  9
14.4. Packing group  III
14.5. Environmental hazards
14.6. Special precautions for user
ERG Code  9L
Sea transport (IMDG)  
14.1. UN number  UN3082
14.2. UN proper shipping name  ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (Polypropylene glycol
monoacrylate)
14.3. Transport hazard class(es)  9
14.4. Packing group  III
14.5. Environmental hazards
14.6. Special precautions for user
EmS  F-A;S-F
14.7  Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code  
Not applicable
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Full text of H-Statements referred to under sections 2 and 3
H317 - May cause an allergic skin reaction
H411 - Toxic to aquatic life with long lasting effects
H301 - Toxic if swallowed
H311 - Toxic in contact with skin
15. REGULATORY INFORMATION
15.1  Safety, health and environmental regulations/legislation specific for the substance or mixture  
International Inventories  
Australia (AICS)
All ingredients are on the inventory or exempt from listing
Canada (DSL)
Some ingredients are not on the inventory.
Canada (NDSL)
Some ingredients are on the inventory.
China (IECSC)
All ingredients are on the inventory or exempt from listing
EINECS (European Inventory of Existing Chemical Substances)
All ingredients are on the inventory or exempt from listing
ELINCS (European List of Notified Chemical Substances)
None of the ingredients are on the inventory.
ENCS (Japan)
All ingredients are on the inventory or exempt from listing
South Korea (KECL)
All ingredients are on the inventory or exempt from listing
Philippines (PICCS)
Some ingredients are not on the inventory.
TSCA (United States)
All ingredients are on the inventory or exempt from listing
Legend 
 AICS  - Australian Inventory of Chemical Substances
 DSL/NDSL  - Canadian Domestic Substances List/Non-Domestic Substances List
 IECSC  - China Inventory of Existing Chemical Substances
 EINECS/ELINCS  - European Inventory of Existing Commercial Chemical Substances/EU List of Notified Chemical Substances
 ENCS  - Japan Existing and New Chemical Substances
 KECL  - Korean Existing and Evaluated Chemical Substances
 PICCS  - Philippines Inventory of Chemicals and Chemical Substances
 TSCA  - United States Toxic Substances Control Act Section 8(b) Inventory
15.2  Chemical Safety Report  
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H314 - Causes severe skin burns and eye damage
H331 - Toxic if inhaled
Key or legend to abbreviations and acronyms used in the safety data sheet
NAV - Not available
This safety data sheet complies with the requirements of:  Regulation (EC) No. 1907/2006.
Additional information
BISOMERÒ is a registered trademark of GEO Specialty Chemicals UK Ltd.
Disclaimer
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The
information given is designed only as a guidance for safe handling, use, processing, storage, transportation, disposal and release and is not to be
considered a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such
material used in combination with any other materials or in any process, unless specified in the text.
_____________________________________________________________________________________________
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SAFETY DATA SHEET 
according to Regulation (EC) No. 453/2010 
Version 5.5 Revision Date 20.09.2015 
Print Date 15.08.2017 
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA  
 
SECTION 1: Identification of the substance/mixture and of the company/undertaking 
1.1 Product identifiers 
Product name : 2-Hydroxyethyl acrylate 
 
Product Number : 292818 
Brand : Aldrich 
Index-No. : 607-072-00-8 
REACH No. : A registration number is not available for this substance as the substance 
or its uses are exempted from registration, the annual tonnage does not 
require a registration or the registration is envisaged for a later 
registration deadline. 
CAS-No. : 818-61-1 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 




Telephone : +32 3 899 1301 
Fax : +32 3 899 1311 
E-mail address : eurtechserv@sial.com 
1.4 Emergency telephone number 
Emergency Phone #  +(32) 28 083237 (CHEMTREC)                                                                   
070 245245 (Anti-poison centre) 
 
 
SECTION 2: Hazards identification 
 
2.1 Classification of the substance or mixture 
Classification according to Regulation (EC) No 1272/2008 
Acute toxicity, Oral (Category 4), H302 
Acute toxicity, Dermal (Category 3), H311 
Skin corrosion (Category 1B), H314 
Skin sensitisation (Category 1), H317 
Acute aquatic toxicity (Category 1), H400 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
2.2 Label elements 
Labelling according Regulation (EC) No 1272/2008 
Pictogram 
  
Signal word Danger 
 
 




H302 Harmful if swallowed. 
H311 Toxic in contact with skin. 
H314 Causes severe skin burns and eye damage. 
H317 May cause an allergic skin reaction. 
H400 Very toxic to aquatic life. 
 
Precautionary statement(s) 
P273 Avoid release to the environment. 
P280 Wear protective gloves/ protective clothing/ eye protection/ face 
protection. 
P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. 
Rinse skin with water/shower. 
P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for 
breathing. Immediately call a POISON CENTER or doctor/ physician. 
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove 
contact lenses, if present and easy to do. Continue rinsing. 





2.3 Other hazards 
This substance/mixture contains no components considered to be either persistent, bioaccumulative and 
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. 
 
 
SECTION 3: Composition/information on ingredients 
3.1 Substances 
Formula : C5H8O3 
Molecular weight : 116,12 g/mol 
CAS-No. : 818-61-1 
EC-No. : 212-454-9 
Index-No. : 607-072-00-8 
 
 
Hazardous ingredients according to Regulation (EC) No 1272/2008 










Acute Tox. 4; Acute Tox. 3; 
Skin Corr. 1B; Skin Sens. 1; 
Aquatic Acute 1; H302, H311, 
H314, H317, H400 
Concentration limits: 
 >= 0,2 %: Skin Sens. 1, H317; 
M-Factor - Aquatic Acute: 1 
<= 100 % 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
 
 
SECTION 4: First aid measures 
4.1 Description of first aid measures 
General advice 
Consult a physician. Show this safety data sheet to the doctor in attendance. 
If inhaled 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. 
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In case of skin contact 
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Take 
victim immediately to hospital. Consult a physician. 
In case of eye contact 
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. 
If swallowed 
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with 
water. Consult a physician. 
4.2 Most important symptoms and effects, both acute and delayed 
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in 
section 11 
4.3 Indication of any immediate medical attention and special treatment needed 
No data available 
 
SECTION 5: Firefighting measures 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Carbon oxides  
5.3 Advice for firefighters 
Wear self-contained breathing apparatus for firefighting if necessary. 
5.4 Further information 
No data available 
 
SECTION 6: Accidental release measures 
6.1 Personal precautions, protective equipment and emergency procedures 
Wear respiratory protection. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. 
Evacuate personnel to safe areas. 
For personal protection see section 8. 
6.2 Environmental precautions 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the 
environment must be avoided. 
6.3 Methods and materials for containment and cleaning up 
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed 
containers for disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
SECTION 7: Handling and storage 
7.1 Precautions for safe handling 
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist. 
For precautions see section 2.2. 
7.2 Conditions for safe storage, including any incompatibilities 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are 
opened must be carefully resealed and kept upright to prevent leakage.  
Recommended storage temperature 2 - 8 °C 
Storage class (TRGS 510): Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous 
materials causing chronic effects 
7.3 Specific end use(s) 
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated 
 




SECTION 8: Exposure controls/personal protection 
8.1 Control parameters 
Components with workplace control parameters 
8.2 Exposure controls 
Appropriate engineering controls 
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling 
the product. 
Personal protective equipment 
Eye/face protection 
Tightly fitting safety goggles.  Faceshield (8-inch minimum). Use equipment for eye protection 
tested and approved under appropriate government standards such as NIOSH (US) or EN 
166(EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique 
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of 
contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
Wash and dry hands. 
 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and 




Minimum layer thickness: 0,6 mm 
Break through time: 480 min 
Material tested:Camapren® (KCL 722 / Aldrich Z677493, Size M) 
 
Splash contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,4 mm 
Break through time: 30 min 
Material tested:Camatril® (KCL 730 / Aldrich Z677442, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, 
test method: EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, 
contact the supplier of the CE approved gloves. This recommendation is advisory only and must 
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of 
anticipated use by our customers. It should not be construed as offering an approval for any 
specific use scenario. 
 
Body Protection 
Complete suit protecting against chemicals, The type of protective equipment must be selected 
according to the concentration and amount of the dangerous substance at the specific workplace. 
Respiratory protection 
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator 
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup 
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air 
respirator. Use respirators and components tested and approved under appropriate government 
standards such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into 
the environment must be avoided. 
 




SECTION 9: Physical and chemical properties 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: liquid 
Colour: colourless 
b) Odour No data available 
c) Odour Threshold No data available 
d) pH No data available 
e) Melting point/freezing 
point 
Melting point/freezing point: < -60 °C 
f) Initial boiling point and 
boiling range 
90 - 92 °C 
g) Flash point 101 °C - closed cup 
h) Evaporation rate No data available 




Lower explosion limit: 1,8 %(V) 
k) Vapour pressure 0,1 hPa at 20 °C 
l) Vapour density No data available 
m) Relative density 1,106 g/cm3 
n) Water solubility 1.000 g/l at 20 °C - soluble 
o) Partition coefficient: n-
octanol/water 
log Pow: -0,17 at 25 °C 
p) Auto-ignition 
temperature 
370 °C at 1.013,25 hPa 
q) Decomposition 
temperature 
No data available 
r) Viscosity No data available 
s) Explosive properties No data available 
t) Oxidizing properties No data available 
9.2 Other safety information 
No data available 
 
SECTION 10: Stability and reactivity 
10.1 Reactivity 
No data available 
10.2 Chemical stability 
Stable under recommended storage conditions. 
Contains the following stabiliser(s): 
Mequinol (>=200 - <=650 ppm) 
10.3 Possibility of hazardous reactions 
No data available 
10.4 Conditions to avoid 
No data available 
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10.5 Incompatible materials 
No data available 
10.6 Hazardous decomposition products 
Other decomposition products - No data available 
In the event of fire: see section 5 
 
SECTION 11: Toxicological information 
11.1 Information on toxicological effects 
Acute toxicity 
LD50 Oral - Rat - male and female - 960,5 mg/kg 
(OECD Test Guideline 401) 
 
Skin corrosion/irritation 
Skin - Rabbit 
Result: Causes burns. 
 
Serious eye damage/eye irritation 
Eyes - Rabbit 
Result: Corrosive 
 
Respiratory or skin sensitisation 
Maximisation Test (GPMT) - Guinea pig 
Result: May cause sensitisation by skin contact. 
 
Germ cell mutagenicity 








IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
Reproductive toxicity 
No data available 
Specific target organ toxicity - single exposure 
No data available 
Specific target organ toxicity - repeated exposure 
No data available 
Aspiration hazard 




Rat - male and female - Oral - NOAEL : 196 - 305 mg/kg 
RTECS: Not available 
 
 
SECTION 12: Ecological information 
12.1 Toxicity 
 
Toxicity to fish flow-through test LC50 - Pimephales promelas (fathead minnow) - 4,8 mg/l  - 
96,0 h 
 
Toxicity to daphnia and 
other aquatic 
invertebrates 
EC50 - Daphnia magna (Water flea) - 0,78 mg/l  - 48 h 
 




Toxicity to algae Growth inhibition EC50 - Pseudokirchneriella subcapitata (green algae) - 6 mg/l  
- 72 h 
(OECD Test Guideline 201) 
12.2 Persistence and degradability 
Biodegradability Biotic/Aerobic  - Exposure time 28 d 
Result: 79 % - Readily biodegradable  
 (OECD Test Guideline 301B) 
12.3 Bioaccumulative potential 
No data available 
12.4 Mobility in soil 
No data available 
12.5 Results of PBT and vPvB assessment 
This substance/mixture contains no components considered to be either persistent, bioaccumulative and 
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. 
12.6 Other adverse effects 
Very toxic to aquatic life. 
 
SECTION 13: Disposal considerations 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company.  
Contaminated packaging 
Dispose of as unused product.  
 
SECTION 14: Transport information 
14.1 UN number 
ADR/RID: 2922 IMDG: 2922 IATA: 2922 
14.2 UN proper shipping name 
ADR/RID:  CORROSIVE LIQUID, TOXIC, N.O.S. (2-Hydroxyethyl acrylate) 
IMDG:  CORROSIVE LIQUID, TOXIC, N.O.S. (2-Hydroxyethyl acrylate) 
IATA:  Corrosive liquid, toxic, n.o.s. (2-Hydroxyethyl acrylate) 
 
14.3 Transport hazard class(es) 
ADR/RID: 8 (6.1) IMDG: 8 (6.1) IATA: 8 (6.1) 
14.4 Packaging group 
ADR/RID: II IMDG: II IATA: II 
14.5 Environmental hazards 
ADR/RID: yes IMDG Marine pollutant: yes IATA: no 
14.6 Special precautions for user 
No data available 
 
SECTION 15: Regulatory information 
This safety datasheet complies with the requirements of Regulation (EC) No. 453/2010. 
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture  
   
15.2 Chemical Safety Assessment 
For this product a chemical safety assessment was not carried out 
 
 




SECTION 16: Other information 
Full text of H-Statements referred to under sections 2 and 3. 
H302 Harmful if swallowed. 
H311 Toxic in contact with skin. 
H314 Causes severe skin burns and eye damage. 
H317 May cause an allergic skin reaction. 
H400 Very toxic to aquatic life. 
Further information 
Copyright 2015 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use 
only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be 
used only as a guide. The information in this document is based on the present state of our knowledge 
and is applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Sigma-Aldrich Corporation and its Affiliates shall not be held 
liable for any damage resulting from handling or from contact with the above product. See www.sigma-
aldrich.com and/or the reverse side of invoice or packing slip for additional terms and conditions of sale. 
 
 




SAFETY DATA SHEET 
according to Regulation (EC) No. 453/2010 
Version 6.1 Revision Date 17.11.2015 
Print Date 15.08.2017 
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA  
 
SECTION 1: Identification of the substance/mixture and of the company/undertaking 
1.1 Product identifiers 
Product name : Isophorone diisocyanate 
 
Product Number : 317624 
Brand : Aldrich 
Index-No. : 615-008-00-5 
REACH No. : 01-2119490408-31-XXXX 
CAS-No. : 4098-71-9 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 




Telephone : +32 3 899 1301 
Fax : +32 3 899 1311 
E-mail address : eurtechserv@sial.com 
1.4 Emergency telephone number 
Emergency Phone #  +(32) 28 083237 (CHEMTREC)                                                                   
070 245245 (Anti-poison centre) 
 
 
SECTION 2: Hazards identification 
 
2.1 Classification of the substance or mixture 
Classification according to Regulation (EC) No 1272/2008 
Acute toxicity, Inhalation (Category 1), H330 
Skin irritation (Category 2), H315 
Eye irritation (Category 2), H319 
Respiratory sensitisation (Category 1), H334 
Skin sensitisation (Category 1), H317 
Specific target organ toxicity - single exposure (Category 3), Respiratory system, H335 
Chronic aquatic toxicity (Category 2), H411 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
2.2 Label elements 
Labelling according Regulation (EC) No 1272/2008 
Pictogram 
  
Signal word Danger 
 
Hazard statement(s) 
H315 Causes skin irritation. 
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H317 May cause an allergic skin reaction. 
H319 Causes serious eye irritation. 
H330 Fatal if inhaled. 
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. 
H335 May cause respiratory irritation. 
H411 Toxic to aquatic life with long lasting effects. 
 
Precautionary statement(s) 
P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. 
P280 Wear protective gloves/ protective clothing/ eye protection/ face 
protection. 
P284 Wear respiratory protection. 
P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for 
breathing. Immediately call a POISON CENTER or doctor/ physician. 
P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/ 
physician. 





2.3 Other hazards 
This substance/mixture contains no components considered to be either persistent, bioaccumulative and 




SECTION 3: Composition/information on ingredients 
3.1 Substances 
Synonyms : 5-Isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane 
 
Formula : C12H18N2O2 
Molecular weight : 222,28 g/mol 
CAS-No. : 4098-71-9 
EC-No. : 223-861-6 
Index-No. : 615-008-00-5 
Registration number : 01-2119490408-31-XXXX 
 
 
Hazardous ingredients according to Regulation (EC) No 1272/2008 










Acute Tox. 1; Skin Irrit. 2; Eye 
Irrit. 2; Resp. Sens. 1; Skin 
Sens. 1; STOT SE 3; Aquatic 
Chronic 2; H330, H315, H319, 
H334, H317, H335, H411 
Concentration limits: 
 >= 0,5 %: Resp. Sens. 1, 
H334; >= 0,5 %: Skin Sens. 1, 
H317; 
<= 100 % 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
 
 
SECTION 4: First aid measures 
4.1 Description of first aid measures 
General advice 
Consult a physician. Show this safety data sheet to the doctor in attendance. 
 




If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. 
In case of skin contact 
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician. 
In case of eye contact 
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. 
If swallowed 
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 
4.2 Most important symptoms and effects, both acute and delayed 
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in 
section 11 
4.3 Indication of any immediate medical attention and special treatment needed 
No data available 
 
SECTION 5: Firefighting measures 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Carbon oxides, Nitrogen oxides (NOx)  
5.3 Advice for firefighters 
Wear self-contained breathing apparatus for firefighting if necessary. 
5.4 Further information 
No data available 
 
SECTION 6: Accidental release measures 
6.1 Personal precautions, protective equipment and emergency procedures 
Wear respiratory protection. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. 
Evacuate personnel to safe areas. 
For personal protection see section 8. 
6.2 Environmental precautions 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the 
environment must be avoided. 
6.3 Methods and materials for containment and cleaning up 
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed 
containers for disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
SECTION 7: Handling and storage 
7.1 Precautions for safe handling 
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist. 
For precautions see section 2.2. 
7.2 Conditions for safe storage, including any incompatibilities 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are 
opened must be carefully resealed and kept upright to prevent leakage.  
Moisture sensitive.  
Storage class (TRGS 510): Non-combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials 
7.3 Specific end use(s) 
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated 
 




SECTION 8: Exposure controls/personal protection 
8.1 Control parameters 
Components with workplace control parameters 
8.2 Exposure controls 
Appropriate engineering controls 
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling 
the product. 
Personal protective equipment 
Eye/face protection 
Face shield and safety glasses Use equipment for eye protection tested and approved under 
appropriate government standards such as NIOSH (US) or EN 166(EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique 
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of 
contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
Wash and dry hands. 
 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and 
the standard EN 374 derived from it. 
 
Splash contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,4 mm 
Break through time: 110 min 
Material tested:Camatril® (KCL 730 / Aldrich Z677442, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, 
test method: EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, 
contact the supplier of the CE approved gloves. This recommendation is advisory only and must 
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of 
anticipated use by our customers. It should not be construed as offering an approval for any 
specific use scenario. 
 
Body Protection 
Complete suit protecting against chemicals, The type of protective equipment must be selected 
according to the concentration and amount of the dangerous substance at the specific workplace. 
Respiratory protection 
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator 
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup 
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air 
respirator. Use respirators and components tested and approved under appropriate government 
standards such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into 
the environment must be avoided. 
 
SECTION 9: Physical and chemical properties 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: liquid 
Colour: colourless, yellow 
b) Odour No data available 
c) Odour Threshold No data available 
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d) pH No data available 
e) Melting point/freezing 
point 
No data available 
f) Initial boiling point and 
boiling range 
158 - 159 °C at 20 hPa - lit. 
g) Flash point 163 °C - closed cup 
h) Evaporation rate No data available 




No data available 
k) Vapour pressure 0,000635 hPa at 20 °C - OECD Test Guideline 104 
l) Vapour density No data available 
m) Relative density 1,049 g/cm3 at 25 °C - lit. 
n) Water solubility ca.0,015 g/l at 23 °C - OECD Test Guideline 105 
o) Partition coefficient: n-
octanol/water 
No data available 
p) Auto-ignition 
temperature 
430 °C at 1.013 hPa 
q) Decomposition 
temperature 
No data available 
r) Viscosity No data available 
s) Explosive properties Not explosive 
t) Oxidizing properties No data available 
9.2 Other safety information 
No data available 
 
SECTION 10: Stability and reactivity 
10.1 Reactivity 
No data available 
10.2 Chemical stability 
Stable under recommended storage conditions. 
10.3 Possibility of hazardous reactions 
No data available 
10.4 Conditions to avoid 
Avoid moisture. 
10.5 Incompatible materials 
Strong oxidizing agents, Strong acids, Alcohols 
10.6 Hazardous decomposition products 
Other decomposition products - No data available 
In the event of fire: see section 5 
 




SECTION 11: Toxicological information 
11.1 Information on toxicological effects 
Acute toxicity 
LD50 Oral - Rat - male and female - 4.814 mg/kg 
(OECD Test Guideline 401) 
 
LC50 Inhalation - Rat - male and female - 4 h - 31 mg/m3 
(OECD Test Guideline 403) 
 
LD50 Dermal - Rat - male and female - > 7.000 mg/kg 
(OECD Test Guideline 402) 
 
Skin corrosion/irritation 
Skin - Rabbit 
Result: Irritating to skin. - 4 h 
(OECD Test Guideline 404) 
 
Serious eye damage/eye irritation 
Eyes - Rabbit 
Result: Irritating to eyes. 
(OECD Test Guideline 405) 
 
Respiratory or skin sensitisation 
in vivo assay - Guinea pig 
May cause sensitisation by skin contact. 
(OECD Test Guideline 406) 
 
in vivo assay - Guinea pig 
May cause sensitisation by inhalation. 
 
Germ cell mutagenicity 
In vitro mammalian cell gene mutation test 
Chinese hamster ovary cells  
Result: negative 
 
OECD Test Guideline 474 




IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
Reproductive toxicity 
Developmental Toxicity - Rat - Inhalation 
No significant adverse effects were reported 
Specific target organ toxicity - single exposure 
No data available 
Specific target organ toxicity - repeated exposure 
No data available 
Aspiration hazard 




Material is extremely destructive to tissue of the mucous membranes and upper respiratory tract, eyes, and 
skin., Cough, Shortness of breath, Headache, Nausea 
 
 




SECTION 12: Ecological information 
12.1 Toxicity 
 
Toxicity to fish static test LC50 - Danio rerio (zebra fish) - >= 72 mg/l  - 96 h 
(Tested according to Directive 92/69/EEC.) 
 
Toxicity to daphnia and 
other aquatic 
invertebrates 
static test EC50 - Daphnia magna (Water flea) - 27 mg/l  - 48 h 
(Directive 67/548/EEC, Annex V, C.2.) 
 
Toxicity to algae static test EC50 - Desmodesmus subspicatus (green algae) - > 70 mg/l  - 72 h 
(Tested according to Directive 92/69/EEC.) 
 
Toxicity to bacteria Respiration inhibition EC50 - activated sludge - 263 mg/l  - 3 h 
(OECD Test Guideline 209) 
12.2 Persistence and degradability 
Biodegradability aerobic  - Exposure time 28 d 
Result: 0 % - Not readily biodegradable.  
12.3 Bioaccumulative potential 
No data available 
12.4 Mobility in soil 
No data available 
12.5 Results of PBT and vPvB assessment 
This substance/mixture contains no components considered to be either persistent, bioaccumulative and 
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. 
12.6 Other adverse effects 
Toxic to aquatic life with long lasting effects. 
 
SECTION 13: Disposal considerations 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company.  
Contaminated packaging 
Dispose of as unused product.  
 
SECTION 14: Transport information 
14.1 UN number 
ADR/RID: 2290 IMDG: 2290 IATA: 2290 
14.2 UN proper shipping name 
ADR/RID:  ISOPHORONE DIISOCYANATE 
IMDG:  ISOPHORONE DIISOCYANATE 
IATA:  Isophorone diisocyanate 
 
14.3 Transport hazard class(es) 
ADR/RID: 6.1 IMDG: 6.1 IATA: 6.1 
14.4 Packaging group 
ADR/RID: III IMDG: III IATA: III 
14.5 Environmental hazards 
ADR/RID: yes IMDG Marine pollutant: yes IATA: no 
14.6 Special precautions for user 
No data available 
 




SECTION 15: Regulatory information 
This safety datasheet complies with the requirements of Regulation (EC) No. 453/2010. 
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture  
   
15.2 Chemical Safety Assessment 
For this product a chemical safety assessment was not carried out 
 
 
SECTION 16: Other information 
Full text of H-Statements referred to under sections 2 and 3. 
H315 Causes skin irritation. 
H317 May cause an allergic skin reaction. 
H319 Causes serious eye irritation. 
H330 Fatal if inhaled. 
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. 
H335 May cause respiratory irritation. 
H411 Toxic to aquatic life with long lasting effects. 
Further information 
Copyright 2015 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use 
only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be 
used only as a guide. The information in this document is based on the present state of our knowledge 
and is applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Sigma-Aldrich Corporation and its Affiliates shall not be held 
liable for any damage resulting from handling or from contact with the above product. See www.sigma-
aldrich.com and/or the reverse side of invoice or packing slip for additional terms and conditions of sale. 
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SIGMA-ALDRICH sigma-aldrich.com 
SAFETY DATA SHEET 
according to Regulation (EC) No. 1907/2006 
Version 5.0 Revision Date 08.06.2012 
Print Date 15.08.2017 
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA 
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 
1.1 Product identifiers 
Product name : Poly(ethylene glycol) 
 
Product Number : 81221 
Brand : Sigma-Aldrich 
CAS-No. : 25322-68-3 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 




Telephone : +32 3 899 1301 
Fax : +32 3 899 1311 
E-mail address : eurtechserv@sial.com 
1.4 Emergency telephone number 
Emergency Phone # : +(32) 28 083237 (CHEMTREC)                                                                   
070 245245 (Anti-poison centre) 
 
2. HAZARDS IDENTIFICATION 
2.1 Classification of the substance or mixture 
 
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. 
This substance is not classified as dangerous according to Directive 67/548/EEC.  
2.2 Label elements 
The product does not need to be labelled in accordance with EC directives or respective national laws. 
2.3 Other hazards - none 
 
3. COMPOSITION/INFORMATION ON INGREDIENTS 
3.1 Substances 
Synonyms : PEG 
 
Formula : (C2H4O)nH2O  
 
 
4. FIRST AID MEASURES 
4.1 Description of first aid measures 
If inhaled 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. 
In case of skin contact 
Wash off with soap and plenty of water. 
In case of eye contact 
Flush eyes with water as a precaution. 
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If swallowed 
Never give anything by mouth to an unconscious person. Rinse mouth with water. 
4.2 Most important symptoms and effects, both acute and delayed 
4.3 Indication of any immediate medical attention and special treatment needed 
no data available 
 
5. FIREFIGHTING MEASURES 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Carbon oxides 
Nature of decomposition products not known. 
5.3 Advice for firefighters 
Wear self contained breathing apparatus for fire fighting if necessary. 
5.4 Further information 
no data available 
 
6. ACCIDENTAL RELEASE MEASURES 
6.1 Personal precautions, protective equipment and emergency procedures 
Avoid dust formation. Avoid breathing vapors, mist or gas. 
6.2 Environmental precautions 
Do not let product enter drains. 
6.3 Methods and materials for containment and cleaning up 
Sweep up and shovel. Keep in suitable, closed containers for disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
7. HANDLING AND STORAGE 
7.1 Precautions for safe handling 
Provide appropriate exhaust ventilation at places where dust is formed. 
7.2 Conditions for safe storage, including any incompatibilities 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.  
7.3 Specific end uses 
no data available 
 
8. EXPOSURE CONTROLS/PERSONAL PROTECTION 
8.1 Control parameters 
Components with workplace control parameters 
8.2 Exposure controls 
Appropriate engineering controls 
General industrial hygiene practice. 
Personal protective equipment 
Eye/face protection 
Use equipment for eye protection tested and approved under appropriate government standards 
such as NIOSH (US) or EN 166(EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique 
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of 
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contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
Wash and dry hands. 
 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and 
the standard EN 374 derived from it. 
 
Immersion protection 
Material: Nitrile rubber 
Minimum layer thickness: 0,11 mm 
Break through time: > 480 min 
Material tested:Dermatril® (Aldrich Z677272, Size M) 
 
Splash protection 
Material: Nitrile rubber 
Minimum layer thickness: 0,11 mm 
Break through time: > 30 min 
Material tested:Dermatril® (Aldrich Z677272, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 873000, e-mail sales@kcl.de, 
test method: EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, 
contact the supplier of the CE approved gloves. This recommendation is advisory only and must 
be evaluated by an Industrial Hygienist familiar with the specific situation of anticipated use by our 
customers. It should not be construed as offering an approval for any specific use scenario. 
 
Body Protection 
Choose body protection in relation to its type, to the concentration and amount of dangerous 
substances, and to the specific work-place., The type of protective equipment must be selected 
according to the concentration and amount of the dangerous substance at the specific workplace. 
Respiratory protection 
Respiratory protection is not required. Where protection from nuisance  levels of dusts are desired, 
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and 
approved under appropriate government standards such as NIOSH (US) or CEN (EU). 
 
9. PHYSICAL AND CHEMICAL PROPERTIES 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: solid 
b) Odour no data available 
c) Odour Threshold no data available 
d) pH no data available 
e) Melting point/freezing 
point 
Melting point/range: 50 - 53 °C 
f) Initial boiling point and 
boiling range 
no data available 
g) Flash point no data available  
h) Evaporation rate no data available 




no data available 
k) Vapour pressure < 0,01 hPa at 20 °C 
l) Vapour density no data available 
m) Relative density no data available 
n) Water solubility no data available 
o) Partition coefficient: n- no data available 
 








no data available 
r) Viscosity no data available 
s) Explosive properties no data available 
t) Oxidizing properties no data available 
9.2 Other safety information 
no data available 
 
10. STABILITY AND REACTIVITY 
10.1 Reactivity 
no data available 
10.2 Chemical stability 
no data available 
10.3 Possibility of hazardous reactions 
no data available 
10.4 Conditions to avoid 
no data available 
10.5 Incompatible materials 
Strong oxidizing agents 
10.6 Hazardous decomposition products 
Other decomposition products - no data available 
 
11. TOXICOLOGICAL INFORMATION 
11.1 Information on toxicological effects 
Acute toxicity 
LD50 Oral - rat - 45.000 mg/kg 
Skin corrosion/irritation 
no data available 
Serious eye damage/eye irritation 
no data available 
Respiratory or skin sensitization 
no data available 
Germ cell mutagenicity 
no data available 
Carcinogenicity 
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
Reproductive toxicity 
no data available 
Specific target organ toxicity - single exposure 
no data available 
Specific target organ toxicity - repeated exposure 
no data available 
Aspiration hazard 
no data available 
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Potential health effects 
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.  
Ingestion May be harmful if swallowed.  
Skin May be harmful if absorbed through skin. May cause skin irritation.  
Eyes May cause eye irritation.  
Additional Information 
RTECS: Not available 
 
12. ECOLOGICAL INFORMATION 
12.1 Toxicity 
no data available 
12.2 Persistence and degradability 
no data available 
12.3 Bioaccumulative potential 
no data available 
12.4 Mobility in soil 
no data available 
12.5 Results of PBT and vPvB assessment 
no data available 
12.6 Other adverse effects 
no data available 
 
13. DISPOSAL CONSIDERATIONS 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company.  
Contaminated packaging 
Dispose of as unused product.  
 
14. TRANSPORT INFORMATION 
14.1 UN number 
ADR/RID:  -  IMDG:  -  IATA:  -  
14.2 UN proper shipping name 
ADR/RID:  Not dangerous goods 
IMDG:  Not dangerous goods 
IATA:  Not dangerous goods 
14.3 Transport hazard class(es) 
ADR/RID:  -  IMDG:  -  IATA:  -  
14.4 Packaging group 
ADR/RID:  -  IMDG:  -  IATA:  -  
14.5 Environmental hazards 
ADR/RID: no IMDG Marine pollutant: no IATA: no 
14.6 Special precautions for user 
no data available 
 
15. REGULATORY INFORMATION 
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture 
no data available 
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15.2 Chemical Safety Assessment 
no data available 
 
16. OTHER INFORMATION 
Further information 
Copyright 2012 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use 
only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be 
used only as a guide. The information in this document is based on the present state of our knowledge 
and is applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Sigma-Aldrich Corporation and its Affiliates shall not be held 
liable for any damage resulting from handling or from contact with the above product. See www.sigma-









SAFETY DATA SHEET 
according to Regulation (EC) No. 1907/2006 
Version 5.1 Revision Date 29.04.2014 
Print Date 15.08.2017 
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA  
 
SECTION 1: Identification of the substance/mixture and of the company/undertaking 
1.1 Product identifiers 
Product name : Phenothiazine 
 
Product Number : 88580 
Brand : Sigma-Aldrich 
REACH No. : A registration number is not available for this substance as the substance 
or its uses are exempted from registration, the annual tonnage does not 
require a registration or the registration is envisaged for a later 
registration deadline. 
CAS-No. : 92-84-2 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 




Telephone : +32 3 899 1301 
Fax : +32 3 899 1311 
E-mail address : eurtechserv@sial.com 
1.4 Emergency telephone number 
Emergency Phone # : +(32) 28 083237 (CHEMTREC)                                                                   
070 245245 (Anti-poison centre) 
 
SECTION 2: Hazards identification 
2.1 Classification of the substance or mixture 
Classification according to Regulation (EC) No 1272/2008 
Acute toxicity, Oral (Category 4), H302 
Skin sensitisation (Category 1), H317 
Specific target organ toxicity - repeated exposure, Oral (Category 2), Blood, H373 
Chronic aquatic toxicity (Category 3), H412 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
Classification according to EU Directives 67/548/EEC or 1999/45/EC 
Xn Harmful R22, R43, R48/22, R52/53 
For the full text of the R-phrases mentioned in this Section, see Section 16. 
2.2 Label elements 
Labelling according Regulation (EC) No 1272/2008 
Pictogram 
  
Signal word Warning 
 
Hazard statement(s) 
H302 Harmful if swallowed. 
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H317 May cause an allergic skin reaction. 
H373 May cause damage to organs (Blood) through prolonged or repeated 
exposure if swallowed. 
H412 Harmful to aquatic life with long lasting effects. 
 
Precautionary statement(s) 
P273 Avoid release to the environment. 





2.3 Other hazards - none 
 
SECTION 3: Composition/information on ingredients 
3.1 Substances 
Formula : C12H9NS  
Molecular Weight : 199,27 g/mol 
CAS-No. : 92-84-2 
EC-No. : 202-196-5 
 
 
Hazardous ingredients according to Regulation (EC) No 1272/2008 








Acute Tox. 4; Skin Sens. 1; 
STOT RE 2; Aquatic Chronic 
3; H302, H317, H373, H412 
<= 100 % 
 
Hazardous ingredients according to Directive 1999/45/EC 








Xn, R22 - R43 - R48/22 - 
R52/53 
<= 100 % 
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16 
 
SECTION 4: First aid measures 
4.1 Description of first aid measures 
General advice 
Consult a physician. Show this safety data sheet to the doctor in attendance. 
If inhaled 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. 
In case of skin contact 
Wash off with soap and plenty of water. Consult a physician. 
In case of eye contact 
Flush eyes with water as a precaution. 
If swallowed 
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 
4.2 Most important symptoms and effects, both acute and delayed 
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in 
section 11 
4.3 Indication of any immediate medical attention and special treatment needed 
no data available 
 




SECTION 5: Firefighting measures 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Carbon oxides, nitrogen oxides (NOx), Sulphur oxides 
5.3 Advice for firefighters 
Wear self contained breathing apparatus for fire fighting if necessary. 
5.4 Further information 
no data available 
 
SECTION 6: Accidental release measures 
6.1 Personal precautions, protective equipment and emergency procedures 
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure 
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. 
For personal protection see section 8. 
6.2 Environmental precautions 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the 
environment must be avoided. 
6.3 Methods and materials for containment and cleaning up 
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed 
containers for disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
SECTION 7: Handling and storage 
7.1 Precautions for safe handling 
Avoid contact with skin and eyes. Avoid formation of dust and aerosols. 
Provide appropriate exhaust ventilation at places where dust is formed. 
For precautions see section 2.2. 
7.2 Conditions for safe storage, including any incompatibilities 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.  
7.3 Specific end use(s) 
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated 
 
SECTION 8: Exposure controls/personal protection 
8.1 Control parameters 
Components with workplace control parameters 
8.2 Exposure controls 
Appropriate engineering controls 
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and 
at the end of workday. 
Personal protective equipment 
Eye/face protection 
Face shield and safety glasses Use equipment for eye protection tested and approved under 
appropriate government standards such as NIOSH (US) or EN 166(EU). 
 




Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique 
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of 
contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
Wash and dry hands. 
 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and 
the standard EN 374 derived from it. 
 
Full contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
Splash contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, 
test method: EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, 
contact the supplier of the CE approved gloves. This recommendation is advisory only and must 
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of 
anticipated use by our customers. It should not be construed as offering an approval for any 
specific use scenario. 
 
Body Protection 
Complete suit protecting against chemicals, The type of protective equipment must be selected 
according to the concentration and amount of the dangerous substance at the specific workplace. 
Respiratory protection 
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher 
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. 
Use respirators and components tested and approved under appropriate government standards 
such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into 
the environment must be avoided. 
 
SECTION 9: Physical and chemical properties 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: pellets 
Colour: light yellow 
b) Odour odourless 
c) Odour Threshold no data available 
d) pH 7 at 10 g/l at 20 °C 
e) Melting point/freezing 
point 
Melting point/range: 182 - 187 °C - lit. 
Melting point/range: 183 - 187 °C 
f) Initial boiling point and 
boiling range 
371 °C - lit. 
g) Flash point no data available  
h) Evapouration rate no data available 
i) Flammability (solid, gas) The product is not flammable. - Flammability (solids) 
j) Upper/lower no data available 
 





k) Vapour pressure 53 hPa at 290 °C 
l) Vapour density no data available 
m) Relative density no data available 
n) Water solubility 0,127 g/l at 23 °C - OECD Test Guideline 105 - slightly soluble 
o) Partition coefficient: n-
octanol/water 
log Pow: ca.3,78 at 25 °C 
p) Auto-ignition 
temperature 
397 °C at 1.013 hPa 
q) Decomposition 
temperature 
> 250 °C -  
r) Viscosity no data available 
s) Explosive properties no data available 
t) Oxidizing properties no data available 
9.2 Other safety information 
 Bulk density 0,65 g/l 
 
SECTION 10: Stability and reactivity 
10.1 Reactivity 
no data available 
10.2 Chemical stability 
Stable under recommended storage conditions. 
10.3 Possibility of hazardous reactions 
no data available 
10.4 Conditions to avoid 
no data available 
10.5 Incompatible materials 
Strong oxidizing agents 
10.6 Hazardous decomposition products 
Other decomposition products - no data available 
In the event of fire: see section 5 
 
SECTION 11: Toxicological information 
11.1 Information on toxicological effects 
Acute toxicity 
LD50 Oral - rat - male and female - 1.370 mg/kg 
 
LD50 Dermal - rat - male and female - > 2.000 mg/kg 
(OECD Test Guideline 402) 
 
Skin corrosion/irritation 
Skin - rabbit 
Result: No skin irritation - 4 h 
(OECD Test Guideline 404) 
 
Serious eye damage/eye irritation 
Eyes - rabbit 
Result: No eye irritation 
(OECD Test Guideline 405) 
 
 
Sigma-Aldrich - 88580  Page 6  of  8 
 
 
Respiratory or skin sensitisation 
Causes photosensitivity. Exposure to light can result in allergic reactions resulting in dermatologic lesions, 
which can vary from sunburnlike responses to edematous, vesiculated lesions, or bullae 
Maximisation Test - guinea pig 
May cause sensitisation by skin contact. 
(OECD Test Guideline 406) 
 
Germ cell mutagenicity 
Ames test 








IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
Reproductive toxicity 
Reproductive toxicity - rat - Oral 
Effects on Fertility: Post-implantation mortality (e.g., dead and/or resorbed implants per total number of 
implants). 
Specific target organ toxicity - single exposure 
no data available 
Specific target organ toxicity - repeated exposure 
Oral - May cause damage to organs through prolonged or repeated exposure. - Blood 
Aspiration hazard 




anemia, Discoloration of the skin. 
 
 
SECTION 12: Ecological information 
12.1 Toxicity 
 
Toxicity to fish static test LC50 - Oncorhynchus mykiss (rainbow trout) - 70,7 mg/l  - 96 h 
(OECD Test Guideline 203) 
 
Toxicity to daphnia and 
other aquatic 
invertebrates 
static test EC50 - Daphnia magna (Water flea) - 11,92 mg/l  - 48 h 
(OECD Test Guideline 202) 
 
Toxicity to algae static test EC50 - Desmodesmus subspicatus (green algae) - > 100 mg/l  - 72 h 
(OECD Test Guideline 201) 
 
Toxicity to bacteria Respiration inhibition IC50 - Sludge Treatment - > 100 mg/l  - 3 h 
(OECD Test Guideline 209) 
12.2 Persistence and degradability 
Biodegradability aerobic  
Result: 0 % - Not readily biodegradable.  





12.3 Bioaccumulative potential 
Bioaccumulation Cyprinus carpio (Carp) - 56 d 
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at 25 °C - 0,02 mg/l 
 
Bioconcentration factor (BCF): 127 - 660 
12.4 Mobility in soil 
no data available 
12.5 Results of PBT and vPvB assessment 
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted 
12.6 Other adverse effects 








 8 mg/g   
 
SECTION 13: Disposal considerations 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material 
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.  
Contaminated packaging 
Dispose of as unused product.  
 
SECTION 14: Transport information 
14.1 UN number 
ADR/RID:  -  IMDG:  -  IATA:  -  
14.2 UN proper shipping name 
ADR/RID:  Not dangerous goods 
IMDG:  Not dangerous goods 
IATA:  Not dangerous goods 
14.3 Transport hazard class(es) 
ADR/RID:  -  IMDG:  -  IATA:  -  
14.4 Packaging group 
ADR/RID:  -  IMDG:  -  IATA:  -  
14.5 Environmental hazards 
ADR/RID: no IMDG Marine pollutant: no IATA: no 
14.6 Special precautions for user 
no data available 
 
SECTION 15: Regulatory information 
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture  
   
no data available 
 
15.2 Chemical Safety Assessment 
For this product a chemical safety assessment was not carried out 
 
 
SECTION 16: Other information 
Full text of H-Statements referred to under sections 2 and 3. 
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Acute Tox. Acute toxicity 
Aquatic Chronic Chronic aquatic toxicity 
H302 Harmful if swallowed.  
H317 May cause an allergic skin reaction. 
H373 May cause damage to organs through prolonged or repeated exposure if swallowed. 
H412 Harmful to aquatic life with long lasting effects. 
Skin Sens. Skin sensitisation 
STOT RE Specific target organ toxicity - repeated exposure 
Full text of R-phrases referred to under sections 2 and 3 
Xn Harmful  
R22 Harmful if swallowed.  
R43 May cause sensitisation by skin contact.  
R48/22 Harmful: danger of serious damage to health by prolonged exposure if swallowed.  
R52/53 Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic 
environment.  
Further information 
Copyright 2014 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use 
only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be 
used only as a guide. The information in this document is based on the present state of our knowledge 
and is applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Sigma-Aldrich Corporation and its Affiliates shall not be held 
liable for any damage resulting from handling or from contact with the above product. See www.sigma-
aldrich.com and/or the reverse side of invoice or packing slip for additional terms and conditions of sale. 
 
 




SAFETY DATA SHEET 
according to Regulation (EC) No. 1907/2006 
Version 5.3 Revision Date 28.01.2014 
Print Date 15.08.2017 
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA  
 
SECTION 1: Identification of the substance/mixture and of the company/undertaking 
1.1 Product identifiers 
Product name : Phosphoric acid, 85% 
 
Product Number : P5811 
Brand : Sigma 
REACH No. : A registration number is not available for this substance as the substance 
or its uses are exempted from registration, the annual tonnage does not 
require a registration or the registration is envisaged for a later 
registration deadline. 
CAS-No. : 7664-38-2 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 




Telephone : +32 3 899 1301 
Fax : +32 3 899 1311 
E-mail address : eurtechserv@sial.com 
1.4 Emergency telephone number 
Emergency Phone # : +(32) 28 083237 (CHEMTREC)                                                                   
070 245245 (Anti-poison centre) 
 
SECTION 2: Hazards identification 
2.1 Classification of the substance or mixture 
Classification according to Regulation (EC) No 1272/2008 
Corrosive to metals (Category 1), H290 
Skin corrosion (Category 1B), H314 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
Classification according to EU Directives 67/548/EEC or 1999/45/EC 
C Corrosive R34 
For the full text of the R-phrases mentioned in this Section, see Section 16. 
2.2 Label elements 




Signal word Danger 
 
Hazard statement(s) 
H290 May be corrosive to metals. 
H314 Causes severe skin burns and eye damage. 
 
 




P280 Wear protective gloves/ protective clothing/ eye protection/ face 
protection. 
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove 
contact lenses, if present and easy to do. Continue rinsing. 






According to European Directive 67/548/EEC as amended. 
Hazard symbol(s) C Corrosive 
  
R-phrase(s) 
R34 Causes burns. 
 
S-phrase(s) 
S26 In case of contact with eyes, rinse immediately with plenty of water and 
seek medical advice. 
S45 In case of accident or if you feel unwell, seek medical advice immediately 
(show the label where possible). 
2.3 Other hazards - none 
 
SECTION 3: Composition/information on ingredients 
3.2 Mixtures 
Synonyms : Orthophosphoric acid 
 
Formula : H3O4P  
Molecular Weight : 98,00 g/mol 
 
Hazardous ingredients according to Regulation (EC) No 1272/2008 










Met. Corr. 1; Skin Corr. 1B; 
H290, H314 
50 - 100 % 
 
Hazardous ingredients according to Directive 1999/45/EC 










C, R34 50 - 100 % 
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16 
 
SECTION 4: First aid measures 
4.1 Description of first aid measures 
General advice 
Consult a physician. Show this safety data sheet to the doctor in attendance. 
If inhaled 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. 
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In case of skin contact 
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Consult a 
physician. 
In case of eye contact 
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. 
If swallowed 
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with 
water. Consult a physician. 
4.2 Most important symptoms and effects, both acute and delayed 
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in 
section 11 
4.3 Indication of any immediate medical attention and special treatment needed 
no data available 
 
SECTION 5: Firefighting measures 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Thermal decomposition may produce toxic fumes of phosphorus oxides and/or phosphine 
Oxides of phosphorus 
5.3 Advice for firefighters 
Wear self contained breathing apparatus for fire fighting if necessary. 
5.4 Further information 
no data available 
 
SECTION 6: Accidental release measures 
6.1 Personal precautions, protective equipment and emergency procedures 
Wear respiratory protection. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. 
Evacuate personnel to safe areas. 
For personal protection see section 8. 
6.2 Environmental precautions 
Do not let product enter drains. 
6.3 Methods and materials for containment and cleaning up 
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed 
containers for disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
SECTION 7: Handling and storage 
7.1 Precautions for safe handling 
Avoid inhalation of vapour or mist. 
For precautions see section 2.2. 
7.2 Conditions for safe storage, including any incompatibilities 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are 
opened must be carefully resealed and kept upright to prevent leakage.  
7.3 Specific end use(s) 
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated 
 




SECTION 8: Exposure controls/personal protection 
8.1 Control parameters 
Components with workplace control parameters 
8.2 Exposure controls 
Appropriate engineering controls 
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and 
at the end of workday. 
Personal protective equipment 
Eye/face protection 
Tightly fitting safety goggles.  Faceshield (8-inch minimum). Use equipment for eye protection 
tested and approved under appropriate government standards such as NIOSH (US) or EN 
166(EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique 
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of 
contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
Wash and dry hands. 
 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and 
the standard EN 374 derived from it. 
 
Full contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
Splash contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, 
test method: EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, 
contact the supplier of the CE approved gloves. This recommendation is advisory only and must 
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of 
anticipated use by our customers. It should not be construed as offering an approval for any 
specific use scenario. 
 
Body Protection 
Complete suit protecting against chemicals, The type of protective equipment must be selected 
according to the concentration and amount of the dangerous substance at the specific workplace. 
Respiratory protection 
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator 
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup 
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air 
respirator. Use respirators and components tested and approved under appropriate government 
standards such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
Do not let product enter drains. 
 




SECTION 9: Physical and chemical properties 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: liquid, clear 
b) Odour no data available 
c) Odour Threshold no data available 
d) pH no data available 
e) Melting point/freezing 
point 
Melting point/range: 40 °C - lit. 
f) Initial boiling point and 
boiling range 
158 °C - lit. 
g) Flash point no data available  
h) Evapouration rate no data available 




no data available 
k) Vapour pressure no data available 
l) Vapour density no data available 
m) Relative density 1,685 g/cm3 at 25 °C 
n) Water solubility no data available 
o) Partition coefficient: n-
octanol/water 
no data available 
p) Auto-ignition 
temperature 
no data available 
q) Decomposition 
temperature 
no data available 
r) Viscosity no data available 
s) Explosive properties no data available 
t) Oxidizing properties no data available 
9.2 Other safety information 
no data available 
 
SECTION 10: Stability and reactivity 
10.1 Reactivity 
no data available 
10.2 Chemical stability 
Stable under recommended storage conditions. 
10.3 Possibility of hazardous reactions 
no data available 
10.4 Conditions to avoid 
no data available 
10.5 Incompatible materials 
Strong bases, Powdered metals 
10.6 Hazardous decomposition products 
Other decomposition products - no data available 
 
Sigma - P5811  Page 6  of  8 
 
 
In the event of fire: see section 5 
 
SECTION 11: Toxicological information 
11.1 Information on toxicological effects 
Acute toxicity 
no data available 
Skin corrosion/irritation 
no data available 
Serious eye damage/eye irritation 
no data available 
Respiratory or skin sensitisation 
no data available 
Germ cell mutagenicity 
no data available 
 
Carcinogenicity 
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
Reproductive toxicity 
no data available 
Specific target organ toxicity - single exposure 
no data available 
Specific target organ toxicity - repeated exposure 
no data available 
Aspiration hazard 
no data available 
Additional Information 
RTECS: Not available 
 
burning sensation, Cough, wheezing, laryngitis, Shortness of breath, spasm, inflammation and edema of 
the larynx, spasm, inflammation and edema of the bronchi, pneumonitis, pulmonary edema, Material is 
extremely destructive to tissue of the mucous membranes and upper respiratory tract, eyes, and skin. 
 
 
SECTION 12: Ecological information 
12.1 Toxicity 
no data available 
12.2 Persistence and degradability 
no data available 
12.3 Bioaccumulative potential 
no data available 
12.4 Mobility in soil 
no data available 
12.5 Results of PBT and vPvB assessment 
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted 
12.6 Other adverse effects 
no data available 
 




SECTION 13: Disposal considerations 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company.  
Contaminated packaging 
Dispose of as unused product.  
 
SECTION 14: Transport information 
14.1 UN number 
ADR/RID: 1805 IMDG: 1805 IATA: 1805 
14.2 UN proper shipping name 
ADR/RID:  PHOSPHORIC ACID SOLUTION 
IMDG:  PHOSPHORIC ACID SOLUTION 
IATA:  Phosphoric acid, solution 
14.3 Transport hazard class(es) 
ADR/RID: 8 IMDG: 8 IATA: 8 
14.4 Packaging group 
ADR/RID: III IMDG: III IATA: III 
14.5 Environmental hazards 
ADR/RID: no IMDG Marine pollutant: no IATA: no 
14.6 Special precautions for user 
no data available 
 
SECTION 15: Regulatory information 
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture  
   
no data available 
 
15.2 Chemical Safety Assessment 
For this product a chemical safety assessment was not carried out 
 
 
SECTION 16: Other information 
Full text of H-Statements referred to under sections 2 and 3. 
H290 May be corrosive to metals. 
H314 Causes severe skin burns and eye damage.  
Met. Corr. Corrosive to metals 
Skin Corr. Skin corrosion 
Full text of R-phrases referred to under sections 2 and 3 
C Corrosive  
R34 Causes burns.  
Further information 
Copyright 2014 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use 
only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be 
used only as a guide. The information in this document is based on the present state of our knowledge 
and is applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Sigma-Aldrich Corporation and its Affiliates shall not be held 
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liable for any damage resulting from handling or from contact with the above product. See www.sigma-
aldrich.com and/or the reverse side of invoice or packing slip for additional terms and conditions of sale. 
 
 




SAFETY DATA SHEET 
according to Regulation (EC) No. 453/2010 
Version 5.8 Revision Date 26.11.2015 
Print Date 15.08.2017 
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA  
 
SECTION 1: Identification of the substance/mixture and of the company/undertaking 
1.1 Product identifiers 
Product name : Triphenyl phosphite 
 
Product Number : T84654 
Brand : Aldrich 
REACH No. : A registration number is not available for this substance as the substance 
or its uses are exempted from registration, the annual tonnage does not 
require a registration or the registration is envisaged for a later 
registration deadline. 
CAS-No. : 101-02-0 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 




Telephone : +32 3 899 1301 
Fax : +32 3 899 1311 
E-mail address : eurtechserv@sial.com 
1.4 Emergency telephone number 
Emergency Phone #  +(32) 28 083237 (CHEMTREC)                                                                   
070 245245 (Anti-poison centre) 
 
 
SECTION 2: Hazards identification 
 
2.1 Classification of the substance or mixture 
Classification according to Regulation (EC) No 1272/2008 
Acute toxicity, Oral (Category 4), H302 
Skin irritation (Category 2), H315 
Eye irritation (Category 2), H319 
Skin sensitisation (Category 1), H317 
Acute aquatic toxicity (Category 1), H400 
Chronic aquatic toxicity (Category 1), H410 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
2.2 Label elements 
Labelling according Regulation (EC) No 1272/2008 
Pictogram 
  
Signal word Warning 
 
 




H302 Harmful if swallowed. 
H315 Causes skin irritation. 
H317 May cause an allergic skin reaction. 
H319 Causes serious eye irritation. 
H410 Very toxic to aquatic life with long lasting effects. 
 
Precautionary statement(s) 
P280 Wear protective gloves. 
P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER or doctor/ physician if you 
feel unwell. Rinse mouth. 
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove 





2.3 Other hazards 
This substance/mixture contains no components considered to be either persistent, bioaccumulative and 
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. 
 
 
SECTION 3: Composition/information on ingredients 
3.1 Substances 
Formula : C18H15O3P 
Molecular weight : 310,28 g/mol 
CAS-No. : 101-02-0 
 
 
Hazardous ingredients according to Regulation (EC) No 1272/2008 










Acute Tox. 4; Skin Irrit. 2; Eye 
Irrit. 2; Skin Sens. 1; Aquatic 
Acute 1; Aquatic Chronic 1; 
H302, H315, H319, H317, 
H400, H410 
Concentration limits: 
 >= 5 %: Skin Irrit. 2, H315; >= 
5 %: Eye Irrit. 2, H319; 
M-Factor - Aquatic Acute: 10 










Acute Tox. 3; Skin Corr. 1B; 
Muta. 2; STOT RE 2; Aquatic 
Chronic 2; H301, H331, H311, 
H314, H341, H373, H411 
Concentration limits: 
 >= 3 %: Skin Corr. 1B, H314; 
1 - < 3 %: Skin Irrit. 2, H315; 1 
- < 3 %: Eye Irrit. 2, H319; 
>= 0,25 - < 1 % 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
 
 
SECTION 4: First aid measures 
4.1 Description of first aid measures 
General advice 
Consult a physician. Show this safety data sheet to the doctor in attendance. 
 




If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. 
In case of skin contact 
Wash off with soap and plenty of water. Consult a physician. 
In case of eye contact 
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. 
If swallowed 
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 
4.2 Most important symptoms and effects, both acute and delayed 
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in 
section 11 
4.3 Indication of any immediate medical attention and special treatment needed 
No data available 
 
SECTION 5: Firefighting measures 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Carbon oxides, Oxides of phosphorus  
5.3 Advice for firefighters 
Wear self-contained breathing apparatus for firefighting if necessary. 
5.4 Further information 
No data available 
 
SECTION 6: Accidental release measures 
6.1 Personal precautions, protective equipment and emergency procedures 
Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. 
For personal protection see section 8. 
6.2 Environmental precautions 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the 
environment must be avoided. 
6.3 Methods and materials for containment and cleaning up 
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed 
containers for disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
SECTION 7: Handling and storage 
7.1 Precautions for safe handling 
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist. 
For precautions see section 2.2. 
7.2 Conditions for safe storage, including any incompatibilities 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are 
opened must be carefully resealed and kept upright to prevent leakage.  
Moisture sensitive.  
Storage class (TRGS 510): Combustible liquids 
7.3 Specific end use(s) 
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated 
 




SECTION 8: Exposure controls/personal protection 
8.1 Control parameters 
Components with workplace control parameters 
8.2 Exposure controls 
Appropriate engineering controls 
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and 
at the end of workday. 
Personal protective equipment 
Eye/face protection 
Face shield and safety glasses Use equipment for eye protection tested and approved under 
appropriate government standards such as NIOSH (US) or EN 166(EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique 
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of 
contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
Wash and dry hands. 
 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and 
the standard EN 374 derived from it. 
 
Full contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,4 mm 
Break through time: 480 min 
Material tested:Camatril® (KCL 730 / Aldrich Z677442, Size M) 
 
Splash contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,4 mm 
Break through time: 480 min 
Material tested:Camatril® (KCL 730 / Aldrich Z677442, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, 
test method: EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, 
contact the supplier of the CE approved gloves. This recommendation is advisory only and must 
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of 
anticipated use by our customers. It should not be construed as offering an approval for any 
specific use scenario. 
 
Body Protection 
Complete suit protecting against chemicals, The type of protective equipment must be selected 
according to the concentration and amount of the dangerous substance at the specific workplace. 
Respiratory protection 
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator 
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup 
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air 
respirator. Use respirators and components tested and approved under appropriate government 
standards such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into 
the environment must be avoided. 
 




SECTION 9: Physical and chemical properties 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: liquid 
Colour: clear 
b) Odour No data available 
c) Odour Threshold No data available 
d) pH No data available 
e) Melting point/freezing 
point 
Melting point/range: 22 - 24 °C - lit. 
f) Initial boiling point and 
boiling range 
360 °C - lit. 
g) Flash point 210 °C 
h) Evaporation rate No data available 




No data available 
k) Vapour pressure >= 0,00 hPa at 25 °C 
l) Vapour density No data available 
m) Relative density 1,184 g/mL at 25 °C 
n) Water solubility No data available 
o) Partition coefficient: n-
octanol/water 
No data available 
p) Auto-ignition 
temperature 
> 400 °C at 1.013,250 hPa 
q) Decomposition 
temperature 
No data available 
r) Viscosity 17,7 mm2/s at 20 °C -  
s) Explosive properties No data available 
t) Oxidizing properties No data available 
9.2 Other safety information 
No data available 
 
SECTION 10: Stability and reactivity 
10.1 Reactivity 
No data available 
10.2 Chemical stability 
Stable under recommended storage conditions. 
Contains the following stabiliser(s): 
Phenol (0,5 %) 
10.3 Possibility of hazardous reactions 
No data available 
10.4 Conditions to avoid 
No data available 
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10.5 Incompatible materials 
No data available 
10.6 Hazardous decomposition products 
Other decomposition products - No data available 
In the event of fire: see section 5 
 
SECTION 11: Toxicological information 
11.1 Information on toxicological effects 
Acute toxicity 
LD50 Oral - Rat - male - 1.590 mg/kg 
(OECD Test Guideline 401) 
 
LC50 Inhalation - Rat - male and female - 1 h - > 6,7 mg/l 
(OECD Test Guideline 403) 
 
LD50 Dermal - Rabbit - male and female - > 2.000 mg/kg 
(OECD Test Guideline 402) 
 
Skin corrosion/irritation 
No data available 
Serious eye damage/eye irritation 
Eyes - Rabbit 
Result: Irritating to eyes. - 7 d 
(OECD Test Guideline 405) 
 
Respiratory or skin sensitisation 
 - Mouse 
Result: May cause sensitisation by skin contact. 
(OECD Test Guideline 429) 
 
Germ cell mutagenicity 
Ames test 
Salmonella typhimurium  
Result: negative 
 
OECD Test Guideline 474 




IARC: 3 - Group 3: Not classifiable as to its carcinogenicity to humans (Phenol) 
Reproductive toxicity 
No data available 
Specific target organ toxicity - single exposure 
No data available 
Specific target organ toxicity - repeated exposure 
No data available 
Aspiration hazard 




Rat - male and female - Oral - NOAEL : 15 mg/kg 
RTECS: Not available 
 








SECTION 12: Ecological information 
12.1 Toxicity 
No data available 
12.2 Persistence and degradability 
Biodegradability aerobic  - Exposure time 28 d 
Result: 0,14 % - Not readily biodegradable.  
 (OECD Test Guideline 301D) 
12.3 Bioaccumulative potential 
No data available 
12.4 Mobility in soil 
No data available 
12.5 Results of PBT and vPvB assessment 
This substance/mixture contains no components considered to be either persistent, bioaccumulative and 
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. 
12.6 Other adverse effects 
Very toxic to aquatic life with long lasting effects. 
 
SECTION 13: Disposal considerations 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company.  
Contaminated packaging 
Dispose of as unused product.  
 
SECTION 14: Transport information 
14.1 UN number 
ADR/RID: 3077 IMDG: 3077 IATA: 3077 
14.2 UN proper shipping name 
ADR/RID:  ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (Triphenyl phosphite) 
IMDG:  ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (Triphenyl phosphite) 
IATA:  Environmentally hazardous substance, solid, n.o.s. (Triphenyl phosphite) 
 
14.3 Transport hazard class(es) 
ADR/RID: 9 IMDG: 9 IATA: 9 
14.4 Packaging group 
ADR/RID: III IMDG: III IATA: III 
14.5 Environmental hazards 
ADR/RID: yes IMDG Marine pollutant: yes IATA: yes 
14.6 Special precautions for user 
 
Further information 
EHS-Mark required (ADR 2.2.9.1.10, IMDG code 2.10.3) for single packagings and combination 
packagings containing inner packagings with Dangerous Goods > 5L for liquids or > 5kg for solids. 
 
SECTION 15: Regulatory information 
This safety datasheet complies with the requirements of Regulation (EC) No. 453/2010. 
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture  
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15.2 Chemical Safety Assessment 
For this product a chemical safety assessment was not carried out 
 
 
SECTION 16: Other information 
Full text of H-Statements referred to under sections 2 and 3. 
H301 Toxic if swallowed. 
H302 Harmful if swallowed. 
H311 Toxic in contact with skin. 
H314 Causes severe skin burns and eye damage. 
H315 Causes skin irritation. 
H317 May cause an allergic skin reaction. 
H319 Causes serious eye irritation. 
H331 Toxic if inhaled. 
H341 Suspected of causing genetic defects. 
H373 May cause damage to organs through prolonged or repeated exposure. 
H400 Very toxic to aquatic life. 
H410 Very toxic to aquatic life with long lasting effects. 
H411 Toxic to aquatic life with long lasting effects. 
Further information 
Copyright 2015 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use 
only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be 
used only as a guide. The information in this document is based on the present state of our knowledge 
and is applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Sigma-Aldrich Corporation and its Affiliates shall not be held 
liable for any damage resulting from handling or from contact with the above product. See www.sigma-
aldrich.com and/or the reverse side of invoice or packing slip for additional terms and conditions of sale. 
 
 




SAFETY DATA SHEET 
according to Regulation (EC) No. 453/2010 
Version 5.2 Revision Date 03.12.2015 
Print Date 15.08.2017 
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA  
 
SECTION 1: Identification of the substance/mixture and of the company/undertaking 
1.1 Product identifiers 
Product name : 2-Butanone 
 
Product Number : 443468 
Brand : Sigma-Aldrich 
Index-No. : 606-002-00-3 
REACH No. : A registration number is not available for this substance as the substance 
or its uses are exempted from registration, the annual tonnage does not 
require a registration or the registration is envisaged for a later 
registration deadline. 
CAS-No. : 78-93-3 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 




Telephone : +32 3 899 1301 
Fax : +32 3 899 1311 
E-mail address : eurtechserv@sial.com 
1.4 Emergency telephone number 
Emergency Phone #  +(32) 28 083237 (CHEMTREC)                                                                   
070 245245 (Anti-poison centre) 
 
 
SECTION 2: Hazards identification 
 
2.1 Classification of the substance or mixture 
Classification according to Regulation (EC) No 1272/2008 
Flammable liquids (Category 2), H225 
Eye irritation (Category 2), H319 
Specific target organ toxicity - single exposure (Category 3), Central nervous system, H336 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
2.2 Label elements 
Labelling according Regulation (EC) No 1272/2008 
Pictogram 
  
Signal word Danger 
 
Hazard statement(s) 
H225 Highly flammable liquid and vapour. 
H319 Causes serious eye irritation. 
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H336 May cause drowsiness or dizziness. 
 
Precautionary statement(s) 
P210 Keep away from heat, hot surfaces, sparks, open flames and other 
ignition sources. No smoking. 
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove 
contact lenses, if present and easy to do. Continue rinsing. 
P370 + P378 In case of fire: Use dry powder or dry sand to extinguish. 
P403 + P235 Store in a well-ventilated place. Keep cool. 
 
Supplemental Hazard information (EU) 
EUH066 Repeated exposure may cause skin dryness or cracking. 
2.3 Other hazards 
This substance/mixture contains no components considered to be either persistent, bioaccumulative and 
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. 
 
 
SECTION 3: Composition/information on ingredients 
3.1 Substances 
Synonyms : Methyl ethyl ketone 
MEK 
Ethyl methyl ketone 
 
Formula : C4H8O 
Molecular weight : 72,11 g/mol 
CAS-No. : 78-93-3 
EC-No. : 201-159-0 
Index-No. : 606-002-00-3 
 
 
Hazardous ingredients according to Regulation (EC) No 1272/2008 
Component Classification Concentration 









Flam. Liq. 2; Eye Irrit. 2; STOT 
SE 3; H225, H319, H336 
<= 100 % 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
 
 
SECTION 4: First aid measures 
4.1 Description of first aid measures 
General advice 
Consult a physician. Show this safety data sheet to the doctor in attendance. 
If inhaled 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. 
In case of skin contact 
Wash off with soap and plenty of water. Consult a physician. 
In case of eye contact 
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. 
If swallowed 
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with 
water. Consult a physician. 
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4.2 Most important symptoms and effects, both acute and delayed 
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in 
section 11 
4.3 Indication of any immediate medical attention and special treatment needed 
No data available 
 
SECTION 5: Firefighting measures 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Carbon oxides  
Flash back possible over considerable distance., Container explosion may occur under fire conditions. 
5.3 Advice for firefighters 
Wear self-contained breathing apparatus for firefighting if necessary. 
5.4 Further information 
Use water spray to cool unopened containers. 
 
SECTION 6: Accidental release measures 
6.1 Personal precautions, protective equipment and emergency procedures 
Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. 
Remove all sources of ignition. Evacuate personnel to safe areas. Beware of vapours accumulating to 
form explosive concentrations. Vapours can accumulate in low areas. 
For personal protection see section 8. 
6.2 Environmental precautions 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. 
6.3 Methods and materials for containment and cleaning up 
Contain spillage, and then collect with an electrically protected vacuum cleaner or by wet-brushing and 
place in container for disposal according to local regulations (see section 13). 
6.4 Reference to other sections 
For disposal see section 13. 
 
SECTION 7: Handling and storage 
7.1 Precautions for safe handling 
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist. 
Keep away from sources of ignition - No smoking.Take measures to prevent the build up of electrostatic 
charge. 
For precautions see section 2.2. 
7.2 Conditions for safe storage, including any incompatibilities 
Store under inert gas. Store in cool place. Keep container tightly closed in a dry and well-ventilated place. 
Containers which are opened must be carefully resealed and kept upright to prevent leakage.  
Hygroscopic.  
7.3 Specific end use(s) 
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated 
 




SECTION 8: Exposure controls/personal protection 
8.1 Control parameters 
Components with workplace control parameters 
8.2 Exposure controls 
Appropriate engineering controls 
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and 
at the end of workday. 
Personal protective equipment 
Eye/face protection 
Face shield and safety glasses Use equipment for eye protection tested and approved under 
appropriate government standards such as NIOSH (US) or EN 166(EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique 
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of 
contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
Wash and dry hands. 
 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and 




Minimum layer thickness: 0,3 mm 
Break through time: 292 min 
Material tested:Butoject® (KCL 897 / Aldrich Z677647, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, 
test method: EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, 
contact the supplier of the CE approved gloves. This recommendation is advisory only and must 
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of 
anticipated use by our customers. It should not be construed as offering an approval for any 
specific use scenario. 
 
Body Protection 
Impervious clothing, Flame retardant antistatic protective clothing., The type of protective 
equipment must be selected according to the concentration and amount of the dangerous 
substance at the specific workplace. 
Respiratory protection 
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator 
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup 
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air 
respirator. Use respirators and components tested and approved under appropriate government 
standards such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. 
 
SECTION 9: Physical and chemical properties 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: liquid, clear 
Colour: colourless 
b) Odour No data available 
c) Odour Threshold No data available 
 
Sigma-Aldrich - 443468  Page 5  of  8 
 
 
d) pH No data available 
e) Melting point/freezing 
point 
-87 °C 
f) Initial boiling point and 
boiling range 
80 °C - lit. 
g) Flash point -3 °C - closed cup 
h) Evaporation rate No data available 




Upper explosion limit: 10,1 %(V) 
Lower explosion limit: 1,8 %(V) 
k) Vapour pressure 95 hPa at 20 °C 
l) Vapour density 2,49 - (Air = 1.0) 
m) Relative density 0,805 g/mL at 25 °C 
n) Water solubility soluble 
o) Partition coefficient: n-
octanol/water 
log Pow: 0,29 
p) Auto-ignition 
temperature 
No data available 
q) Decomposition 
temperature 
No data available 
r) Viscosity No data available 
s) Explosive properties No data available 
t) Oxidizing properties No data available 
9.2 Other safety information 
 Surface tension 24,6 mN/m at 20 °C 
 Relative vapour density 2,49 - (Air = 1.0) 
 
SECTION 10: Stability and reactivity 
10.1 Reactivity 
No data available 
10.2 Chemical stability 
Stable under recommended storage conditions. 
10.3 Possibility of hazardous reactions 
No data available 
10.4 Conditions to avoid 
Exposure to moisture 
Heat, flames and sparks. Extremes of temperature and direct sunlight. 
10.5 Incompatible materials 
Oxidizing agents, Strong reducing agents 
10.6 Hazardous decomposition products 
Other decomposition products - No data available 
In the event of fire: see section 5 
 




SECTION 11: Toxicological information 
11.1 Information on toxicological effects 
Acute toxicity 
LD50 Oral - Rat - 2.737 mg/kg 
 
LC50 Inhalation - Mouse - 4 h - 32.000 mg/m3 
 
LC50 Inhalation - Mammal - 38.000 mg/m3 
 
LD50 Dermal - Rabbit - 6.480 mg/kg 
 
Skin corrosion/irritation 
Skin - Rabbit 
Result: No skin irritation 
(OECD Test Guideline 404) 
 
Serious eye damage/eye irritation 
Eyes - Rabbit 
Result: Irritating to eyes. 
(OECD Test Guideline 405) 
 
Respiratory or skin sensitisation 
No data available 
Germ cell mutagenicity 
No data available 
 
Carcinogenicity 
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
Reproductive toxicity 
No data available 
Specific target organ toxicity - single exposure 
May cause drowsiness or dizziness. 
Specific target organ toxicity - repeated exposure 
No data available 
Aspiration hazard 




Central nervous system depression, Gastrointestinal disturbance, narcosis 
 
Liver - Irregularities - Based on Human Evidence 
 
SECTION 12: Ecological information 
12.1 Toxicity 
 
Toxicity to fish mortality NOEC - Cyprinodon variegatus (sheepshead minnow) - 400 mg/l  - 96 
h 
 
 LC50 - Pimephales promelas (fathead minnow) - 3.130 - 3.320 mg/l  - 96 h 
 
Toxicity to daphnia and 
other aquatic 
invertebrates 
LC50 - Daphnia magna (Water flea) - > 520 mg/l  - 48 h 
 
 EC50 - Daphnia magna (Water flea) - 7.060 mg/l  - 24 h 
12.2 Persistence and degradability 
No data available 
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12.3 Bioaccumulative potential 
No data available 
12.4 Mobility in soil 
No data available 
12.5 Results of PBT and vPvB assessment 
This substance/mixture contains no components considered to be either persistent, bioaccumulative and 
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. 
12.6 Other adverse effects 
 
No data available 
 
SECTION 13: Disposal considerations 
13.1 Waste treatment methods 
Product 
Burn in a chemical incinerator equipped with an afterburner and scrubber but exert extra care in igniting 
as this material is highly flammable. Offer surplus and non-recyclable solutions to a licensed disposal 
company.  
Contaminated packaging 
Dispose of as unused product.  
 
SECTION 14: Transport information 
14.1 UN number 
ADR/RID: 1193 IMDG: 1193 IATA: 1193 
14.2 UN proper shipping name 
ADR/RID:  ETHYL METHYL KETONE 
IMDG:  ETHYL METHYL KETONE 
IATA:  Ethyl methyl ketone 
 
14.3 Transport hazard class(es) 
ADR/RID: 3 IMDG: 3 IATA: 3 
14.4 Packaging group 
ADR/RID: II IMDG: II IATA: II 
14.5 Environmental hazards 
ADR/RID: no IMDG Marine pollutant: no IATA: no 
14.6 Special precautions for user 
No data available 
 
SECTION 15: Regulatory information 
This safety datasheet complies with the requirements of Regulation (EC) No. 453/2010. 
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture  
   
15.2 Chemical Safety Assessment 
For this product a chemical safety assessment was not carried out 
 
 
SECTION 16: Other information 
Full text of H-Statements referred to under sections 2 and 3. 
EUH066 Repeated exposure may cause skin dryness or cracking. 
H225 Highly flammable liquid and vapour. 
H319 Causes serious eye irritation. 
H336 May cause drowsiness or dizziness. 
 




Copyright 2015 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use 
only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be 
used only as a guide. The information in this document is based on the present state of our knowledge 
and is applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Sigma-Aldrich Corporation and its Affiliates shall not be held 
liable for any damage resulting from handling or from contact with the above product. See www.sigma-
aldrich.com and/or the reverse side of invoice or packing slip for additional terms and conditions of sale. 
 
 




SAFETY DATA SHEET 
according to Regulation (EC) No. 1907/2006 
Version 5.3 Revision Date 18.06.2014 
Print Date 15.08.2017 
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA  
 
SECTION 1: Identification of the substance/mixture and of the company/undertaking 
1.1 Product identifiers 
Product name : Butylated hydroxytoluene 
 
Product Number : W218405 
Brand : Aldrich 
REACH No. : A registration number is not available for this substance as the substance 
or its uses are exempted from registration, the annual tonnage does not 
require a registration or the registration is envisaged for a later 
registration deadline. 
CAS-No. : 128-37-0 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 




Telephone : +32 3 899 1301 
Fax : +32 3 899 1311 
E-mail address : eurtechserv@sial.com 
1.4 Emergency telephone number 
Emergency Phone # : +(32) 28 083237 (CHEMTREC)                                                                   
070 245245 (Anti-poison centre) 
 
SECTION 2: Hazards identification 
2.1 Classification of the substance or mixture 
Classification according to Regulation (EC) No 1272/2008 
Acute aquatic toxicity (Category 1), H400 
Chronic aquatic toxicity (Category 1), H410 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
Classification according to EU Directives 67/548/EEC or 1999/45/EC 
N Dangerous for the 
environment 
R50/53 
For the full text of the R-phrases mentioned in this Section, see Section 16. 
2.2 Label elements 
Labelling according Regulation (EC) No 1272/2008 
Pictogram 
  
Signal word Warning 
 
Hazard statement(s) 
H410 Very toxic to aquatic life with long lasting effects. 
 
 




P273 Avoid release to the environment. 





2.3 Other hazards - none 
 
SECTION 3: Composition/information on ingredients 
3.1 Substances 







Formula : C15H24O  
Molecular Weight : 220,35 g/mol 
CAS-No. : 128-37-0 
EC-No. : 204-881-4 
 
 
Hazardous ingredients according to Regulation (EC) No 1272/2008 








Aquatic Acute 1; Aquatic 
Chronic 1; H410 
<= 100 % 
 
Hazardous ingredients according to Directive 1999/45/EC 








N, R50/53 <= 100 % 
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16 
 
SECTION 4: First aid measures 
4.1 Description of first aid measures 
General advice 
Consult a physician. Show this safety data sheet to the doctor in attendance. 
If inhaled 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. 
In case of skin contact 
Wash off with soap and plenty of water. Consult a physician. 
In case of eye contact 
Flush eyes with water as a precaution. 
If swallowed 
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 
4.2 Most important symptoms and effects, both acute and delayed 
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in 
section 11 
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4.3 Indication of any immediate medical attention and special treatment needed 
no data available 
 
SECTION 5: Firefighting measures 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Carbon oxides 
5.3 Advice for firefighters 
Wear self contained breathing apparatus for fire fighting if necessary. 
5.4 Further information 
no data available 
 
SECTION 6: Accidental release measures 
6.1 Personal precautions, protective equipment and emergency procedures 
Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. 
For personal protection see section 8. 
6.2 Environmental precautions 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the 
environment must be avoided. 
6.3 Methods and materials for containment and cleaning up 
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed 
containers for disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
SECTION 7: Handling and storage 
7.1 Precautions for safe handling 
Provide appropriate exhaust ventilation at places where dust is formed. 
For precautions see section 2.2. 
7.2 Conditions for safe storage, including any incompatibilities 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.  
7.3 Specific end use(s) 
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated 
 
SECTION 8: Exposure controls/personal protection 
8.1 Control parameters 
Components with workplace control parameters 
8.2 Exposure controls 
Appropriate engineering controls 
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and 
at the end of workday. 
Personal protective equipment 
Eye/face protection 
Use equipment for eye protection tested and approved under appropriate government standards 
such as NIOSH (US) or EN 166(EU). 
 




Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique 
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of 
contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
Wash and dry hands. 
 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and 
the standard EN 374 derived from it. 
 
Full contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
Splash contact 
Material: Nitrile rubber 
Minimum layer thickness: 0,11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, 
test method: EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, 
contact the supplier of the CE approved gloves. This recommendation is advisory only and must 
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of 
anticipated use by our customers. It should not be construed as offering an approval for any 
specific use scenario. 
 
Body Protection 
Choose body protection in relation to its type, to the concentration and amount of dangerous 
substances, and to the specific work-place., The type of protective equipment must be selected 
according to the concentration and amount of the dangerous substance at the specific workplace. 
Respiratory protection 
Respiratory protection is not required. Where protection from nuisance  levels of dusts are desired, 
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and 
approved under appropriate government standards such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into 
the environment must be avoided. 
 
SECTION 9: Physical and chemical properties 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: crystalline 
Colour: white 
b) Odour no data available 
c) Odour Threshold no data available 
d) pH no data available 
e) Melting point/freezing 
point 
Melting point/range: 69 - 73 °C - lit. 
f) Initial boiling point and 
boiling range 
265 °C - lit. 
g) Flash point 127,0 °C - closed cup 
h) Evapouration rate no data available 
i) Flammability (solid, gas) no data available 
j) Upper/lower no data available 
 





k) Vapour pressure 0,01 hPa at 20,0 °C 
l) Vapour density no data available 
m) Relative density 1,05 g/cm3 at 20 °C 
n) Water solubility 0,0004 g/l at 20 °C - slightly soluble 
o) Partition coefficient: n-
octanol/water 






no data available 
r) Viscosity 3,47 mm2/s at 80 °C -  
s) Explosive properties no data available 
t) Oxidizing properties no data available 
9.2 Other safety information 
 Solubility in other 
solvents 
Toluene  - soluble 
Methanol  - soluble 
Acetone  - soluble 
 Dissociation constant 12,2 
 
SECTION 10: Stability and reactivity 
10.1 Reactivity 
no data available 
10.2 Chemical stability 
Stable under recommended storage conditions. 
10.3 Possibility of hazardous reactions 
no data available 
10.4 Conditions to avoid 
no data available 
10.5 Incompatible materials 
Acid chlorides, Acid anhydrides, Oxidizing agents, Bases, Brass, Copper 
10.6 Hazardous decomposition products 
Other decomposition products - no data available 
In the event of fire: see section 5 
 
SECTION 11: Toxicological information 
11.1 Information on toxicological effects 
Acute toxicity 
LD50 Oral - rat - male and female - > 6.000 mg/kg 
(OECD Test Guideline 401) 
 
LD50 Dermal - rat - male and female - > 2.000 mg/kg 
(OECD Test Guideline 402) 
 
Skin corrosion/irritation 
no data available 
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Serious eye damage/eye irritation 
Eyes - rabbit 
Result: No eye irritation 
(Read-across (Analogy)) 
 
Respiratory or skin sensitisation 
no data available 
Germ cell mutagenicity 
Ames test 








This product is or contains a component that is not classifiable as to its carcinogenicity based on its IARC, 
ACGIH, NTP, or EPA classification. 
 
IARC: 3 - Group 3: Not classifiable as to its carcinogenicity to humans (2,6-di-tert-Butyl-p-cresol) 
Reproductive toxicity 
no data available 
Specific target organ toxicity - single exposure 
no data available 
Specific target organ toxicity - repeated exposure 
no data available 
Aspiration hazard 
no data available 
Additional Information 
Repeated dose toxicity - rat - male and female - Oral - No observed adverse effect level - 25 mg/kg 
RTECS: GO7875000 
 




SECTION 12: Ecological information 
12.1 Toxicity 
 
Toxicity to fish LC50 - Oryzias latipes - 5,3 mg/l  - 48 h 
 
Toxicity to daphnia and 
other aquatic 
invertebrates 
static test EC50 - Daphnia magna (Water flea) - 0,48 mg/l  - 48 h 
(OECD Test Guideline 202) 
 
Toxicity to bacteria Growth inhibition EC50 - Protozoa - 1,7 mg/l  - 24 h 
12.2 Persistence and degradability 
no data available 
12.3 Bioaccumulative potential 
no data available 
12.4 Mobility in soil 
no data available 
12.5 Results of PBT and vPvB assessment 
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted 
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12.6 Other adverse effects 
Very toxic to aquatic life with long lasting effects. 
 
SECTION 13: Disposal considerations 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material 
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.  
Contaminated packaging 
Dispose of as unused product.  
 
SECTION 14: Transport information 
14.1 UN number 
ADR/RID: 3077 IMDG: 3077 IATA: 3077 
14.2 UN proper shipping name 
ADR/RID:  ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (2,6-di-tert-Butyl-p-cresol) 
IMDG:  ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (2,6-di-tert-Butyl-p-cresol) 
IATA:  Environmentally hazardous substance, solid, n.o.s. (2,6-di-tert-Butyl-p-cresol) 
14.3 Transport hazard class(es) 
ADR/RID: 9 IMDG: 9 IATA: 9 
14.4 Packaging group 
ADR/RID: III IMDG: III IATA: III 
14.5 Environmental hazards 
ADR/RID: yes IMDG Marine pollutant: yes IATA: yes 
14.6 Special precautions for user 
 
Further information 
EHS-Mark required (ADR 2.2.9.1.10, IMDG code 2.10.3) for single packagings and combination 
packagings containing inner packagings with Dangerous Goods > 5L for liquids or > 5kg for solids. 
 
SECTION 15: Regulatory information 
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture  
   
no data available 
 
15.2 Chemical Safety Assessment 
For this product a chemical safety assessment was not carried out 
 
 
SECTION 16: Other information 
Full text of H-Statements referred to under sections 2 and 3. 
Aquatic Acute Acute aquatic toxicity 
Aquatic Chronic Chronic aquatic toxicity  
H400 Very toxic to aquatic life. 
H410 Very toxic to aquatic life with long lasting effects. 
Full text of R-phrases referred to under sections 2 and 3 
N Dangerous for the environment  
R50/53 Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic 
environment.  
 




Copyright 2014 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use 
only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be 
used only as a guide. The information in this document is based on the present state of our knowledge 
and is applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Sigma-Aldrich Corporation and its Affiliates shall not be held 
liable for any damage resulting from handling or from contact with the above product. See www.sigma-
aldrich.com and/or the reverse side of invoice or packing slip for additional terms and conditions of sale. 
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SIGMA-ALDRICH sigma-aldrich.com 
SAFETY DATA SHEET 
according to Regulation (EC) No. 1907/2006 
Version 5.0 Revision Date 24.05.2012 
Print Date 15.08.2017 
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA 
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 
1.1 Product identifiers 
Product name : Bismuth neodecanoate 
 
Product Number : 544132 
Brand : Aldrich 
CAS-No. : 34364-26-6 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 




Telephone : +32 3 899 1301 
Fax : +32 3 899 1311 
E-mail address : eurtechserv@sial.com 
1.4 Emergency telephone number 
Emergency Phone # : +(32) 28 083237 (CHEMTREC)                                                                   
070 245245 (Anti-poison centre) 
 
2. HAZARDS IDENTIFICATION 
2.1 Classification of the substance or mixture 
 
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. 
This substance is not classified as dangerous according to Directive 67/548/EEC.  
2.2 Label elements 
The product does not need to be labelled in accordance with EC directives or respective national laws. 
2.3 Other hazards - none 
 
3. COMPOSITION/INFORMATION ON INGREDIENTS 
3.1 Substances 
Formula : C30H57BiO6  
Molecular Weight : 722,75 g/mol 
 
 
4. FIRST AID MEASURES 
4.1 Description of first aid measures 
If inhaled 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. 
In case of skin contact 
Wash off with soap and plenty of water. 
In case of eye contact 
Flush eyes with water as a precaution. 
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If swallowed 
Never give anything by mouth to an unconscious person. Rinse mouth with water. 
4.2 Most important symptoms and effects, both acute and delayed 
4.3 Indication of any immediate medical attention and special treatment needed 
no data available 
 
5. FIREFIGHTING MEASURES 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Carbon oxides, Bismuth oxides 
5.3 Advice for firefighters 
Wear self contained breathing apparatus for fire fighting if necessary. 
5.4 Further information 
no data available 
 
6. ACCIDENTAL RELEASE MEASURES 
6.1 Personal precautions, protective equipment and emergency procedures 
Avoid breathing vapors, mist or gas. 
6.2 Environmental precautions 
Do not let product enter drains. 
6.3 Methods and materials for containment and cleaning up 
Keep in suitable, closed containers for disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
7. HANDLING AND STORAGE 
7.1 Precautions for safe handling 
Normal measures for preventive fire protection. 
7.2 Conditions for safe storage, including any incompatibilities 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are 
opened must be carefully resealed and kept upright to prevent leakage.  
7.3 Specific end uses 
no data available 
 
8. EXPOSURE CONTROLS/PERSONAL PROTECTION 
8.1 Control parameters 
Components with workplace control parameters 
8.2 Exposure controls 
Appropriate engineering controls 
General industrial hygiene practice. 
Personal protective equipment 
Eye/face protection 
Use equipment for eye protection tested and approved under appropriate government standards 
such as NIOSH (US) or EN 166(EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique 
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of 
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contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
Wash and dry hands. 
 
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and 
the standard EN 374 derived from it. 
 
Body Protection 
impervious clothing, The type of protective equipment must be selected according to the 
concentration and amount of the dangerous substance at the specific workplace. 
Respiratory protection 
Respiratory protection not required. For nuisance exposures use type OV/AG (US) or type ABEK 
(EU EN 14387) respirator cartridges. Use respirators and components tested and approved under 
appropriate government standards such as NIOSH (US) or CEN (EU). 
 
9. PHYSICAL AND CHEMICAL PROPERTIES 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: liquid 
Colour: light yellow 
b) Odour no data available 
c) Odour Threshold no data available 
d) pH no data available 
e) Melting point/freezing 
point 
no data available 
f) Initial boiling point and 
boiling range 
300 °C 
g) Flash point > 110,00 °C - closed cup 
h) Evaporation rate no data available 




no data available 
k) Vapour pressure no data available 
l) Vapour density no data available 
m) Relative density 1,145 g/mL at 25 °C 
n) Water solubility no data available 
o) Partition coefficient: n-
octanol/water 
no data available 
p) Autoignition 
temperature 
no data available 
q) Decomposition 
temperature 
no data available 
r) Viscosity no data available 
s) Explosive properties no data available 
t) Oxidizing properties no data available 
9.2 Other safety information 
no data available 
 
10. STABILITY AND REACTIVITY 
10.1 Reactivity 
no data available 
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10.2 Chemical stability 
no data available 
10.3 Possibility of hazardous reactions 
no data available 
10.4 Conditions to avoid 
no data available 
10.5 Incompatible materials 
Strong oxidizing agents 
10.6 Hazardous decomposition products 
Other decomposition products - no data available 
 
11. TOXICOLOGICAL INFORMATION 
11.1 Information on toxicological effects 
Acute toxicity 
no data available 
Skin corrosion/irritation 
no data available 
Serious eye damage/eye irritation 
no data available 
Respiratory or skin sensitization 
no data available 
Germ cell mutagenicity 
no data available 
Carcinogenicity 
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
Reproductive toxicity 
no data available 
Specific target organ toxicity - single exposure 
no data available 
Specific target organ toxicity - repeated exposure 
no data available 
Aspiration hazard 
no data available 
Potential health effects 
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.  
Ingestion May be harmful if swallowed.  
Skin May be harmful if absorbed through skin. May cause skin irritation.  
Eyes May cause eye irritation.  
Additional Information 
RTECS: Not available 
 
12. ECOLOGICAL INFORMATION 
12.1 Toxicity 
no data available 
12.2 Persistence and degradability 
no data available 
12.3 Bioaccumulative potential 
no data available 
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12.4 Mobility in soil 
no data available 
12.5 Results of PBT and vPvB assessment 
no data available 
12.6 Other adverse effects 
no data available 
 
13. DISPOSAL CONSIDERATIONS 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company.  
Contaminated packaging 
Dispose of as unused product.  
 
14. TRANSPORT INFORMATION 
14.1 UN number 
ADR/RID:  -  IMDG:  -  IATA:  -  
14.2 UN proper shipping name 
ADR/RID:  Not dangerous goods 
IMDG:  Not dangerous goods 
IATA:  Not dangerous goods 
14.3 Transport hazard class(es) 
ADR/RID:  -  IMDG:  -  IATA:  -  
14.4 Packaging group 
ADR/RID:  -  IMDG:  -  IATA:  -  
14.5 Environmental hazards 
ADR/RID: no IMDG Marine pollutant: no IATA: no 
14.6 Special precautions for user 
no data available 
 
15. REGULATORY INFORMATION 
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture 
no data available 
15.2 Chemical Safety Assessment 
no data available 
 
16. OTHER INFORMATION 
Further information 
Copyright 2012 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use 
only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be 
used only as a guide. The information in this document is based on the present state of our knowledge 
and is applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Sigma-Aldrich Corporation and its Affiliates shall not be held 
liable for any damage resulting from handling or from contact with the above product. See www.sigma-





Revision date  2017-03-30 Revision number  3.05
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE
COMPANY/UNDERTAKING
1.1  Product identifier  
Product name BISOMERÒ PEA 6
Product code 745785
Synonyms None
1.2  Relevant identified uses of the substance or mixture and uses advised against  
Recommended use [RU] Monomer for special polymers
Uses advised against None known
1.3  Details of the supplier of the safety data sheet  
Responsibility Statement For further information, please contact  safety-data-sheet-fp@geosc.com
1.4  Emergency telephone number  
Emergency telephone 24 Hour Emergency Phone Number
GEO Specialty Chemicals UK Ltd
+44 (0)23 80891806
2. HAZARDS IDENTIFICATION
2.1  Classification of the substance or mixture  
Classification according to Regulation (EC) No. 1272/2008 [CLP]  
Skin Corrosion/Irritation Category 2
Serious eye damage/eye irritation Category 2
Skin sensitization Category 1
2.2  Label elements  
Labeling according to Regulation (EC) No. 1272/2008 [CLP]  
_____________________________________________________________________________________________
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Supplier
GEO Specialty Chemicals UK Ltd
Charleston Road, Hardley, Hythe
Southampton, Hampshire SO45 3ZG
United Kingdom
Phone: +44 (0)23 80894666
Fax No: +44 (0)23 80243113
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Signal word  WARNING
Hazard statements  
H315 - Causes skin irritation
H317 - May cause an allergic skin reaction
H319 - Causes serious eye irritation
Precautionary statements
P262 - Do not get in eyes, on skin, or on clothing
P280 - Wear protective gloves/protective clothing/eye protection/face protection
P303 + P361 + P353 - IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with
water/shower
P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and
easy to do. Continue rinsing
Special labeling of certain preparations  Contains 4-Methoxyphenol. May produce an allergic reaction
2.3  Other Information  
None known
3. COMPOSITION/INFORMATION ON INGREDIENTS
3.1  Substances  
Component EU EINECS weight-% Classification according to Regulation
(EC) No. 1272/2008 [CLP]
(REACh) Regulation (EC
1907/2006)
Acrylate oligomers Not applicable > 65 - < 80% Not Classified as Hazardous In compliance
Polyethylene Glycol
 25322-68-3
Not applicable > 15 - < 25% Not Classified as Hazardous In compliance
Acrylic acid, 2-hydroxyethyl ester
 818-61-1
212-454-9 < 8% Acute Tox. 3 (H311)
Skin Corr. 1B (H314)
Skin Sens. 1 (H317)




205-769-8 <= 0.15% Acute Tox. 4 (H302)
Eye Irrit. 2 (H319)
Skin Sens. 1 (H317)
Repr. 2 (H361d)
Aquatic Chronic 3 (H412)
In compliance
For the full text of the H-Statements mentioned in this Section, see Section 16.  
3.2  Mixtures  
Not applicable
4. FIRST AID MEASURES
4.1  Description of first aid measures  
General advice
In case of adverse health effects seek medical advice.
_____________________________________________________________________________________________
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Eye contact
Remove contact lenses, if worn. Immediately flush with plenty of water for at least 10 minutes, holding eyelids apart to ensure
flushing of the entire surface. Seek medical advice immediately.
Skin contact
Rinse with running water and soap. Remove contaminated clothing and shoes.
Ingestion
Rinse mouth with water, then drink one or two glasses of water. Do NOT induce vomiting. Never give anything by mouth to an
unconscious person. If vomiting should occur spontaneously, keep airway clear. Get medical attention.
Inhalation
Remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical attention.
4.2  Most important symptoms and effects, both acute and delayed  
Most important symptoms and effects
No information available.
Chronic effects
Repeated or prolonged exposure may result in liver or kidney damage.




5.1  Extinguishing media  
Suitable extinguishing media
Water spray jet, Alcohol-resistant foam, Extinguishing powder, Carbon dioxide.
Extinguishing media which must not be used for safety reasons
High pressure waterjet.
5.2  Special hazards arising from the substance or mixture  
Special Hazard
Formation of toxic gases is possible during heating or in fires.  The product may undergo spontaneous polymerization at high
temperatures.  Polymerization is exothermic and may cause damage to the container and/or release of thermal decomposition
products.
5.3  Advice for firefighters  
Special protective equipment for firefighters
Firefighters should wear self-contained breathing apparatus and full firefighting turnout gear.
Firefighting measures
Cool exposed containers with water spray after extinguishing fire.
6. ACCIDENTAL RELEASE MEASURES
6.1  Personal precautions, protective equipment and emergency procedures  
Personal precautions
Wear suitable protective clothing and gloves.
6.2  Environmental precautions  
_____________________________________________________________________________________________
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Environmental precautions
Do not empty into drains/surface water/ground water. Inform authorities in the event of product spillage to water courses or
sewage systems.
6.3  Methods and material for containment and cleaning up  
Methods for cleaning up
Remove with liquid-absorbing material (sand, peat, sawdust). Dispose of contaminated material as waste according to Section
13.
6.4  Reference to other sections  
See Section 12 for additional Ecological Information
7. HANDLING AND STORAGE
7.1  Precautions for safe handling  
Advice on safe handling
Avoid contact with eyes, skin and clothing
Avoid breathing vapor or mist
Use only in well-ventilated areas
Personal protective equipment comprising: suitable protective gloves, safety goggles and protective clothing.
Wash thoroughly after handling
Ensure that eyewash stations and safety showers are close to the workstation location
7.2  Conditions for safe storage, including any incompatibilities  
Technical measures and storage conditions
The product is stabilized against spontaneous polymerization before delivery.  However, if the permissible storage time or
storage temperature are greatly exceeded the product may polymerize.
Keep only in the original container in a cool, well-ventilated place
Store at temperatures not exceeding 25  °C/ 77 °F
Store in a dry place. Store away from direct heat or sunlight.
Tanks should preferably contain no dead spaces where the product can be trapped and polymerize. Internal structural
members should therefore be kept to a minimum and tanks should be welded.
Storage tank vents, especially those fitted with flame arrestors, should be inspected regularly for polymer fouling which can
arise from vapor phase polymerization.
Do not store together with reductants.
Do not store together with oxidants.
7.3  Specific end use(s)  
Specific use(s)
 Not applicable
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
8.1  Control parameters  
Occupational exposure limit value  
Component European Union United Kingdom Spain Germany Turkey
Polyethylene Glycol
 25322-68-3
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Component Ireland France Italy Portugal
4-Methoxyphenol
 150-76-5
TWA: 5 mg/m3 TWA: 5 mg/m3 NAV TWA: 5 mg/m3










TWA: 5 mg/m3 NAV TWA: 5 mg/m3
Skin
Component Finland Norway Denmark Netherlands
4-Methoxyphenol
 150-76-5
NAV STEL: 10 mg/m3
TWA: 5 mg/m3
TWA: 5 mg/m3 NAV
Biological limit values  
Component European Union United Kingdom Spain Germany Turkey
Polyethylene Glycol
 25322-68-3
NAV NAV NAV NAV NAV
4-Methoxyphenol
 150-76-5
NAV NAV NAV NAV NAV
Legend
NAV - Not available
8.2  Exposure controls  
Personal Protective Equipment 
Eye/face Protection
If splashes are likely to occur: Chemical Goggles.
Hand Protection
Polychloroprene gloves.  Coating thickness 1.1 mm.  Level 5 > 240 min breakthrough time.
Skin and body protection
Wear suitable protective clothing.
Respiratory protection
Filter A2 is recommended in cases of prolonged exposure.
Other personal protection data
Eyewash fountains and safety showers must be easily accessible.
Hygiene measures
Handle in accordance with good industrial hygiene and safety practice.
Environmental exposure controls
No information available.
9. PHYSICAL AND CHEMICAL PROPERTIES





Odor threshold No information available
Property  Values  Remarks  
pH No information available No information available
_____________________________________________________________________________________________
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9.2  Other information  
Bulk Density No information available
Explosive properties Can polymerize violently.
Oxidizing properties The substance or mixture is not classified as oxidizing.
Softening point No information available
Molecular weight 336  g/mol
Volatile Organic Compound (VOC) content, wt.% No information available
Percent Volatile, wt.% No information available
10. STABILITY AND REACTIVITY
10.1  Reactivity  
Reactivity
Polymerizes readily unless inhibited. Polymerization is highly exothermic and, if not controlled, may be violent.
10.2  Chemical stability  
Chemical stability
Stable under normal conditions of handling, use and transportation. Periodic air sparging in storage will assist long term
stability.
10.3  Possibility of hazardous reactions  
Melting / freezing point No information available No information available
Boiling point / boiling range No information available No information available
Flash point >  100.0  °C  /  >  212  °F CC (closed cup)
Evaporation rate No information available No information available
Flammability (solid, gas) No information available No information available
Flammability Limit in Air
Upper flammability limit No information available No information available
Lower flammability limit No information available No information available
Vapor pressure No information available No information available
Vapor density No information available No information available
Specific gravity  No information available No information available
Solubility (water) Soluble No information available
Solubility in other solvents No information available No information available
Partition coefficient: n-octanol/water < 2.27 A8 92/69/EEC
Autoignition temperature No information available No information available
Decomposition temperature No information available No information available
Kinematic viscosity No information available No information available
Dynamic viscosity No information available No information available
Density  1.1220  g/cm3 ASTM D 1298-99
_____________________________________________________________________________________________
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Hazardous polymerization
May occur if inhibitor is depleted or if exposed to high temperature.
10.4  Conditions to avoid  
Conditions to avoid
This product contains a peroxidation inhibitor. To maintain inhibitor activity, oxygen must not be eliminated from the
atmosphere above the product. Avoid radical forming substances (metal-ions, peroxides). Avoid heating. If prolonged
excursions above the recommended storage temperature occur, then the rate of inhibitor depletion could accelerate, leading to
an increased risk of polymerization. In these circumstances it is recommended that the inhibitor level be checked periodically
using ASTM procedure D 3125, and more inhibitor added if depletion is observed.
10.5  Incompatible materials  
Materials to avoid
Reaction with reducing agents. Reaction with oxidants.
10.6  Hazardous decomposition products  
Hazardous decomposition products
Carbon monoxide. Carbon dioxide. Irritating vapors.
11. TOXICOLOGICAL INFORMATION
11.1  Information on toxicological effects  




Irritating to skin. May cause sensitization by skin contact.
Ingestion
May be harmful if swallowed.
Inhalation
Vapors may be irritating.
Acute toxicity 
Oral LD50 > 2,000 mg/kg
Method: OECD Test No. 401: Acute Oral Toxicity
Dermal LD50 > 2,000 mg/kg
Method: OECD Test No. 402: Acute Dermal Toxicity
Inhalation LC50 No information available
Skin corrosion/irritation
Irritating (Experiment)
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Mutagenicity






Specific target organ toxicity - Single exposure
No information available





12.1  Toxicity  
Acute aquatic toxicity  
Fish No information available
Crustacea EC50 (48 hour) > 10 - <= 100
Algae/aquatic plants No information available




Good biodegradability. All organic substances contained in the product achieve > 60% BOD/COD or CO2 liberation, or > 70%
DOC reduction in tests for ease of degradability.
12.3  Bioaccumulative potential  
Bioaccumulative potential
No information available
12.4  Mobility in soil  
Mobility
No information available.
12.5  Results of PBT and vPvB assessment  
PBT and vPvB assessment
No information available
12.6  Other adverse effects  
Other information
No other ecological studies have been carried out on this product.
_____________________________________________________________________________________________
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14. TRANSPORT INFORMATION
US DOT  Not regulated
14.1. UN number
14.2. UN proper shipping name
14.3. Transport hazard class(es)
14.4. Packing group
14.5. Environmental hazards
14.6. Special precautions for user
Land transport (ADR/RID)  Not regulated
14.1. UN number
14.2. UN proper shipping name
14.3. Transport hazard class(es)
14.4. Packing group
14.5. Environmental hazards
14.6. Special precautions for user
Inland waterway transport (ADN)  Not regulated
14.1. UN number
14.2. UN proper shipping name
14.3. Transport hazard class(es)
14.4. Packing group
14.5. Environmental hazards
14.6. Special precautions for user
Air transport (ICAO-TI / IATA-DGR)  Not regulated
14.1. UN number
14.2. UN proper shipping name
14.3. Transport hazard class(es)
14.4. Packing group
14.5. Environmental hazards
14.6. Special precautions for user
Sea transport (IMDG)  Not regulated
14.1. UN number
14.2. UN proper shipping name
14.3. Transport hazard class(es)
14.4. Packing group
14.5. Environmental hazards
14.6. Special precautions for user
14.7  Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code  
Not applicable
13. DISPOSAL CONSIDERATIONS
13.1  Waste treatment methods  
Disposal of wastes
Waste incineration with the approval of the responsible local authority.
Contaminated packaging
Packaging that cannot be cleaned are to be disposed of in the same manner as the product. Disposal must be made according
to official regulations.
_____________________________________________________________________________________________
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Full text of H-Statements referred to under sections 2 and 3
H315 - Causes skin irritation
H317 - May cause an allergic skin reaction
H319 - Causes serious eye irritation
H302 - Harmful if swallowed
H311 - Toxic in contact with skin
15. REGULATORY INFORMATION
15.1  Safety, health and environmental regulations/legislation specific for the substance or mixture  
International Inventories  
Australia (AICS)
Some ingredients are not on the inventory.
Canada (DSL)
Some ingredients are not on the inventory.
Canada (NDSL)
Some ingredients are on the inventory.
China (IECSC)
All ingredients are on the inventory or exempt from listing
European Union (EINECS)
All ingredients are on the inventory or exempt from listing
European Union (ELINCS)
None of the ingredients are on the inventory.
Japan (ENCS)
All ingredients are on the inventory or exempt from listing
South Korea (KECL)
All ingredients are on the inventory or exempt from listing
Philippines (PICCS)
Some ingredients are not on the inventory.
United States (TSCA)
All ingredients are on the inventory or exempt from listing
Legend 
 AICS  - Australian Inventory of Chemical Substances
 DSL/NDSL  - Canadian Domestic Substances List/Non-Domestic Substances List
 IECSC  - China Inventory of Existing Chemical Substances
 EINECS/ELINCS  - European Inventory of Existing Commercial Chemical Substances/EU List of Notified Chemical Substances
 ENCS  - Japan Existing and New Chemical Substances
 KECL  - Korean Existing and Evaluated Chemical Substances
 PICCS  - Philippines Inventory of Chemicals and Chemical Substances
 TSCA  - United States Toxic Substances Control Act Section 8(b) Inventory
15.2  Chemical Safety Report  
_____________________________________________________________________________________________
Page  10 / 11
No information available.
_____________________________________________________________________________________________
745785 -  BISOMERÒ PEA 6 Revision date  2017-03-30
H314 - Causes severe skin burns and eye damage
H361d - Suspected of damaging the unborn child
H400 - Very toxic to aquatic life
H412 - Harmful to aquatic life with long lasting effects
Key or legend to abbreviations and acronyms used in the safety data sheet
NAV - Not available
This safety data sheet complies with the requirements of:  Regulation (EC) No. 1907/2006.
Additional information
BISOMERÒ is a registered trademark of GEO Specialty Chemicals UK Ltd.
Disclaimer
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The
information given is designed only as a guidance for safe handling, use, processing, storage, transportation, disposal and release and is not to be
considered a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such
material used in combination with any other materials or in any process, unless specified in the text.
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